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Abstract 
Since 1980, the global prevalence of obesity has more than doubled. According 
to the World Health Organization (WHO) more than one in ten of the world’s 
adult population are now obese. The prevalence of obesity is high both in the 
developed and developing countries, leading to suggestions of an “obesity 
pandemic” or “globesity”. In Scotland alone, 28% of adults are now obese, and a 
further 36% are overweight. Historically, the main focus of healthcare has been 
the avoidance of preventable mortality. As life-expectancy has increased, 
attention has focused on the need to improve health, as well as longevity. The 
WHO definition of health encompasses mental and social, as well as physical, 
well-being. It is widely accepted that obesity causes, or aggravates, a number of 
medical conditions, and is also associated with reduced life-expectancy. 
However, the research on adiposity and subjective well-being is still in its 
infancy and previous studies suggest that the relationship is complex.   
This thesis starts by demonstrating the importance of subjective well-being in 
terms of its association with adverse outcomes: all-cause death, coronary heart 
disease (CHD), cancer incidence, and psychiatric hospitalisations. This is 
followed by six complementary studies that explore the relationship between 
adiposity and subjective well-being. Subjective well-being is explored using 
various approaches including self-reported health (SRH), health-related quality 
of life (overall, physical and mental/psychosocial), mental health and mood 
disorder, and adiposity is assessed using four measures:  body mass index (BMI), 
waist circumference (WC), waist-to-hip ratio (WHR) and body fat percentage 
(BF%) across the whole range of adiposity (from underweight to class III obese).  
The first study (chapter 2) examined the association between SRH and mental 
health (measured using the General Health Questionaire-12 [GHQ-12]), and long-
term adverse outcomes over 17 years of follow-up among 19,625 Scottish adults. 
Poor SRH was a significant independent predictor of a range of adverse clinical 
outcomes, including incident cancer, CHD events, psychiatric hospitalisations 
and all-cause mortality. There was evidence of dose relationships and the 
associations remained significant after adjustment for mental health. The 
associations between poor mental health and non-psychiatric outcomes were 
  
 
3 
 
mediated by SRH, but poor mental health was an independent predictor of 
psychiatric hospitalisations.  
The second study (chapter 3) examined whether health-related quality of life 
(HRQoL) was an independent predictor of the long-term adverse outcomes over 8 
years of follow-up, among 5,272 Scottish adults recruited from the general 
population. Being in the lowest quintile of physical HRQoL (worst HRQoL) was a 
strong independent predictor of all-cause death, incident cancer, and CHD 
events, compared to the highest quintile. Mental HRQoL was not associated with 
incident cancer and CHD. 
The third and fourth studies (chapter 4 and 5) collated the existing evidence. 
The third study (chapter 4) was a meta-analysis of the published literature on 
the separate relationships between adult obesity and mental and physical 
HRQoL. It comprised a total of 43,086 participants. Different patterns were 
observed for physical and mental HRQoL. In comparison with normal weight 
adults, mental HRQoL was reduced among class III obese adults and increased 
among overweight. In contrast, both overweight and obese adults had 
significantly reduced physical HRQoL with a clear dose relationship across all 
categories of adiposity.  
The fourth study (chapter 5) was a meta-analysis of the published literature on 
the relationship between childhood and adolescent obesity and HRQoL. It 
comprised a total of 13,210 participants. Obese children and adolescents 
reported significantly reduced overall, physical and psychosocial HRQoL with a 
clear dose relationship across all categories of adiposity. Parents reported the 
same pattern but a larger effect size.  
The fifth study (chapter 6) assessed the association between adiposity and 
overall HRQoL, and whether it varied by sex and comorbidity, among 5,608 
Scottish adults. There were significant interactions of BMI with sex (p<0.001) and 
with metabolic comorbidity (p=0.007). Being overweight was associated with 
significantly higher utility scores (indicating the overall HRQoL of the individuals, 
ranges from 0 “death” to 1 “full health) in men only. In contrast, being 
underweight and obese was associated with significantly lower utility score in 
women only. Individuals with metabolic comorbidity had lower utility scores and 
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a steeper decline in utility with increasing BMI. However, increased BMI was 
associated with reduced HRQoL, even in the absence of metabolic comorbidity, 
casting doubt on the notion of “healthy obesity” (obesity in the absence of 
metabolic comorbidity). 
The sixth study (chapter 7) investigated the relationship between BMI and self-
reported mental health (assessed by the GHQ-12), and whether it varied by sex 
among 37,272 Scottish adults. Overall, overweight participants reported better 
mental health than the normal-weight group, and underweight, class II or class 
III obese individuals had poorer mental health. However, the adverse 
associations between adiposity and mental health were specific to women. In 
contrast, overweight men had better mental health than normal weight men. 
The seventh study (chapter 8) investigated the associations between four 
different measurements of adiposity (BMI, WC, WHR and BF%) and probable 
major depression and whether they varied by sex, among 140,564 middle-aged 
UK Biobank participants. Overall, both overweight and obese individuals were 
significantly more likely to have probable major depression with evidence of 
dose relationship, irrespective of the measurement used. The relationship 
between adiposity and depression varied significantly by sex, such that the 
overall association was largely driven by women. In contrast, only men with class 
III obesity were at significantly increased risk of major depression 
The eight study (chapter 9) explored the relationship between the same four 
measurements of adiposity (BMI, WC, WHR and BF%) and self-reported poor 
health and unhappiness among 163,066 middle-aged UK Biobank participants. 
Obesity was associated with both unhappiness and poor SRH, but the association 
with unhappiness was no longer statistically significant after adjustment for SRH, 
indicating this may be mediated by poor health. Compared with obese men, 
obese women were less likely to report poor health but more likely to feel 
unhappy.  
In summary, poor subjective well-being was a significant independent predictor 
of a range of adverse outcomes, including mortality. There were overall 
associations between obesity and different measures of subjective well-being 
including: poor physical and mental HRQoL, poor SRH, unhappiness, and poor 
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mental health. However, there were significant differences between men and 
women. Compared with obese men, obese women were less likely to report poor 
physical health but more likely to report poor mental health and unhappiness. 
Furthermore, only severely obese men reported poorer well-being, whereas the 
adverse associations between adiposity and well-being were apparent in all 
groups of women with above normal weight. This thesis provides further 
evidences to support the injurious effects of obesity on all aspects of health, and 
supports the need to take action to reverse the higher prevalence of obesity. 
Subjective well-being should be considered by health care providers and policy 
makers in addition to objective measures of health risk, when devising strategies 
to improve individual and population health.  
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MVPA  moderate to vigorous physical activity 
NHS  National Health Service 
OECD  Organisation for Economic Co-operation and Development 
OR  odds ratio 
PCS  physical component summary  
PedsQL Pediatric Quality of Life Inventory 
Qol  quality of life 
RR  relative risk 
SD  standard deviation 
SF  short form 
SHeS  Scottish Health Survey 
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SIMD  Scottish Index of Multiple Deprivation 
SMR  Scottish Morbidity Record 
SRH  self-reported health 
UK  United Kingdom 
USA   United States of America 
WC  waist circumference 
WHO  World Health Organization 
WHR  waist-to-hip ratio 
WMD  weighted mean difference 
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1.1 Chapter outline 
In this chapter, a general introduction of the adiposity is presented along with a 
discussion on the development, measurements, and trends of adiposity. A short 
overview of subjective well-being and its association with adiposity is also 
discussed. Finally the aims and objectives of this thesis are discussed. 
Section 1.2: Introduction and causes of adiposity 
Section 1.3: Measurements of adiposity 
Section 1.4: Trends of adiposity 
Section 1.5: Impact of adiposity on physical health 
Section 1.6: Adiposity and mortality 
Section 1.7: Introduction of subjective well-being and its different measures  
Section 1.8: Association between adiposity and subjective well-being 
Section 1.9: Summary of the introduction 
Section 1.10: Aims and objectives of this thesis 
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Introduction 
“Overweight”, “obesity” and “adiposity” are terms used to describe the 
accumulation of abnormal or excessive body fat that may impair individuals’ 
health and well-being (World Health Organization 2013). The fundamental cause 
of adiposity (overweight and obesity) is imbalance between energy intake and 
output. When calorie intake exceeds calorie expenditure, the remainder energy 
is stored as “fat” throughout the body, in specialized cells called adipocytes. On 
average, the human body stores around 50,000 to 60,000 kilocalories of energy 
in adipocytes (Coyle 1995). A normal weight adult has about 130,000 kilocalories 
of energy stored in around 35 billion fats cells, while morbidly obese adult can 
have about 1 million kilocalories of energy stored in around 140 billion fats cells 
(Hall KD et al. 2012). This stored energy works as fuel for most body organs, 
including the liver, muscle and heart. The function of adipocytes was thought to 
be limited to the passive storage and release of fat but recently, they have been 
recognized as being a critical component of metabolic control and as endocrine 
organs that have both beneficial and harmful effects (Kershaw & Flier 2004). 
Obesity is associated with increases in both adipocyte number and size. It has 
been documented that when human body weight exceeds 170% of the healthy 
range, the size of fat cells doubles (Hirsch & Batchelor 1976).  
1.2 Development of adiposity 
The development of adiposity is a complex, multifactorial process that is 
influenced by lifestyle, genetic and environmental factors as described below. 
1.2.1 Lifestyle factors 
Lifestyle factors that are strongly associated with adiposity include high energy 
dietary intake, sedentary behavior and low levels of physical activity.  
1.2.1.1 Diet 
Easily available food which is high in fat and added sugar and low in fibre and 
starch predisposes to obesity. Caloric intake can be reduced by avoiding energy 
dense food and drinks and increasing the consumption of vegetables which have 
high fibre content. Reducing daily intake by 600 calories (20-25% of energy 
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intake) can achieve the recommended loss of 0.5 kg per week (McNeill & 
Cummings 2004). The intake of sugar-sweetened soft drinks is independently 
associated with a significant increase in body weight (Ludwig et al. 2001), and 
avoiding these alone can achieve significant reductions in weight (Ebbeling et al. 
2006). In a large study, conducted across 25 different countries, Scottish 
children had the second highest intake of sweetened drinks, after Israel, with 
more than 40% of Scottish children consuming sweetened drinks on a daily basis, 
(Candace et al. 2004). In the same study, Scottish children were also ranked 
third in terms of the consumption of sweets, after Malta and Netherlands. In 
another study, Scottish children were found to obtain 17.4% of their food energy 
from non-milk extrinsic sugar which is higher than the UK recommendation of 
11% (McNeill et al. 2010). The authors concluded that, changing this unhealthy 
dietary behaviour would require the support and involvement of family, schools, 
retailers, advertisers and food policy makers.  
A recently published systematic review of systematic reviews advocated caution 
when reading the results of industry sponsored research on the association 
between sugar sweetened beverages and weight gain or adiposity (Bes-Rastrollo 
et al. 2013). Of the 12 (83.3%) reviews which had no stated conflict of interest, 
10 found a significant association between the consumption of sugar-sweetened 
beverages and weight gain. In contrast, 83.2% (5/6) of the reviews which had 
some form of connection with the food industry report insufficient evidence of a 
positive association. The risk ratio for independent versus industry sponsored 
reviews was 5.0 (95% confidence interval [CI] 1.29, 19.3). 
1.2.1.2 Sedentary behaviour and low physical activity 
The second most important factor in the development of adiposity is sedentary 
behaviour which has been recently re-defined as “any waking behaviour 
characterized by an energy expenditure ≤1.5 metabolic equivalent (METS) while 
in a sitting or reclining posture” (Sedentary Behaviour 2012). In contrast, it was 
suggested that the term “inactive” should be used to describe those “who are 
performing insufficient amounts of moderate to vigorous-intensity physical 
activity (i.e., not meeting specified physical activity guideline”).  
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Sedentary behaviour and low levels of physical activity are consistently reported 
to be associated with adiposity and they often cluster in the same individuals 
(Tremblay et al. 2010). Furthermore, sedentary behaviour increases the 
consumption of high energy diets. In a large, multi-centre, longitudinal study, 
participants aged 9 or 10 years were followed for 18 or 19 years (Kimm et al. 
2005). BMI and skin fold thickness were measured annually and physical activity 
was measured at baseline, 3, 5 and 7-10 years. A reduction in physical activity of 
10 METS per week (equivalent to 30 minutes of brisk walking 2.5 times per week) 
was associated with a significant increase in BMI of 0.14 kg/m2 and 0.09 kg/m2 in 
African and caucasian girls, respectively. At the end of the study, there was a 3 
kg/m2 difference in BMI between active and non-active participants. Similar 
results were observed for skinfold thickness. 
1.2.1.3 Other lifestyle factors 
Other lifestyle factors such as not eating breakfast and increased alcohol 
consumption are also associated with adiposity (Croezen et al. 2009). Most 
studies demonstrate a negative association between smoking and adiposity but 
smokers have more metabolically adverse fat distributions and BMI increases 
with the amount smoked (Kim et al. 2012). Smoking cessation is also associated 
with increased  BMI (Froom et al. 1998).  
Even though current smokers have a lower BMI, advocating smoking as a means 
of reducing BMI would injurious to public health. A large prospective study, 
examined the combined effects of adiposity and smoking on mortality (Koster et 
al. 2008). Current smokers with a high BMI had a 6-8 times higher risk of all-
cause mortality, compared to non-smokers with normal BMI. Similarly, smokers 
with a high WC were at more than 5 times higher risk of all-cause mortality than 
non-smokers with a normal WC.  
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1.2.2 Genetic factors 
Whilst lifestyle factors, such as high energy diets and physical inactivity, are the 
main contributors to obesity, genetic predisposition also plays a role (O'Rahilly & 
Farooqi 2006). Genetic variations have effects on metabolism, tolerance to 
physical activity and appetite which makes a strong argument for their role in 
the current conducive environment for adiposity (Frayling 2012). Genetic 
heritability is estimated to be as high as 70% for BMI and 80% for body fat 
(Andreasen 2009). A study of 37,000 twin pairs was conducted in eight European 
countries, including the United Kingdom (Schousboe et al. 2003). The correlation 
between self-reported BMI was significantly stronger for identical twins (range 
0.65 to 0.83) than non-identical twins (ranges 0.31 to 0.58). Similarly a meta-
analysis of twin and adoption studies was conducted to investigate the impact of 
both genetics and environment on the development of adiposity (Silventoinen et 
al. 2010). Data from nine twin and five adoption studies were extracted and 
analyzed. The analyses of data from twin studies revealed that genetic factors 
made a significant and consistent contribution to BMI at all ages. In contrast, 
common environmental factors were significant in childhood but became non-
significant in adolescence. The analyses of data from adoptive studies 
demonstrated a significant correlation between the role of family environment 
in adoptees’ children and their adoptive parents but it was much stronger 
between children and their biological parents, further supporting the role of 
genetics.  
In the recent past, scientists have identified many genes that predispose to 
obesity (O'Rahilly & Farooqi 2006), the most important of which is “fat mass and 
obesity associated gene or FTO” discovered in 2007 and since analysed in many 
studies (Frayling et al. 2007). A meta-analysis was recently published focusing on 
the interaction between FTO and physical activity (Kilpelainen et al. 2011). 
Forty five studies conducted on a total of 218,166 adults were included. The 
analysis showed that physical activity attenuated the effect of FTO variation on 
BMI. The odds of adiposity, defined using BMI, were reduced by 30%. Interactions 
were also demonstrated for adiposity measured using WC and BF%. These 
findings demonstrate the importance of physical activity in adults who are 
genetically predisposed to obesity.  
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1.2.3 Environmental factors 
There is consistent evidence that highlights the role of genetic predisposition in 
the development of adiposity, but emerging studies reflect that environmental 
factors have a vital contribution as well. The increases prevalence of adiposity 
has occurred predominantly over the past three decades across the globe. This 
rapid change cannot be explained by genetics alone (Stunkard et al. 1990; 
Wilding 2012). In contrast, marked changes occurred in the environment over 
that period that promote sedentary behaviour, increased consumption of energy 
dense food and low physical activity (Cohen 2008). In the last few decades, a 
remarkable change has occurred in food production which is often called the 
“green revolution”. This has been made possible by new research such as 
advancement in molecular genetics and increased use of modern technology, 
including new irrigation projects, sophisticated cultivators, fertilizer, pesticides, 
herbicides and seed development. It is now possible to plant multiple cycles of 
crops in the same year. This increased production has made food more 
affordable. Moreover, the accessibility of food has risen enormously due to the 
increased number and type of food outlets. Energy dense food is now available 
in grocery stores, hardware stores, petrol stations, leisure facilities and 
workplaces, in addition of vending machines which are installed in many public 
places. Also by applying new marketing techniques and advertisements, 
individuals are encouraged to chose branded energy dense foods (Pieters et al. 
2002).     
In addition to increased food production and accessibility, low prices, and 
stimulation of individuals towards the use of energy dense food, the requirement 
of physical activity has been significantly reduced over the past few decades 
(Hill & Peters 1998). The increased use of cars and greater availability of other 
modes of transport has reduced the need to walk. There are now fewer physical 
demands both in domestic and work life due to modern technologies and 
conveniences. Sedentary time has also increased due an escalation in indoor 
activities such as playing computer games, chatting on online social network 
sites, watching increasing numbers of television channels. Fears relating to child 
safety have reduced the willingness of parents to allow their children to play 
outside (Helen & Shirley 2008). Current guidelines recommend at least 60 
minutes of daily moderate-to-vigorous physical activity (MVPA) for children aged 
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5-18 years. For adults aged 19-64 years, guidelines recommend 30 minutes of 
MVPA on 5 or more days a week, or collectively 150 minutes over a week (NHS 
2014). Children younger than 5 years of age should be encouraged to undertake 
physical activity and reduce the time spent watching television, playing video-
games and travelling by car, bus or train. Based on self-report, about 62% of 
Scottish adults and 70% of children achieved the recommended level of MVPA 
(The Scottish Government 2014). However, self-reported levels of physical 
activity are likely to exceed direct measurements (Prince et al. 2008). For 
example, in 2005, a representative cross-sectional survey of US adults conducted 
by the Centers for Disease Control and Prevention (CDC) showed that, according 
to self-report, 49.1% of US adults met the recommended level of MVPA (Carlson 
et al. 2009). In contrast, less than 5% of US adults actually met the 
recommended MVPA when their physical activity was measured directly by using 
accelerometers (Troiano et al. 2008).  
The “communicable” nature of adiposity has also been documented in different 
studies of social networks. In one particular study, a significant “person-to-
person” spread of adiposity was observed in a social network of more than 
12,000 individuals who were followed over the period of 32 years (Christakis & 
Fowler 2007).There were clusters of obese individuals and the likelihood of 
becoming obese increased by 57% if an individual’s friend became obese around 
the same time. The corresponding increased likelihood for siblings and spouses 
were 40% and 37% respectively. The association was more pronounced in people 
of the same sex. However, there was no spread among neighbours suggesting 
that adiposity spread mainly through peers.  
In summary, the development of adiposity is a complex phenomenon and 
involves multiple factors: including the consumption of high caloric diets, 
sedentary behaviour, lack of physical activity, genetic predisposition, and an 
obesogenic environment. People influence the behaviours of others (Christakis 
2004). It has been shown that smoking and alcohol cessation programmes which 
involved social networks were more successful than those targeting only 
individuals (Malchodi et al. 2003; Wechsler et al. 1995), and the same is true of 
weight management programmes (Wing & Jeffery 1999).Tackling the current 
obesity epidemic will require a multi-faceted approach including: both individual 
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and community level multi-sector and multi-disciplinary approaches, which are 
culturally relevant and easily adaptable. 
1.3 Measures of adiposity 
The most commonly used measures of adiposity are those that indirectly 
measured body fat mass including: BMI, WC, and WHR. The direct measures of 
adiposity, including skin fold thickness, bioelectrical impedance, underwater 
weighing, dual-energy x-ray absorptiometry (DXA) and isotope dilution, are used 
less commonly in  population studies. These measures are briefly discussed 
below: 
1.3.1 Body mass index 
BMI is the most widely used measure of adiposity. It is derived by dividing an 
individual’s weight, measured in kilograms (kg), by the square of their height, 
measured in metres (kg/m2). Based on the strength of association between BMI 
and comorbidity, standardized cut-off points have been developed by the WHO 
that are also used by various national and international organizations (Table 
1.1). The National Health Service (NHS), in the United Kingdom, recommends 
using the same cut-offs to identify those needing interventions, and they are 
used in their online BMI calculator (www.nhs.uk).   
Table 1.1 Body mass index categories 
 
 
 
 
 
 
The relative risk (RR) of obesity-related comorbidity is higher in Asian population 
so additional intermediate cut-off points were suggested in this population group 
Classification BMI range (kg/m2) 
Underweight <18.5 
Normal-weight 18.5 to 24.9 
Overweight 25 to 29.9 
Obese ≥30 
Class I 30 to 34.9 
Class II 35 to 39.9 
Class III ≥40 
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as trigger points for public health action; 23.0 kg/m2 and 27.5 kg/m2 for 
“increased risk” and “higher risk” respectively (WHO Expert Consultation 2004).  
The main advantage of BMI is that the same cut-off can be applied to all ages 
and both genders, only height and weight is required for calculation, and it is a 
relatively cheap and easy method for measuring clinically or in population 
studies. In calculating BMI, weight is standardized for height which enables 
people of different heights to be compared. In children and adolescents, BMI is 
calculated in the same way as for adults but age and sex specific percentiles are 
used to determine cut-offs. BMI has been used across the globe over the last few 
decades thus providing the opportunity to do comparisons over time and 
between different populations. A BMI value higher than 25 is significantly 
associated with adverse outcomes and mortality (Calle et al. 1999). Obese 
individuals are at higher risk of medical complications than overweight or 
normal-weight individuals. However, BMI is only a screening and not a diagnostic 
tool for diagnosis of obesity (Mei et al. 2002). BMI correlates reasonably well at 
population level with the direct measure of body fat but it has some limitations. 
A major criticism of BMI is that it categorizes individuals as overweight or obese 
on the basis of the total body weight (fat and muscle) which can be misleading, 
particularly in the case of athletes and body builders who have a high lean body 
mass. However, misclassified individuals are relatively uncommon at a 
population level (US Department of Health 1998). At a similar BMI, older people 
and women are likely to have more body fat than young adults and men 
respectively. In summary, BMI is a proxy measure of body fat and has some 
limitations, but remains a commonly used tool in population studies.  
1.3.2 Waist Circumference 
WC is the most widely used estimate of central adiposity and is strongly 
correlated with central or abdominal fat mass (Pouliot et al. 1994). It can be 
easily assessed with a normal inelastic measuring tape. It should be measured 
between the two bony landmarks; this is mid-way between the lower border of 
last palpable rib and the upper border of the iliac crest in standing position and 
at the end of a gentle expiration (World Health Organization 2008). The WHO 
has recommended sex-specific thresholds for interventions which are followed 
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by many national and international organizations for community and clinical 
settings (Table 1.2).  
Table 1.2 Waist circumference categories 
 
Classification Men Women 
Normal-weight <94 cm <80 cm 
Overweight 94 cm to 102 cm 80-88 cm 
Obese >102 cm >88 cm 
 
For South Asian and Chinese adults, lower thresholds of ≥90 cm and ≥80 cm are 
recommended for men and women respectively (International Diabetes 
Federation 2014). Several studies have shown that BMI may not be a reliable 
measure of adiposity across age, sex, and ethnic groups (Gallagher et al. 1996). 
For this reason, WC has gained a considerable attention as a complementary 
measure or alternative anthropometric measure to BMI (Janssen et al. 2004). 
Abdominal adiposity is reported to be more strongly associated with metabolic 
syndrome, diabetes, cardiovascular disease (CVD), and all-cause mortality when 
measured by WC than BMI (Pischon et al. 2008). The limitations of WC include 
the lack of recommended cut-offs for use in children. It can be more challenging 
to use in some population studies because of the need for physical contact and 
lifting up participants’ shirts and some basic training is required to ensure 
accurate measurements. It is not used as commonly as BMI, particularly in 
population studies, and so is less useful for historical and international 
comparisons.  
 
1.3.3 Waist-to-hip ratio 
WHR is the second most widely used measure of central adiposity after WC, and 
is shown to be significantly correlated with abdominal fat (World Health 
Organization 2008). It requires two measurements; waist and hip circumference. 
Hip circumference should be measured at the widest part of the buttocks (at the 
level of the greater trochanter) using a stretch resistant measuring tape. Both 
measurements should be done in a relaxed standing position and at the end of 
gentle expiration with feet together. The measurement should be repeated 
twice and in the case of one centimetre difference, the mean should be 
calculated. As with WC, the WHO has recommended sex-specific thresholds of 
Chapter 1 General introduction 
32 
 
WHR on the basis of its association with adverse outcomes and mortality (Table 
1.3).  
Table 1.3 Waist-to-hip-ratio categories  
 
Classification Men Women 
Normal-weight <0.94 <0.80 
Overweight 0.94 to 0.99 0.80-0.84 
Obese ≥1 ≥0.85 
  
There are fewer studies from which to derive appropriate WHR cut-offs for South 
Asian and other non-White ethnic groups. A recent review concluded that the 
cut-offs for threshold of higher risk WHR for the South Asian ethnic groups; ≥0.90 
and ≥0.80 for men and women, respectively (Lear et al. 2010). Some studies 
have reported that central obesity is a stronger predictor of adverse outcomes 
than BMI (Lee et al. 2008). Two recent studies showed that WHR was more 
strongly associated with CVD than BMI and WC (Chen et al. 2007; Dalton et al. 
2003). WC is strongly associated with diabetes (Mamtani & Kulkarni 2005) but 
WHR is the strongest predictor of myocardial infarction (Yusuf et al. 2005). WHR 
is an indirect estimate of abdominal and hip fat mass. The limitations of WHR 
include: the need for two measurements thereby increasing the chance of 
measurement error, expression of the result as a ratio which may be more 
difficult to interpret, the need for physical contact and training; fewer studies 
from which to derive ethnic-specific cut-offs, less widespread use making 
comparisons more difficult and the absence of reference percentiles for use in 
children.  
1.3.4 Other measures of adiposity 
A number of other measures exist for measuring fat mass. A special caliper can 
be used to measure subcutaneous fat. Skin fold thickness is measured by 
pinching the skin at a number of predefined points on the body, such as upper 
arm, trunk, and thighs (Deurenberg & Deurenberg-Yap 2002). The readings are 
then compared with age-sex-specific charts. Bioelectrical impedance can be 
measured by passing a low electrical current through the body and measuring 
the difference of flow in body fat, water and lean body mass (Jebb et al. 2000). 
Underwater weighing is the gold standard method of directly measuring body 
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fat. Participants are weighed in air and then submerged in a specialized tank in 
a laboratory setting. Individuals with high fat mass weigh less inside the water 
compared to those with a high lean body mass. However, Air displacement 
plethysmography (ADP) has replaced underwater weighing as the best two-
compartment method for measuring adiposity (Fields 2002). ADP has the same 
principle as underwater weighing but it is based on air displacement. It has the 
advantage of being rapid, non-invasive, automated and safe process. It is 
suitable for children, older, morbidly obese and disabled individuals. Dual-
energy x-ray absorptiometry (DEXA), uses low dose x-ray to accurately record 
the fat distribution in the body. Isotope dilution is another method where 
participants drink isotope-labelled water and are then analyzed for isotope 
levels to calculate body fat mass. Computerized tomography (CT) and magnetic 
resonance imaging (MRI) can also be used for directly measuring body fat mass in 
different parts of the body. The advantage of these direct measures of body fat 
is their accuracy. However, they are expensive, time consuming, and unsuitable 
for serial measurements making them impractical for use in large population 
studies. They are mostly used in clinical settings or for validating other measures 
such as BMI, WC and WHR. No agreed cut-offs are available but generally BF% is 
classified among men as; normal weight (<18%), overweight (18-25%) and obese 
(>25%). The equivalent cut-off values for women are <25%, 25-32% and >32%, 
respectively (The American Council on Exercise 2013). 
In summary, BMI is the anthropometric measure of choice for most large 
population studies, and is likely to remain so for the near future. However, it is 
only a surrogate measure of body fat since it actually measures total body 
weight in relation to height. Therefore, BMI might give misleading results in 
some scenarios, such as increasing age (Deurenberg et al. 1991), different ethnic 
groups (Deurenberg et al. 1998), sportsmen and women (Katch & Katch 1984),  
and weight loss with enhancing physical activity (Whatley et al. 1994). It is 
evident that using both BMI and WC or WHR produces more informative results 
(Pischon et al.2008). It is now argued that this is the time that adiposity 
researchers should shift toward direct measurements of body fat mass rather 
than relying only on proxy measures (Prentice & Jebb 2001). Recently UK 
Biobank, which is one of the world’s largest population studies with more than 
500,000 UK participants, included a series of anthropometric measures such as 
Chapter 1 General introduction 
34 
 
WC, WHR and bio-impedance, as well as BMI, and therefore will be interesting to 
explore (Allena et al. 2012).   
1.4 Trends in adiposity 
Adiposity is a global health problem and according to the WHO, if immediate 
action is not taken, many will suffer from a range of serious health problems. In 
2008, more than 1.4 billion adults, worldwide, were overweight and more than 
0.5 billion were obese (World Health Organization 2013). The prevalence of 
adiposity has nearly doubled from 1995 to 2008 (Finucane et al. 2011). 
Historically, the adiposity epidemic was thought to be restricted to developed 
countries but the prevalence is now high dramatically in both low and middle-
income countries. One large study used data from 243 national health surveys 
across 199 countries to estimate the trends in the global prevalence of 
overweight and obesity between 1980 and 2008 (Stevens et al. 2012). The age-
standardized global prevalence of adults (aged 20 years or above) classified as 
overweight increased from 24.6% (95% CI 22.7%, 26.7%) in 1980 to 34.4% (95% CI 
33.2%, 35.5%) in 2008. The corresponding global prevalence of obesity increased 
from 6.4% (95% CI 5.7%, 7.2%) in 1980 to 12.0% (95% CI 11.5%, 12.5%) in 2008.  
Among the OECD countries, 18% of the adult population are obese (OECD 2014).  
Since 1990, the prevalence of obesity has increased at a faster rate in England, 
USA and Australia than other OECD country (Figure 1.1). However, since 2008 
the adiposity rates have almost stabilized in most of the countries and slightly 
increased in others. This could be attributed to the adaptation of “obesity 
tackling policies” in many of the OECD countries. 
 
 
 
 
 
Chapter 1 General introduction 
35 
 
Figure 1.1 Obesity rates (age and gender adjusted) in the OECD countries 
 
Source:  from OECD obesity update 2014 
http://www.oecd.org/els/health-systems/Obesity-Update-2014.pdf 
 
Among the European countries, the UK has the second highest prevalence of 
obesity after Hungry, where 2 out of 3 men are overweight and 1 in 4 individuals 
are obese (OECD 2014). In 2011, among adults in England, 65% of men and 58% of 
women had a BMI above 25 kg/m2 (overweight and obese). This had increased 
from 58% and 49%, respectively in 1993 (NHS 2013). The prevalence of obesity 
(BMI ≥30 kg/m2) in 2011 was 24% in men and 26% in women and had increased 
from 13% and 16% respectively in 1993. Among all the countries in the UK, 
Scotland continues to have the highest prevalence of obesity (Figure 1-2). The 
prevalence of obesity in the UK is predicted to reach 60% in men, 50% in women 
and 25% in children by 2050 (Foresight 2007), but more  recent data shows that 
the adiposity rates have almost stabilized or slightly decreased in all of the UK 
countries (Figure 1.2). The Department of Health, UK aimed to achieve the 
downward trend of excess body weight among adult and the sustained decline in 
childhood obesity by 2020 (Department of Health 2013). 
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Figure 1.2 Trends in adult (≥16 years) prevalence of obesity in the UK and Ireland 
 
Source: from Public Health, England 
http://www.noo.org.uk/NOO_about_obesity/adult_obesity/international 
In Scotland, the percentage of overweight or obesity in adults rose from 52.4% in 
1995 to 61.9% in 2012, and that of obesity from 17.2% to 26.1%, respectively 
(Keenan et al. 2011). However, the prevalence of both obesity and overweight 
has been levelling off since 2008 (Figure 1.3). In 2010, the Scottish Government 
showed its commitment by producing a comprehensive Route Map “Preventing 
overweight and obesity in Scotland. A route map towards health weight” (The 
Scottish Government 2010). The ultimate goal of which is to reduce the 
prevalence of obesity in Scotland. 
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Figure 1.3 Prevalence of overweight and obesity in Scottish adults 1995 to 2010 (aged 16 to 
64 years), 2003 to 2012 (age 16 years and above) 
 
 
Source: from the Scottish Health Survey 2012 report 
http://www.scotland.gov.uk/Resource/0043/00434580.pdf 
Similarly, childhood adiposity is highly prevalent in both developed and 
developing countries. A larger study collated data on 43 million children from 
450 nationally cross-sectional surveys conducted in 144 countries (de OM et al. 
2010). In 2010, the global prevalence of childhood overweight and obesity was 
6.7% (95% CI 5.6%, 7.7%). This was dramatically higher than, in 1990, when the 
global prevalence was estimated to be 4.2% (95% CI 3.2%, 5.2%) (Figure 1.4). 
Furthermore, the global prevalence is expected to rise further and reach 9.1% 
(95% CI 7.3%, 10.9%) by 2020 (de OM et al. 2010, Foresight 2007). 
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Figure 1.4 Global, prevalence and trends of overweight and obesity in preschool children 
 
 
 
 
Source: from Onis de et al. Global prevalence and trends of overweight and 
obesity among preschool children. Am J Clin Nutr 2010;92:1257-64. 
 
However, in line with the trend of adult obesity, the latest data shows that the 
rate of childhood obesity is not only stabilizing but is on the decline in most of 
the OECD countries (OECD 2014). From 2003-2004 through 2011-2012 in USA 
alone, the prevalence of obesity among 2 to 5 years old children significantly 
decreases by 43% (from 13.9% to 8.4%) (Ogden et al. 2014). Similarly, in Scotland 
since 2008, the prevalence of overweight and obesity is not only stabilized but is 
on decline (Figure 1.5). In 2012, 30.6% of children (aged 2 to 15 years) were at 
risk of overweight or obese in Scotland, 16.8% of which were at risk of obese 
only. The Scottish Government is working on the national indicator for children 
to “reduce the rate of increase in the proportion of children with their body 
mass index outwith a healthy range by 2018” (The Scottish Government 2010). 
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Figure 1.5 Prevalence of children at risk of overweight and obesity, 2003 to 2012 (aged 2 to 
15 years) 
 
 
Source: from the Scottish Health Survey 2012 report 
http://www.scotland.gov.uk/Resource/0043/00434580.pdf 
 
In summary, the prevalence of adiposity has dramatically increased over the past 
three decades across the globe, to such an extent that being overweight has 
become the norm in most countries (Finucane et al. 2011). If effective strategies 
are not adopted then more than 50% of the population might become obese in 
the next few decades (Foresight 2007). However, since 2008 there is no 
significant change in the trend of obesity prevalence among adults, and there is 
even evidence of decline in children. This could be attributed to the reduction 
of soft drink sales, improvement in the intake of healthy diet, increase in leisure 
activities and decline in the time spent in front of TV in the recent past 
(http://www.scotland.gov.uk/Publications/2013/11/4898). 
 
 
Chapter 1 General introduction 
40 
 
1.5 Impact of adiposity on physical health 
There is a plethora of evidence that adiposity has an adverse impact on physical 
health and mortality. These are discussed below. 
1.5.1 Cardiovascular diseases  
During the 14 year follow-up of the 5,881 Framingham Heart Study participants, 
a 5% increase in the RR of heart failure for men, and 7% for women, was 
demonstrated for each one unit increment in BMI (Kenchaiah et al. 2002). 
Overall, obese individuals had a 2-fold higher risk of heart failure than normal-
weight individuals (adjusted hazard ratio (HR) 2.04 (95% CI 1.59, 2.63, 
p<0.001).For women, the adjusted HR was 2.12 (95% CI 1.51, 2.97, p-value 
<0.001), and for men it was 1.90 (95% CI 1.30, 2.79, p-value <0.001). The overall 
HR for overweight was 1.34 (95% CI 1.08, 1.67, p-value 0.007); HR 1.50 (95% CI 
1.12, 2.02, p-value 0.007) for women and HR 1.20 (95% CI 0.87, 1.64, p-value 
0.27) for men. Furthermore, 11% of total heart failure cases in men, and 14% in 
women, were attributable to obesity. A prospective cohort study conducted in 
the United States measured BMI in 1,132 white men, and followed up over a 
much longer period (median 46 years) (Shibab et al. 2012). In comparison to 
normal weight men, both overweight (adjusted HR 1.65, 95% CI 1.29, 2.09) and 
obese (adjusted HR 4.83, 95% CI 2.47, 9.44) men were more likely to develop 
incident hypertension. In another study,379 middle-aged normotensive men from 
Finland were followed for 11 years, a 5 cm increase in WC was significantly 
associated with development of hypertension (adjusted OR 1.31, 95% CI 1.04,  
1.66) (Niskanen et al. 2004). The 21,414 participants of the US physician’s health 
study were followed-up for more than 12 years (Kurth et al. 2002). In 
comparison with normal weight, obesity was found to be an independent 
predictor of total stroke (adjusted HR 2.00, 95% CI 1.48, 2.71), ischemic stroke 
(adjusted HR 1.95, 95% CI 1.39, 2.72) and haemorrhagic stroke (adjusted HR 
2.25, 95% CI 1.01, 5.01). Similarly, each unit increase in BMI, was associated 
with a 6% (95% CI 4%, 8%) increase in the risk of stroke.  
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1.5.2 Type 2 Diabetes 
Adiposity is a major modifiable risk factor for developing type 2 diabetes. In the 
Nurses’ Health Study of 114,281 registered female nurses, even modest baseline 
adiposity was found to be an independent predictor of type 2 diabetes (Colditz 
et al. 1995). Over 14 years follow-up, 5, 40 and 93 fold higher risk of type 2 
diabetes was recorded in women with a BMI 24.0-24.9 kg/m2, 31.0-32.9 kg/m
2, 
and≥35.0 kg/m2 respectively, compared to women of BMI less than 22 kg/m2. In 
another study, similar associations were reported among 6,916 men over 12 
years of follow-up (Wannamethee and Shaper 1999); for BMI 25.0-27.9 kg/m2 the 
adjusted RR was 2.25 (95% CI 1.45, 3.47), for BMI 28.0 -29.9 kg/m2 it was 4.74 
(95% CI 2.99, 7.51), and for BMI ≥30.0 kg/m2 it was 8.04 (95% CI 5.06, 12.74), 
compared to normal-weight men. In a clinical trial 3,234, participants were 
randomly assigned to one of three interventions groups; placebo, metformin or 
intensive lifestyle intervention (Knowler et al. 2002). The target for participants 
assigned to the intensive lifestyle modification arm was to achieve and maintain 
a weight reduction of at least 7% of their baseline body weight. After a mean 
follow-up of 2.8 years the incidence of diabetes was reduced by 58% (95% CI 48%, 
66%) in the lifestyle modification arm and 31% (95% CI 17%, 43%) in the 
metformin arm, compared to the placebo group, suggesting weight reduction 
was more effective than the use of metformin.  
1.5.3 Cancer 
The WHO International Agency for Research on Cancer (IARC) concluded that 
there is now adequate evidence for the association between adiposity and 
cancer, particularly with oesophageal adenocarcinoma, post-menopausal breast 
cancer, colorectal cancer, endometrial cancer and renal cell cancer 
(International Agency for Research on Cancer 2002). Overweight and inactivity 
were responsible for one quarter to a third of these cancers. A meta-analysis 
was conducted, in 2008, to quantify the association between a 5 kg/m2 increase 
in BMI and the risk of 20 common and less common cancers (Renehan et al. 
2008). A total of 28,2137 incident cases were included from 141 longitudinal 
studies: 28 conducted in North America,35 in Europe and Australia and 11 in 
Asia-Pacific. Among women, there were positive significant associations with 
endometrial cancer (RR 1.59, 95% CI 1.50 to 1.68, p<0.001), gallbladder cancer 
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(RR 1.59, 95% CI 1.02 to 2.47, p=0.04), oesophageal adenocarcinoma (RR 1.59, 
95% CI 1.31 to 1.74, p-value <0.001), and kidney cancer (RR 1.34, 95% CI 1.25 to 
1.43, p<0.001). There were also significant associations with leukaemia, thyroid 
cancer, postmenopausal breast cancer, pancreatic cancer, multiple myeloma 
and colon cancer. Among men, there were significant associations with 
oesophageal adenocarcinoma (RR 1.52, 95% CI 1.33 to 1.74, p<0.001), thyroid 
cancer (RR 1.33, 95% CI 1.04, 1.70, p=0.020), colon cancer (RR 1.24, 95% CI 1.20, 
1.28, p<0.001), and renal cancer (RR 1.24, 95% CI 1.15, 1.34, p<0.001). There 
were also significant associations with malignant melanoma, multiple myeloma, 
rectal cancer and leukaemia. This evidence suggests that adiposity is important 
modifiable risk factors for cancer. 
 
1.5.4 Respiratory diseases 
Adiposity imposes extra load on the respiratory system to fulfil the increased 
metabolic demand. It alters normal respiratory physiology due to reduced chest 
wall compliance because of the extra fat accumulated in the thorax and 
abdomen, reduction of lung volumes, rate of total oxygen consumption and 
carbon dioxide production, pattern of breathing, and respiratory drive. About 
half of sleep apnoea patients are obese (Young et al. 1993). The sleep apnoea 
has several complications, such as cardiac arrhythmias, pulmonary and systemic 
hypertension, CVD and daytime somnolence. Adiposity is a significant risk factor 
for the development of other respiratory diseases, including bronchial asthma, 
pneumonia, deep vein thrombosis, pulmonary embolism, pulmonary hypertension 
and chronic obstructive pulmonary disease (Murugan & Sharma 2008). 
1.5.5 Other physical health conditions 
Adiposity is associated with a number of other physical conditions. About six 
percent of primary infertility is linked with adiposity due to hormonal imbalance 
which causes disruption in normal female reproductive function and impotency 
in men (Esposito et al. 2004; Green et al. 1988). Adiposity predisposes to a 
number of musculoskeletal disorders, including back pain, osteoarthritis, 
rheumatoid arthritis and gout (Grotle et al. 2008). Obese individuals have a 42% 
higher risk of Alzheimer’s disease compared to normal-weight individuals 
(Beydoun et al. 2008). Class III obese women and men have a seven-fold and 
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two-fold higher risk of developing gallstones than normal-weight women and 
men respectively (Stampfer et al. 1992; Tsai et al. 2004). Adiposity is also an 
independent predictor of kidney disease, and non-alcoholic fatty liver disease 
(Fox et al. 2004).   
In summary, adiposity is a significant risk factor for the development of many 
chronic non-communicable diseases, including CVD (hypertension, CHD, varicose 
vein, deep venous thrombosis), respiratory diseases (sleep apnoea, asthma, 
chronic-obstructive pulmonary disease), metabolic disorders 
(hypercholesterolemia, type 2 diabetes, menstrual irregularity), gastrointestinal 
diseases (fatty liver, gallstones) and cancer (post-menopausal breast, 
oesophageal, colorectal, endometrial, kidney). Recent studies have shown that 
adiposity is associated with more physical health conditions than smoking, 
alcohol and socio-economic deprivation (Sturm & Wells 2001). Adiposity is a 
modifiable risk factor and its prevention could lead to significant improvements 
in health, reduced morbidity and annual savings of billions of pounds in direct 
and indirect health care costs (Vlad 2003). 
1.6 Adiposity and mortality 
Adiposity predisposes to many chronic conditions, which themselves are 
associated with mortality. However, there is a growing literature that suggests 
that whilst obesity is associated with higher mortality, being overweight is not 
and may, in fact, be protective for all-cause death. In a recent meta-analysis 
including 97 studies with 2.88 million participants and more than 270,000 
deaths, classes II and III obesity were significantly associated with higher all-
cause mortality than normal-weight participants (Flegal et al. 2013). In contrast, 
overweight individuals were 6% less likely to die over follow-up (HR 0.94, 95% CI 
0.91, 0.96) (Flegal et al. 2013). In a meta-analysis of 26 published studies with 
388,622 participants and 60,374 deaths, obesity was associated with higher all-
cause death, among both men (RR 1.28, 95% CI 1.18,1.37) and women (RR 1.20, 
95% CI 1.12, 1.29) but being overweight was protective for all-cause death 
among both men (RR 0.97, 95% CI 0.93, 0.99) and women (RR 0.97, 95% CI 0.92, 
1.0) (McGee 2005).  
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In a recent Scottish study, the birth records of 37,709 adult offspring (of 28,540 
mothers) aged 34 to 61 years were linked to their death records from 1950 to 
2011 inclusive (Reynolds et al. 2013). All cause mortality was significantly 
increased among the adult offspring of overweight (adjusted HR 1.11 
(overweight and obesity), 95% CI 1.03, 1.19), and obese (adjusted HR 1.35, 95% 
CI 1.17, 1.55) mothers, compared with the offspring of normal-weight mothers. 
In another Scottish study, 3,613 women who had never smoked were followed up 
for 28 years (Hart et al. 2011). Obese (class II and III) women had higher risk of 
all-cause mortality (adjusted RR 1.56, 95% CI 1.29, 1.89) compared to the 
normal-weight women, but the association did not reach statistical significance 
in overweight women (adjusted RR 1.02, 95% CI 0.92, 1.14),. There is no 
consensus as to why being overweight may be protective against all-cause 
mortality. Some of the potential reasons proposed include a cardio-protective 
role of higher body fat in overweight patients, an advantage conferred by 
increased metabolic reserves, earlier presentation, and increased chance of 
screening and optimal health care (Flegal et al.2013). 
Although, being overweight may not increase the risk of death, there is 
substantial published evidence that all-cause mortality increases in a dose-
response fashion with increasing obesity. Therefore, the current obesity 
epidemic threatens to halt and possibly reverse the steady increase that has 
occurred in life expectancy (Lavie et al. 2009). 
1.7 Subjective well-being 
Subjective well-being has been defined in several ways. The Organisation for 
Economic Co-operation and Development (OECD) defined it as “all of various 
evaluations, positive and negative, that people make of their lives and the 
affective reactions of people to their experiences”. It has also been described as 
“the personal perception and experience of positive and negative emotional 
response and global and specific cognitive evaluations of satisfaction with life… 
Simply, subjective well-being is the individual’s evaluation of quality of life” 
(European framework for measuring progress 2012).  
More recently, subjective well-being has been redefined as “An umbrella term 
for the different valuations people make regarding their lives, the events 
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happening to them, their bodies and minds, and the circumstances in which they 
live” (Diener 2006). This later definition of subjective well-being is very close to 
that of quality of life; “An individual’s perception of their position in life, in the 
context of the culture and value systems in which they live, and in relation to 
their goals, expectations, standards, and concerns”. It is a broad ranging 
concept, affected in a complex way by the person’s physical health, 
psychological state, level of independence, social relationships, and their 
relationship to salient features of their environment” (WHOQOL Group 1995). 
The terms life satisfaction, happiness, and subjective well-being are often used 
interchangeably as synonyms. Similarly, health status, well-being, life-
satisfaction and happiness are sometimes used interchangeably with quality of 
life. On closer scrutiny of the current definitions of subjective well-being, and 
quality of life, researchers have reported that both these terms are virtually 
synonymous (Camfield & Skevington 2008). Subjective well-being, or quality of 
life, is therefore the scientific term relating to how individuals evaluate their 
lives. 
1.7.1  Health-related quality of life 
Health extends beyond the absence of disease, to encompass physical, mental 
and social well-being. An ideal health assessment would include all these aspects 
of health. But conventionally, health is measured narrowly using symptoms, 
physical signs and objective measurements, such as laboratory tests, to indicate 
the presence or absence of disease. Although health makes an important 
contributor to overall “quality of life”, the latter is also influenced by many 
other aspects of life, such as education, housing, employment, leisure time, 
neighbourhood and social belonging. So the concept of HRQoL was developed to 
encompass those aspects of overall quality of life that can are clearly related to 
health, either physical or mental (Figure 1.6). HRQoL is defined as “the impact 
of general medical conditions or symptoms on functional health and well-being 
and includes physical, mental, emotional, and social aspects of health (Turner-
Bowker et al. 2003). In simple terms, HRQoL is “an individual’s or group’s 
perceived physical and mental health over time” (Centers for Disease Control 
and Prevention 2000). In the recent past, HRQoL has gained increasing 
acceptance as a useful measure and has been incorporated into an increasing 
number of population studies.  
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Figure 1.6 Health, function, health-related quality of life, quality of life and related factors 
 
Source: from Centers for Disease Control and Prevention. Measuring healthy days: Population 
assessment of health-related quality of life. CDC, Atlanta, Georgia 2000. 
 
Worldwide, the life expectancy at birth has considerably increased, due to which 
the concept of “well-being” has gained popularity. How individuals consider 
their own health is an important indicator of health status. A subjective measure 
of overall health is now an important part of measuring health outcomes 
(Bowling 2014), and is normally determined through national health interview 
surveys on a regular basis in many countries. Self-perceived health is 
multidimensional and includes at a minimum, the dimensions of general and 
mental health, physical, social and role functioning (Hennessy et al. 1994). In 
contrast the traditional dominant model is the biomedical one, which relies on 
the medical history, physical examination, laboratory investigation, and 
treatment and ultimately the outcome is measured on the basis of clinical 
improvement (Asadi-Lari et al. 2004). This narrow concept of health could lead 
to the “paternalism” in doctor-patient relationship (McKinstry 1992). In which 
the doctor considers himself superior than the sick person on the basis of his 
technical knowledge in taking important decisions for the patient. It is argued 
that if a mentally sound sick person is capable of taking important decision in his 
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personal life then it should also be extended to the treatment choice (Gillan 
1985).    
Therefore, self-perceived health is gradually becoming a part of the clinical 
practice to help in the diagnosis of otherwise unobserved physical and mental 
health conditions, monitoring the health and treatment response and assessing 
the delivery of health care (Detmar et al. 2002). The inclusion of self-perceived 
health assessment to the daily clinical consultation is reported to be acceptable 
to both doctors and patient and is feasible in terms of financial and human 
resources investment (Wagner et al. 1997; Detmar & Aaronson 1998). This also 
encourages the doctors to inquire about the detailed aspects of patient’s health 
and well-being. A prospective randomized controlled trial of 10 doctor and 214 
palliative chemotherapy patients revealed that the doctors in the intervention 
group (inclusion of HRQoL questionnaire and education session to both doctors 
and patient before the consultation) identified significantly greater proportion 
of moderate to severe medical conditions, compared to the control group 
(Detmar et al. 2002). Moreover, all of the doctors and majority of the patients 
noted improvement in the communications and were happy for its further use in 
the OPD.  
However, there are studies which reported no improvements after addition of 
self-assessment of health to the clinical consultations. A systematic review of 
breast cancer patients were published in 2003, which showed that the 
introduction of self-assessment of health to the clinical trials did not make a 
considerable contribution to the clinical decision making (Goodwin et al. 2003). 
This contribution was too little in comparison to the introduction of increased 
burden, in terms of time consumption and expenses and addition of complexity 
to the trails. However, an updated systematic review was published in 2011, 
which demonstrated that with growing experience the standard of HRQoL studies 
has improved over the last decade, due to more robust techniques than those 
used in earlier studies (Osoba 2011). The self-assessment of health provides 
additional useful information and is now a more accurate predictor of survival 
than many clinical parameters. It is likely that the self-assessment of health will 
become the standard part of routine clinical assessment in near future but there 
is still a need for a universal standard of “clinically minimum important 
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difference” which is possible with the completion of more individual studies 
(Osoba 2011).  
Studies have reported that self-perceived health is a reliable measure of 
overall/disease-specific mortality (Benjamins et al. 2004; Idler & Benyamini 
1997). It provides additional information by covering those aspects of health 
which are difficult to capture by objective measurements such as subclinical 
disease, help-seeking behaviour and health system use (Nielsen et al. 2008). The 
exact mechanism by which self-perceived health may impact on health and life-
expectancy is not known. Self-perceived health is more inclusive and may 
identify accurate health status by incorporating both objectively measured and 
subjective assumptions of health risk factors, the full array of medical condition 
and possibly may detect very early symptoms of underlying disease even at 
subclinical or prodromal stages (Idler et al. 2000). Better perceived health may 
reflect an individual’s attitude towards improving health, and thus adopting 
preventive measures. In contrast, the poor perception of own health may result 
in neglecting of the primary or secondary prevention such as balance diet, 
physical activity, screening and taking medication for existing medical conditions 
which may eventually result in early death or disease incidence (Idler & 
Benyamini 1997). Some have suggested that personality traits, such as optimism, 
may inflate self-assessment of health (Benyamini et al. 2000). Self-perceived 
health may reflect changes in health status (improvement or decline) rather 
than only relying on the current or static health status. It may be influenced by 
the existing knowledge about familial risk factors and longevity. Others have 
related better perception of health with better immune responses (Lekander et 
al. 2004). However, these are all speculations and further qualitative and 
quantitative research is needed to explore these mechanisms. 
Self-perceived health is a relative measure and studies have reported that 
individuals’ perceive their health according to their situation, culture and 
expectation, and their peers (Idler & Benyamini 1997). Therefore, caution is 
required when comparing the self-perceived health status among different 
populations due to socio-cultural diversity and the variation in survey questions 
and answer categories (OECD 2011).  
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In summary, self-perceived health is an important indicator of both health and 
health risk and its routine use may enhance individuals and community health. 
However, our knowledge about the self-perception of health is still in its early 
phase and more scientific research is needed. 
1.7.2 Measure of subjective well-being 
The Short Form 36 (SF-36) is one of the most commonly used instruments of 
functional health and well-being. It has been translated into many languages and 
validated in more than 50 countries across the globe (http://www.sf-
36.org/tools/sf36.shtml). SF-36 is a generic measure and consists of 36 questions, 
covering eight physical and mental health domains. Summary scores can be 
derived for physical and mental health HRQoL, called the physical component 
summary (PCS) and mental component summary (MCS) respectively (Ware Jr. 
2000). Higher PCS and MCS scores indicate better physical and mental health 
status, respectively.  
The strength of SF-36 or any generic instrument is that they could be used across 
a wider scope of health conditions. The limitation of generic instruments is that 
they are less sensitive to clinically important change and the broader 
applicability may compromise the detailed information, compared to disease-
specific measures (Chen 2005; Brazier et al. 1999). The wider and generic use of 
SF-36 provides the opportunity of comparing the results across the studies and 
different population. It is a shorter, simple to administer and reproducible 
measure of general population and different subgroups.  However, there is 
evidence that the survey mode; telephone or postal questionnaire influence the 
rating of SF-36 (Jörngården et al. 2006). Both men and women are more likely to 
score higher (better HRQoL) in the telephonic mode than the postal 
questionnaire. This may be due to the difference in the anonymity between the 
two modes of questionnaire administration. There is no clearly defined 
standardized clinically important difference among the SF-36 score. But a 
between-groups difference of 5 points in individual SF-36 domains, or 2-3 points 
in the PCS and MCS is generally considered clinically significant (Samsa et al. 
1999; Kosinski et al. 2000; Ware 1994). The time to complete the SF-36 
questionnaire is 10-12 minutes, compared to 2 minutes for the SF-12 
questionnaire (Pickard et al. 1999). Other limitations include a higher rate of 
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missing data among older participants due to expressing concerns over the 
relevance of some of the SF-36 questions (Brazier et al. 1996; Hayes et al. 1995). 
There is loss of information when calculating the two summary scores of PCS or 
MCS (Hobart et al. 2002). SF-36 is originally designed for self-reporting and may 
not produce accurate results in proxy reporting for impaired patients (Dikmen et 
al. 2001). 
The Short Form 12 (SF-12) is a shorter version of SF-36 and is also a validated 
and a widely used tool for measuring generic HRQoL (Ware Jr, et al. 1996). The 
advantage of the SF-12 is that it only takes one third of the time needed to 
complete the SF-36 and is therefore used in many large surveys. The 12 
questions of the SF-12 can also be combined to form summary scores for physical 
and mental health. These summary scores are reported to be closely correlated 
with that of SF-36 (Wee et al. 2008). Overall SF-12 scores can also be converted 
to utility scores, via an algorithm developed by Brazier and colleagues at the 
University of Sheffield (http://www.shef.ac.uk/scharr/sections/heds/mvh/sf-
6d/revisions.html). Utilities are values that correspond to people preferences for 
various health outcomes (Drummond et al. 2005). In health economics, the 
utilities are used to generate quality-adjusted life years (QALYs). It can be 
calculated directly such as standard gamble, time trade-off or visual analogue 
scale or indirectly by applying the utility algorithm to the disease specific or 
generic HRQoL questionnaire such EQ5D or SF-6D, and HUI (Szende et al. 2006). 
The indirect method of applying the SF-6D algorithm to the SF-12 questionnaire 
produce a single digit utility score, indicating the overall HRQoL of the 
individuals ranges from 0 “death” to 1 “full health”. 
The strength of SF-12 includes the reduced burden on the respondents, in terms 
of less number of questions and the required time for completion. SF-12 
produces precise estimates when the summary scores are used, particularly in 
larger studies (Ware et al. 1996). The limitations include the 10% loss in ability 
to differentiate between various disease groups and the generation of less 
precise results in the individual domains in smaller studies, compared to the SF-
36 (Ware et al. 1999). When the sample size is less than 500, it is generally 
recommended to use the SF-36 for accurate results (Ware et al. 1996). 
Compared t o SF-36, there is inability of SF-12 to produce PCS and MCS when a 
single item is left unanswered (Pickard et al. 1999). Moreover, the SF-12 may 
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have less sensitivity and specificity when used as a screening tool, compared to 
SF-36 (Pickard et al. 1999). 
The Pediatric Quality of Life Inventory (PedsQL) is a generic HRQoL index 
developed for self-reporting by children and adolescents aged 5-18 years, as well 
as parent-proxy reporting for participants aged 2-18 years (Varni et al. 2003). It 
comprises of 23 items that encompass physical, emotional, social and school 
functioning. It produces standardized scores for overall, physical and 
psychosocial HRQoL, ranging from 0 to 100, with higher scores indicating better 
HRQoL. 
The strength of PedsQL is that it comprises of child-self reports and 
corresponding parents-proxy reports forms. Child self-reports is believed to be 
the standard for assessing the child’s own health, but it is reported that the 
parent assessment of child’s perceived health plays decisive role in utilizing the 
health care (Campo 2002; Varni et al. 1999; Sawyer et al. 2005). However, there 
is generally a poor agreement between child self-report and parent-proxy 
reports (r < 0.30), particularly for social and emotional domains (Eiser & Morse 
2001). It is reported that parent reports usually explain only 10-25% of variance 
in child perception of their own health (Varni et al. 2007). The PedsQL is used 
frequently in both clinical settings and general population as it is multi-
dimensional, requires only 5 minutes to complete, and is a straightforward 
scoring method. The 4.4 points change in the total score for child self-report is 
considered as minimal clinical importance difference (Varni 2003). The 
corresponding difference for parents is 4.5. PedsQL can be administered over 
the telephone from the child as young as eight years, which results in less 
burdensome and also reduce the possibility of missing outcome data (Dunaway et 
al. 2010).  
Self-reported health (SRH) is a simple but reliable measure of overall, 
subjective well-being (World Health Organization 2014). Several studies have 
demonstrated that it is a significant predictor of all-cause mortality. The 
participants are usually asked “In general how would you rate your overall 
health?: excellent, good, fair or poor”. In most studies, SRH is recoded into good 
(excellent or good) or poor (fair or poor) for analysis. 
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There is an ongoing debate that if a single question such as, SRH is available and 
is consistently reported to be a reliable measure then why to use a lengthy and 
multiple item questionnaires such as SF-36. The SRH has clear advantage of 
reducing burden on respondents, particularly when the researchers are only 
interested for a broader view of overall health rather than a detail assessment. 
Nonetheless, SRH is a simple and reliable measure but it is at the cost of a 
detailed assessment on the individual domains of subjective well-being (Bowling 
2005). A multi-item measure, such as SF-36 and SF-12 offer more precise and 
complete multi-dimensional information of the individual’s perception of their 
own health. Health is a central element of SRH; but it is not the only 
determinant. SRH may differ in different age-groups, men and women, socio-
economic status, comorbidity, employment, education, geographic location, 
psychological sense of community, and mental health status (Ross 2002; Idler & 
Benyamini 1997; Benyamini et al. 2000).  
Individuals give more importance to physical well-being than psychological well-
being when self-reporting their health (Smith et al. 1999). Compared to men, 
women are reported to consider a wider range of both health and non-health-
related factors in the course of reporting their self-assessed health (Idler & 
Benyamini 1997). SRH is influenced by the ongoing changes in the health status 
over time; improvement or decline rather than the current health status (Idler & 
Benyamini 1997). SRH is measured regularly in the OECD countries through 
national health surveys. Although the life expectancy in the OECD countries has 
considerably increased but there is a relative stability in the trend of SRH. This 
indicates that people in OECD countries have a longer life but may not be 
healthier (OECD 2011). There is also variation in the response categories in some 
countries. Most of the countries used 2 positive responses i.e, very good, good, 
fair, poor, very poor. In contrast, some countries like USA, Australia, New Zeland 
and Canada use 3 positive responses i.e, excellent, very good, good, fair, poor. 
The later may produce more positive results compared to the earlier one (OECD 
2011). 
The General Health Questionnaire-12 (GHQ-12) is a validated and widely-used 
measure of psychological well-being, and is suitable for use in the general 
population (Goldberg et al. 1997). The 12 questions ask about relevant 
experiences over the previous few weeks (including sleep disturbance, feelings 
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of tension, anxiety, stress, depression, lack of confidence and inability to cope). 
The responses to each question are summed producing an overall score ranging 
from 0 to 12. Higher GHQ scores (usually defined as ≥4) indicate poor 
psychological well-being.  
GHQ-12 is as robust as the GHQ-28, but it is very quick as can be administered 
only in two minutes (Goldberg et al. 1997). It is suggested that the longer GHQ 
should only be chosen if the investigators are interested in scaled score rather 
than the total score. GHQ-12 is widely used, which makes it possible to do 
comparisons between groups and monitor trends over time. However, it assesses 
the current mental health status and is not suitable for screening the long-term 
individual attributes. The GHQ can be used in adolescents but it is not 
recommended to be used for the screening of children psycho-social health. It is 
only a screening tool and an aid to diagnosis but it is not a detailed assessment 
of mental health (Goldberg et al. 1998). Many studies have found it as a valid 
and reliable measure of detecting the minor psychological distress (Quek 2001; 
Tait 2003), but some studies have revealed that GHQ-12 has lower positive 
predictive value in screening, and using it alone may misclassify people with 
psychiatric disorder (Gilbody 2001). Others have questioned its reliability as a 
screening tool for psychiatric morbidity (Hankins 2008; Hahn et al. 2006). It is 
not designed to detect specific mental disorder such as depression, anxiety or 
others but as a general indicator of mental health status. 
There is no single standardized happiness questionnaire, but overall happiness is 
usually self-reported and based on the response to the question “In general, how 
happy are you?; extremely happy, very happy, moderately happy, moderately 
unhappy, very unhappy or extremely unhappy”. 
1.8 Adiposity and subjective well-being 
There is a strong association between adiposity and a number of physical health 
conditions. In contrast, the research on adiposity and subjective well-being is 
still in its infancy. However, in the recent past, some studies have started to 
address this issue. Most have been based on the association between BMI and 
HRQoL. There is a need to review the existing literature on the association 
between BMI and HRQoL and to see if these results are corroborated by other 
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measures of subjective well-being, including self-rated health, happiness, GHQ-
12, and mood disorder. Further work is needed to explore whether the 
association between BMI and subjective well-being is robust to other measures of 
adiposity (BMI, WC, WHR and BF%), and whether it varies by sex and 
comorbidity, and to investigate the long-term outcomes of these different 
measures of subjective well-being. 
1.9 Summary of the introduction 
Adiposity is the accumulation of excessive body fat, mainly caused by the 
imbalance between energy intake and output. There are multiple factors 
involved in the development of adiposity, but the most important is the 
presence of an obesogenic environment. Adiposity can be spread through social 
networks. There are many measures of adiposity, but BMI has been the most 
commonly used measure, particularly in population studies. However, 
researchers are increasingly using additional measures such as WC, WHR and 
BF%. Therefore, many population studies are now recording multiple measures of 
adiposity on the same individuals. 
Over the past three decades, the prevalence of adiposity has nearly doubled. 
Traditionally, the adiposity epidemic was thought to be limited to developed 
countries but it is now known to be equally prevalent in developing countries. 
Worldwide, about one and a half billion adults are overweight and more than 
half a billion are obese. In Scotland alone, 53% of the adult population are either 
overweight or obese, and about 27% are obese (Figure 1.2). The prevalence of 
adiposity is expected to further rise.  
Adiposity is a significant predictor of many diseases, including CVD, respiratory 
disease, metabolic disorder, gastrointestinal diseases, and many malignancies. 
The impact of adiposity on morbidity and disease incidence is thought to be even 
greater than that of smoking, alcoholism and poverty. Being overweight is not 
significantly associated with mortality in many larger studies. However, obesity 
is thought to be a serious threat to the improvements in life-expectancy 
achieved over the last few decades. 
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As adiposity has reached epidemic levels in both developed and developing 
countries, the impact of this modifiable risk factor on the community is of 
greater concern, not only in terms of physical health and life-expectancy but 
possibly also in terms of subjective well-being. Previous studies have been 
limited in number and scope and suggest a complex relationship between 
adiposity and subjective well-being. This in an ideal time to collate and build on 
the existing evidence. 
1.10 Aims and objectives 
The aims of this thesis were to use large samples from the United Kingdom adult 
general population, firstly, to investigate the long-term outcomes associated 
with different measures of subjective well-being. Secondly, to determine overall 
relationships between different measures of adiposity (measured by BMI, WC, 
WHR, BF%) and different measures of subjective well-being (HRQoL, happiness, 
SRH, GHQ-12 and mood disorder) across the whole range of adiposity (from 
underweight to class III obese) and, thirdly, to determine whether any 
associations varied by sex, and comorbidity.  
The thesis comprises eight complementary studies that address the following 
specific objectives: 
1. To determine whether SRH and mental health (measured using the GHQ-
12) were independent predictors of incident cancer, psychiatric 
hospitalisations, incident CHD and all-cause deaths, and whether it varied 
by sex.  
2. To determine whether physical and mental HRQoL (measured using the 
SF-12) were independent predictors of incident cancer, incident CHD and 
all-cause deaths, and whether it varied by sex.  
3. To undertake a systematic review and meta-analysis of published studies 
to determine the relationships between adult BMI and mental and physical 
HRQoL.  
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4. To undertake a systematic review and meta-analysis of published studies 
to determine the relationships between childhood/adolescent BMI and 
overall, physical and psychosocial HRQoL.  
5. To investigate the relationship between “healthy obesity” (obesity 
without metabolic comorbidity) and overall HRQoL, and whether it varied 
by sex. 
6. To investigate the relationship between adiposity (measured by BMI) and 
mental health (measured using the GHQ-12), and whether it varies by sex.  
7. To investigate the relationship between adiposity (measured by BMI, WC, 
WHR and BF%) and probable major depression, and whether it varied by 
sex.  
8. To investigate the relationship between adiposity (measured by BMI, WC, 
WHR and BF%) and SRH, and whether it varied by sex. 
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2.1 Chapter summary 
Self-reported general health (GH) and mental health (MH) are independent 
predictors of all-cause mortality. This study examines whether they are also 
independent predictors of incident cancer, CHD and psychiatric hospitalisation.  
I conducted a retrospective, population cohort study by linking the 19,625 
Scottish adults who participated in the Scottish Health Surveys (SHeS) 1995-
2003, to hospital admissions, cancer registrations and death certificate records. I 
conducted Cox proportional hazard models adjusting for potential confounders 
including age, sex, socioeconomic status, alcohol, smoking status, BMI, 
hypertension and diabetes.  
Poor GH was reported by 1,215 (6.2%) participants and was associated with 
cancer registrations (adjusted HR 1.30, 95% CI 1.10, 1.55), CHD events (adjusted 
HR 2.30, 95% CI 1.86, 2.84) and psychiatric hospitalisations (adjusted HR 2.42, 
95% CI 1.65, 3.56). There was evidence of dose relationships and the associations 
remained significant after adjustment for MH. 3,172 (16%) participants had poor 
MH (GHQ ≥4). After adjustment for GH, the associations between poor MH and 
CHD events (adjusted HR 1.36, 95% CI 1.13, 1.63) and all-cause death (adjusted 
HR 1.38, 95% CI 1.23, 1.55) became non-significant, but MH remained associated 
with psychiatric hospitalisations (fully adjusted HR 2.02, 95% CI 1.48, 2.75).  
GH is a significant predictor of a range of clinical outcomes independent of MH. 
The association between MH and non-psychiatric outcomes is mediated by GH 
but it is an independent predictor of psychiatric outcome. Individuals with poor 
GH or MH warrant close attention.  
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2.2 Introduction 
GH is a simple but reliable measure of overall, subjective well-being 
(Martikainen et al. 1999; World Health Organization 1996). Several studies have 
demonstrated that it is a significant predictor of all-cause mortality (Benjamins 
et al. 2004; Idler & Benyamini 1997; Nielsen et al. 2008). There is a relative 
paucity of studies on the association between GH and specific diseases, 
especially in relation to non-fatal outcomes such as hospitalisation. Also, it is not 
clear to what extent the association is independent of lifestyle factors (Salomon 
et al. 2004; Sen 2002). Studies suggest that GH is influenced more by physical 
health than mental health (Mavaddat et al. 2011; Smith & Assmann 1999). 
Therefore, it is unclear whether GH predicts psychiatric hospitalisations as well 
as physical disease.  
The GHQ-12 is a validated measure of MH and has been widely used in 
population studies (Goldberg et al. 1997). GHQ score is predictive of both all-
cause mortality (Lazzarino et al. 2013; Robinson et al. 2004; Russ et al. 2012) 
and CVD (Brotman et al. 2007; Nicholson et al. 2006). It is not clear whether the 
association is independent of GH. Higher GHQ scores, indicative of poor MH, 
have also been observed among patients with other chronic diseases such as 
cancer in cross-sectional studies (Gao et al. 2010), but the association has rarely 
been studied longitudinally. Relatively few studies have formally tested for 
interactions but those that have suggest that the association between poor GH 
and all-cause death is greater in men than women, whilst the association 
between poor MH and all-cause death is stronger in women than men (Kivimaki 
et al. 2003; Tiainen et al. 2013).   
I hypothesized that GH may be an independent predictor of other forms of 
morbidity and that any association between MH and physical morbidity will be 
explained by GH. Some other recent studies have made similar hypotheses but 
they have rarely been tested, particularly in longitudinal studies (van der Linde 
et al. 2013). It is possible that they have a direct causal effect. Perceived health 
(general or mental) may impact on lifestyle and therefore incident disease and 
survival. It is also possible that subjective well-being is a marker of sub-clinical 
morbidity or that the incident diseases and subjective well-being share common 
risk factors. The aim of this study was to determine whether GH and MH were 
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independent predictors of incident cancer, psychiatric and CHD as well as all-
cause deaths, and whether the associations varied by sex.  
2.3 Material and methods 
2.3.1 Data sources  
The SHeS collects information on health and health-related risk factors in the 
Scottish general population 
(http://www.scotland.gov.uk/Topics/Statistics/Browse/Health/scottish-
healthsurvey). The first SHeS was undertaken in 1995. It was repeated in 1998 
and 2003 and, since 2008, has been undertaken annually. Different households 
have been targeted in each survey and the recruitment rates have exceeded 
60%. The members of participating households are interviewed by trained data 
collectors who use computer assisted personal interviewing (CAPI) to collect 
information on demographics (including age, sex, postcode of residence and 
social class), lifestyle (including smoking status and alcohol consumption) and 
SRH. During a subsequent visit, a nurse uses standard operating procedures and 
calibrated tools to record height, weight and blood pressure. More than 90% of 
SHeS participants have consented to passive follow up via record linkage to 
routine administrative data. The SHeS records have been linked, at an individual 
level, to several Scotland-wide databases including: death certificates (collated 
by the General Registrar Office), admissions to acute hospitals (Scottish 
Morbidity Record SMR01), psychiatric hospitalisation (Scottish Morbidity Record 
SMR04) and cancer registrations (Scottish Morbidity Record SMR06) (Gray et al. 
2010). Cancer was defined by the International Classification of Diseases-10 (ICD-
10) codes C00-C97. Psychiatric hospitalisation was defined as first hospitalisation 
with an ICD-10 code F00-F99 in principal position. CHD event was defined as 
death or hospitalisation due to CHD. The latter was defined as first 
hospitalisation with an ICD-10 code I20-I25 in the principal position. The SMR 
data are reported to be 94% accurate and 99% complete (NHS Scotland 2010). 
The extract of linked data provided follow-up to a censor date of 31 December 
2011.  
Chapter 2 SRH and adverse outcomes 
 
61 
 
2.3.2 Inclusion criteria and definitions 
For this study, I combined the first three SHeS surveys (1995, 1998 and 2003) and 
restricted my analyses to participants aged ≥16 years. I excluded participants 
with established cancer, CHD or psychiatric disease at recruitment. Age was 
categorised into 16-29, 30-44, 45-59 and ≥60 years. BMI was categorised into 
underweight (<18.5 kg/m2), normal weight (18.5-24.9 kg/m2), overweight (25.0-
29.9 kg/m2), class I (30.0-34.9 kg/m2), class II (35.0-39.9 kg/m2) and class III 
obese (≥40 kg/m2). The occupation of the household’s main income earner was 
used to derive social class: I (professional), II (managerial), III NM (skilled non 
manual), III M (skilled manual), IV (semi-skilled manual) and V (unskilled manual) 
(General Register Office), and area-based deprivation was derived from the 
postcode of residence using general population quintiles of the Scottish Index of 
Multiple deprivation (SIMD) 
(http://www.scotland.gov.uk/Topics/Statistics/SIMD). Smoking status and 
alcohol consumption were both self-reported and were categorised as never, 
previous and current, and never, previous, within limit and excessive 
respectively. Prevalent hypertension (blood pressure ≥140/90 mmHg or use of 
anti-hypertensive medication) and diabetes were based on self-report of a 
physician diagnosis. GH was self-reported and based on responses to the 
question; “In general, how would you rate your overall health.”  Possible 
responses were: very good, good, fair, bad and very bad. In this study, the five 
responses were collapsed into three categories: good (very good or good), fair 
and bad (bad or very bad). MH was based on participants’ responses to the GHQ-
12 questionnaire. GHQ-12 scores range from 0 to 12, with 12 indicating the 
poorest mental health. In this study, the scores were collapsed into three 
categories: 0, 1-3 and ≥4.  
2.3.3 Statistical analyses 
Differences in the characteristics of participants by GH and MH were analysed 
using chi-square tests for categorical data, and chi-square tests for trend for 
ordinal data. Separate Cox proportional hazard models were used to examine 
the association between GH and four separate outcomes: all-cause deaths, 
cancer registrations, CHD events (admissions or death) and psychiatric 
admissions. The model was run in three stages: adjusted for age only (model 1); 
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adjusted for age, sex, social class, SIMD quintile, BMI, alcohol consumption, 
smoking status, hypertension, diabetes and survey year (model 2); and adjusted 
for these covariates plus MH (model 2a). I tested for statistical interactions 
between GH and the covariates, including sex. The same Cox proportional 
hazard models were then repeated for MH, adjusting for GH in the final model. 
Global test was used to check the proportional-hazards assumption of the 
survival models (StataCorp 2011). All statistical analyses were performed using 
Stata version 12.1 (StataCorp, College Station, Texas). Statistical significance 
was defined as p<0.05. 
2.4 Results 
Of the 21,252 survey participants, 1,627 were excluded because of prevalent 
disease: 559 had cancer, 629 CHD and 439 psychiatric disease. Therefore, 19,625 
were eligible for inclusion. Of these, 8,858 (45.1%) were men, 6,494 (33.1%) 
were current smokers, 4,228 (21.5%) consumed excessive amounts of alcohol and 
3,919 (20.0%) had either hypertension, diabetes or both (Table 2.1). Their mean 
age at recruitment was 45 years (SD 16 years), and their mean BMI was 26.7 
kg/m2 (SD 5.0 kg/m2). Participants were followed-up for up to 17 years (median 
13 years), providing a total of 237,463 person years of follow-up. Incident events 
included 2,077 all-cause deaths, 1,777 cancer registrations, 829 CHD 
hospitalisations or deaths and 287 hospitalisations for psychiatric disease.  
Overall, 3,669 (18.7%) participants classified themselves as being in fair GH and 
1215 (6.2%) in bad GH. There was no significant difference between men and 
women. Compared to those with good GH, those with bad GH were more likely 
to be old, socioeconomically deprived, obese, smoke and have hypertension or 
diabetes, but were less likely to consume excessive amounts of alcohol (Table 
2.1). Overall, 3,172 (16.2%) participants had poor MH (GHQ-12 score ≥4). 
Compared to those with good MH (GHQ-12 score 0), they were more likely to be 
women, young, socioeconomically deprived, smoke, and have diabetes or 
hypertension, but were not significantly different in terms of alcohol 
consumption and BMI (Table 2.1). Of the 1,215 participants with bad GH, 202 
(16.6%) had good MH (GHQ-12 score 0), and of the 3,172 participants who had 
poor MH (GHQ-12 score ≥4), 1526 (48.1%) reported good GH.  
Chapter 2 SRH and adverse outcomes 
 
63 
 
 
Table 2.1 Baseline characteristics of study population in relation to self-reported general 
health and mental health (measured by GHQ-12) 
 
  
 
Self-reported General Health  GHQ-12 score   
 
Good Fair Bad 
 
0 1-3 ≥4 
 
 
N=14 741 N=3669 N=1215 
 
N=11 720 N=4733 N=3172 
 
 
N (%) N (%) N (%) P  N (%) N (%) N (%) P  
 
Sex         
    Male 6630 (45.0) 1644 (44.8) 584 (48.1) 0.104 5574 (47.6) 2087 (44.1) 1197 (37.7) <0.001 
    Female 8111 (55.0) 2025 (55.2) 631 ( 51.9) 
 
6146 (52.4) 2646  (55.9) 1975 (62.3) 
 
Age (years) 
       
   16-29 2990 (20.3) 504 (13.7) 59 (4.9) <0.001 2062 (17.6) 966 (20.4) 525 (16.6) 0.001 
   30-44 5294 (35.9) 904 (24.6) 257 (21.2) 
 
3845 (32.8) 1506 (31.8) 1104 (34.8) 
 
   45-59 3947 (26.8) 1131 (30.8) 458 (37.7) 
 
3253  (27.8) 1294 (27.3) 989 (31.2) 
 
   ≥60 2510 (17.0) 1130  (30.8) 441 (36.3) 
 
2560 (21.8) 967 (20.4) 554 (17.5) 
 
Body Mass Index 
       
Underweight 179 (1.2) 73 (2.0) 31 (2.6) <0.001 142 (1.2) 66 ( 1.4) 75 ( 2.4) 0.152 
Normal-weight 6079 (41.2) 1185 (32.3) 360 (29.6) 
 
4437 (37.9) 1913(40.4) 1274 (40.2) 
 
 Overweight 5738 (38.9) 1308 (35.7) 411 (33.8) 
 
4684 (40.0) 1704 (36.0) 1069 ( 33.7) 
 
Class I obese  2071 (14.1) 738 (20.1) 238 (19.6) 
 
1803 (15.4) 761 (16.1) 483 ( 15.2) 
 
Class II obese  493 (3.3) 256 (7.0) 108 (8.9) 
 
461 (3.9) 208 (4.4) 188 (5.9) 
 
Class III obese  181 (1.2) 109 (3.0) 67 (5.5) 
 
193 (1.7) 81 (1.7) 83 (2.6) 
 
SIMD 
        
1  2582 (17.5) 1083 (29.5) 488 (40.2) <0.001 2157 (18.4) 1073 (22.7) 923 (29.1) <0.001 
 2 2969 (20.1) 911 (24.8) 331 (27.2) 
 
2418 (20.6) 1023 (21.6) 770 (24.3) 
 
 3 3150 (21.4) 736 (20.1) 184 (15.1) 
 
2516 (21.5) 1000 (21.1) 554 (17.5) 
 
 4 3075 (20.9) 574 (15.7) 136 (11.2) 
 
2458 (21.0) 841 (17.8) 486 (15.3) 
 
5  2965 (20.1) 365 (10.1) 76 (6.3) 
 
2171 (18.5) 796 (16.8) 439 (13.8) 
 
Social Class 
     
  I & II 5111 (34.7) 807 (22.0) 201 (16.5) <0.001 3713 (31.7) 1558 (32.9) 848 (26.7) <0.001 
  III NM 2223 (15.1) 466 (12.7) 129 (10.6) 
 
1654 (14.1) 664 ( 14.0) 500 (15.8) 
 
  III M 4452 (30.2) 1297 (35.4) 472 (38.9) 
 
3826 (32.7) 1413 (29.9) 982 (31.0) 
 
  IV/V 2955 (20.1) 1099 (30.0) 413 (34.0) 
 
2527 (21.6) 1098 (23.2) 842 (26.5) 
 
Smoking status 
       
  Never 6994 (47.5) 1195 (32.6) 244 (20.1) <0.001 5330 (45.5) 2021 (42.7) 1082 (34.1) <0.001 
  Previous 3445 (23.4) 911 (24.8) 342 (28.2) 
 
2904 (24.8) 1140 ( 24.1) 654 (20.6) 
 
  Current 4302 (29.2) 1563 (42.6) 629 (51.8) 
 
3486 (29.7) 1572 (33.2) 1436 (45.3) 
 
Alcohol consumption 
       
  Never 650 (4.4) 218 (5.9) 101 (8.3) <0.001 581 (5.0) 233 (4.9) 155 (4.9) 0.244 
  Previous 401 (2.7) 248 (6.8) 152 (12.5) 
 
380 (3.2) 198 (4.2) 223 (7.0) 
 
  Within limits 
10421 
(70.7) 
2436 (66.4) 770 (63.4) 
 
8291 (70.7) 3255 (68.8) 2081 (65.6) 
 
  Excessive 3269 (22.2) 767 (20.9) 192 (15.8) 
 
2468 (21.1) 1047 (22.1) 713 (22.5) 
 
Medical comorbidity 
       
  No 12591 (85.4) 2467 (67.3) 648 (53.3) <0.001 9637 (82.2) 3736 (78.9) 2333 (73.6) <0.001 
  Yes 2150 (14.6) 1202 (32.8) 567 (46.7) 
 
2083 (17.8) 997 (21.1) 839 (26.5) 
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GHQ-12 score 
  0 9930 (67.4) 1588 (43.3) 202 (16.6) <0.001 - - - 
 
  1-3 3285  (22.3) 1114 (30.4) 334 (27.5) 
 
- - - 
 
  ≥4 1526  (10.4) 967 (26.4) 679 (55.9) 
 
- - - 
 
Self-reported general health 
      
 Good - - - 
 
9930 (84.7) 3285 (69.4) 1526 (48.1) <0.001 
 Fair - - - 
 
1588 (13.6) 1114 (23.5) 967 (30.5) 
 
 Bad - - - 
 
202 (1.7) 334 (7.1) 679 (21.4) 
 
P values were determined by χ2 test.GHQ General Health Questionnaire; N number; SIMD 
Scottish Index of Multiple Deprivation 1 most deprived, 1 least deprived; NM non-   manual; M 
manual 
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There were positive dose relationships between baseline GH and all-cause 
deaths, cancer registrations, CHD events, and psychiatric hospitalisations (Figure 
2.1). Compared with those with good GH, participants with bad GH were 
significantly more likely to experience all of the adverse outcomes when 
adjusted for age only (Table 2.2). Further adjustment, for all potential 
confounders (model 2), attenuated the associations slightly but they all 
remained statistically significant (Table 2.2). Studies have reported that the 
baseline MH may also influence the GH (Han 2002; DeSalvo et al. 2006). To 
explore this, the model 2 was adjusted for MH, but it did not bring any 
significant change (model 2a, Table 2.2). There was a significant interaction 
with age (p<0.001), but not with sex (p=0.443). 
 
There were positive dose relationships between MH and all-cause death, CHD 
events and psychiatric hospitalisations, but not with cancer registrations (Figure 
2.1). In the Cox proportional hazard model, poor MH was associated with a 
significantly increased risk of all-cause death and cardiovascular events (Table 
2.3). After adjustment for potential confounders, the HR were attenuated but 
remained statistically significant. When also adjusted for GH, the associations 
became statistically non-significant. There was no significant association 
between MH and cancer registrations. MH was a significant, independent 
predictor of psychiatric admissions, and remained so after adjustment for GH 
(Table 2.3). There was no significant interaction with sex (p=0.163).  
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Table 2.2 Cox proportional hazard models of the association between self-reported general 
health and adverse outcomes of Scottish adults (n=19,625) 
 
HR, hazard ratio; CI, confidence interval 
Model 1 adjusted for age; Model 2 adjusted for age, sex, social class, SIMD quintile, body mass 
index, alcohol consumption, smoking status, hypertension, diabetes and survey year; Model 2a 
adjusted for same covariates as Model 2 plus self-rated mental health (GHQ-12 score) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Model 1 
 
Model 2 
 
Model 2a 
  
HR (95% CI) 
 
P value HR (95% CI) P value HR (95% CI) P value 
All-cause death 
   
  
Good 1.00 
 
1.00 
 
1.00  
Fair 2.10 (1.90, 2.31) <0.001 1.67 (1.51, 1.86) <0.001 1.66 (1.50, 1.85) <0.001 
Bad 3.74 (3.32,4.20) <0.001 2.50 (2.20, 2.83) <0.001 2.48 (2.16, 2.85) <0.001 
Cancer registration 
   
  
Good 1.00 
 
1.00 
 
1.00  
Fair 1.13 (1.01, 1.27) 0.032 1.08 (0.96, 1.22) 0.195 1.08 (0.96, 1.22) 0.189 
Bad 1.41 (1.20, 1.66) <0.001 1.30 (1.10, 1.55) 0.003 1.32 (1.09, 1.58) 0.003 
 
Coronary heart disease hospitalisation/death 
 
  
Good 1.00 
 
1.00 
 
1.00  
Fair 1.75 (1.49, 2.06) <0.001 1.39 (1.18, 1.64) <0.001 1.37 (1.16, 1.63) <0.001 
Bad 3.34 (2.75, 4.06) <0.001 2.30 (1.86, 2.84) <0.001 2.26 (1.79, 2.84) <0.001 
Psychiatric hospitalisation 
 
  
Good 1.00 
 
1.00 
 
1.00  
Fair 2.37 (1.82, 3.09) <0.001 1.88 (1.43, 2.47) <0.001 1.60 (1.21, 2.13) 0.001 
Bad  
 
3.80 (2.65, 5.46) <0.001 2.42 (1.65, 3.56) <0.001 1.73 (1.15, 2.62) 0.009 
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Table 2.3 Cox proportional hazard models of the association between self-
reported mental health (GHQ-12 score) and adverse outcomes of Scottish adults 
(n=19,625) 
 
 
 
Model 1 Model 2 
 
Model 2a 
 
 
HR (95% CI) 
 
P value 
 
HR (95% CI) 
 
P value 
 
HR (95% CI) 
 
P value 
 
All-cause death 
 
  
 
  0 1.00 
 
1.00  1.00 
 
 1-3 1.33 (1.20, 1.47) <0.001 1.25 (1.13, 1.39) <0.001 1.06 (0.95, 1.18) 0.273 
  ≥4  1.75 (1.57, 1.96) <0.001 1.38 (1.23, 1.55) <0.001 1.00 (0.88, 1.13) 0.968 
Cancer registration 
 
  
  0 1.00 
 
1.00  1.00 
 
1-3 1.04 (0.93, 1.16) 0.515 1.04 (0.93, 1.16) 0.509 1.01 (0.90, 1.13) 0.883 
 ≥4  1.09 (0.95, 1.24) 0.210 1.05 (0.92, 1.20) 0.468 0.97 (0.84, 1.13) 0.724 
Coronary heart disease hospitalisation/death   
  0 1.00 
 
1.00  1.00 
 
 1-3 1.20 (1.02, 1.42) 0.027 1.18 (1.00, 1.39) 0.055 1.05 (0.89, 1.24) 0.571 
≥4  1.57 (1.32, 1.88) <0.001 1.36 (1.13, 1.63) 0.001 1.04 (0.85, 1.27) 0.732 
Psychiatric hospitalisation  
 
  
  0 1.00 
 
1.00  1.00 
 
 1-3 1.88 (1.42, 2.49) <0.001 1.76 (1.33, 2.33) <0.001 1.61 (1.21, 2.14) 0.001 
 ≥4  
 
3.02 (2.28, 4.00) 
 
<0.001 
 
2.41 (1.81, 3.21) 
 
<0.001 
 
2.02 (1.48, 2.75) 
 
<0.001 
 
 
HR, hazard ratio; CI, confidence interval 
Model 1 adjusted for age; Model 2 adjusted for age, sex, social class, SIMD quintile, body mass 
index, alcohol consumption, smoking status, hypertension, diabetes and survey year; Model 2a 
adjusted for same covariates as Model 2 plus self-rated general health  
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Figure 2.1 Frequency (%) of adverse outcomes by self-reported general health (GH) and mental Health [GHQ-12 score]. 
a. All-cause death (N=2,077)                                                                               b. Cancer registration (N=1,777)          
      
c. Coronary heart disease hospitalisation/death (N=829)                                  d. Psychiatric hospitalisation (N=287)                               
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2.5 Discussion 
GH was a significant predictor of incident cancer, psychiatric hospitalisations 
and CHD events as well as all-cause mortality. The associations were 
independent of potential confounders and MH, and there was evidence of a dose 
relationship. In contrast, MH was not associated with cancer and the association 
with CHD and all-cause death was lost when adjusted for GH. However, it was a 
significant independent predictor of psychiatric hospitalisations. There were no 
statistically significant differences in the associations between men and women.   
The United Kingdom “Annual Population Survey 2011/12” revealed that GH was 
the most important determinant of personal well-being; followed by 
employment and relationship status (Oguz et al. 2013). Those with poor GH 
were, on average, less satisfied, more unhappy and more likely to be depressed.  
Poor GH has been widely studied as a predictor of all-cause mortality. The latest 
meta-analysis collated data from 14 studies published up to 2003, and reported a 
pooled RR of 1.92 (95% CI 1.64, 2.25) (DeSalvo et al. 2006). Five of the 14 
studies adjusted for baseline depression, reducing the pooled RR to 1.87 (95% CI 
1.31, 2.67). None of the studies used the GHQ to measure MH. This study 
corroborates the previous studies in demonstrating an association between poor 
GH and all-cause mortality (adjusted HR 2.50, 95% CI 2.20, 2.83, p<0.001) but 
adjustment for MH made very little difference to the magnitude of the 
association; the HR changing from 2.50 to 2.48. Most of the studies included in 
the meta-analysis were conducted in the USA. Only one of the studies was 
conducted in the United Kingdom; it did not adjust for mental health and 
included only participants aged 65 years and above (Bath PA 2003). Overall, the 
number of participants ranged from 630 to 6,523, with a total of 31,350 
participants. The maximum number of deaths in any study was 1,919, with a 
total of 8,437 deaths. Among the studies that adjusted for depression, the 
maximum number of participants in any study was 3,971 and the maximum 
number of deaths was 854. This study of almost 20,000 adults followed-up for up 
to 17 years provided information on more than 2,000 deaths.  
In contrast to all-cause mortality, GH has not been extensively studied as a 
predictor of other health outcomes. In a cohort study of 4,770 US adults aged 
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51-61 years, Latham and Peek demonstrated associations between GH and a 
number of self-reported incident conditions including arthritis, diabetes, lung 
disease, stroke (Latham & Peek 2013). Compared with participants who had poor 
GH, those with excellent GH were significantly less likely to report subsequent 
CHD (adjusted HR 0.80). In contrast, GH was not associated with cancer. Van der 
Linde and colleagues conducted a prospective cohort study of 20,041 residents 
of Norfolk, England, aged 39-74 years. Over an average follow-up period of 11 
years (range 0-14 years), they recorded 2,176 CVD events, and they reported a 
HR of 3.3 (95% CI 2.4, 4.4) for the association between poor GH and CVD (van 
der Linde et al. 2013). In my study, poor GH was associated with both CHD and 
cancer but the association with CHD (HR 2.30, 95% CI 1.86, 2.84, p<0.001) was 
stronger than with cancer (HR 1.30, 95% CI 1.10, 1.55, p=0.003) and only the 
former demonstrated a dose-relationship. Very few studies have explored the 
relationship between GH and subsequent depression. Kosloski et al. showed a 
small but significant effect of GH on depressive symptoms over time in an 
autoregressive, cross-lagged panel study of 7,475 US participants (Kosloski et al. 
2005). Badawi G et al analyzed repeated cross-sectional surveys of 1,265 
Canadian adults with type II diabetes (Badawi et al. 2013). When re-assessed 
after three years, those with poor GH at baseline had a two-fold increased risk 
of self-reported depression even after controlling for potential confounders 
(adjusted odds ratio [OR] 2.05, 95% CI 1.20, 3.48). In a prospective cohort study 
of 1,468 Canadians aged 65 years or older, St John and Montgomery reported 
that GH was associated with future dementia among participants who were 
cognitively intact at baseline (St John & Montgomery 2013). Similar findings 
were reported in a French prospective cohort study (Montlahuc et al. 2011). 
Both studies reported HR of around 2.5. 
Some studies have reported that GH was a stronger predictor of health outcomes 
in men than women (Hirve et al. 2012), whilst others have reported the reverse 
(Nery Guimaraes et al. 2012), and some have reported no difference (Bath PA 
2003; van der Linde et al. 2013). Most studies have not reported interaction 
tests and many were underpowered to do so. I formally tested for an interaction 
with sex but no significant difference was found.  
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Fewer studies have been conducted on MH than GH. A recent large study using 
multiple English Health Surveys reported a HR for all-cause death of 1.37 (95% CI 
1.23, 1.51) for GHQ scores of 4-6, and a HR of 1.67 (95% CI 1.41, 2.00) for GHQ 
scores ≥7 (Russ et al. 2012). In contrast, other studies have reported no 
significant associations in either men or women (Kivimaki et al. 2003). This study 
demonstrated a dose relationship between MH and all-cause mortality with 
significantly higher risk even among participants with GHQ-12 scores between 1 
and 3 (adjusted HR 1.25, 95% CI 1.13, 1.39, p<0.001). Nicholson et al followed-
up 5,449 men aged 35-55 years who were living in London, over a mean of 6.8 
years. They reported a significant association between poor MH and CHD events, 
which was highest among those with recent onset distress (HR 1.77, 95% CI 1.13, 
2.78) (Nicholson et al. 2006). Another study reported an OR of 1.83 (95% CI 1.5, 
2.3) for the association between psychological distress at baseline and self-
reported CHD among 2,383 middle-aged participants working in London 
(Stansfeld et al. 2002). My finding of no association between MH and cancer is 
consistent with previous studies. A prospective cohort study of Scottish adults 
with 30 years follow-up reported a significant association between moderate 
stress (GHQ 4-5) and both breast cancer (HR 2.16, 95% CI 1.00, 4.71) and 
prostate cancer (HR 1.65, 95% CI 1.20, 2.27), but no significant association with 
more severe stress (≥6) (Russ et al. 2012). A Scottish retrospective cohort study 
of 15,453 participants who were followed up for an average of 7 years, 
demonstrated a significant association with cancer mortality among the 295 
participants who had a history of cancer at baseline (HR 1.97, 95% CI 1.05, 3.71), 
but not in cancer-free individuals (Hamer et al. 2009).  
The study included in this Chapter did not explore the underlying mechanism by 
which subjective well-being may impact on health and life-expectancy. It has 
been suggested that subjective well-being provides additional information by 
incorporating both subjective assumptions and objectively measured health 
(Idler et al. 2000). Previous studies have suggested that personality traits, such 
as optimism, may inflate self-assessment of health (Benyamini et al. 2000). 
Others have related good GH with better immune responses (Lekander et al. 
2004). GH may detect very early symptoms of underlying disease at subclinical 
stage. Finally, subjective well-being may reflect an individual’s attitude towards 
improving health, and thus adopting preventive measures (Idler & Benyamini 
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1997). MH was not associated with risk of all-cause mortality when adjusted for 
GH. This possibly reflects the fact that GH is a measure of perceived overall 
health and includes perceived MH, whereas MH is only one component. 
2.6 Strengths and limitations 
Use of the SHeS provided me with a large, representative sample of Scottish 
adults recruited from the general population, and enabled me to adjust for a 
series of potential confounders and test for interactions. Many previous studies 
have used GH and MH as binary variables. By using ordinal data I was able to 
examine whether there were evidence of a dose relationship. The GHQ-12 is 
validated measure of MH and has been widely used in epidemiological studies. 
The WHO recommended that GH should be a standard component of health 
surveys and is, thus, worldwide, the most frequently used measure of health in 
surveys (World Health Organization 1996). Use of a cohort, rather than cross-
sectional, design enabled me to demonstrate a temporal relationship between 
baseline GH and MH and incident disease, and avoid reverse causation. The 
Scottish Morbidity Record system has Scotland wide coverage and is subjected to 
regular quality assurance checks. Linkage to SMR records and death certificates 
enabled me to study both all-cause mortality and disease-specific outcomes in 
the same cohort.  
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2.7 Implications of this research 
GH is a strong predictor of all-cause death, cancer, CHD events and psychiatric 
hospitalisations. The association is independent of potential confounders and 
MH. Further research is required to understand the underlying mechanism. 
Individuals with poor GH are a higher risk group who may merit closer 
surveillance and earlier intervention. Subjective well-being is as important as 
objective measures of health risk, and should be considered in identifying how 
best to target public health and health care interventions.  
This chapter suggests that SRH is a strong independent predictor of fatal and non 
fatal adverse outcomes in the Scottish adult population but SRH is only one 
aspect of subjective well-being. Therefore, in the next chapter (Chapter 3), I 
will explore whether the same associations exist for another measure of 
subjective well-being: HRQoL.
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3.1 Chapter summary 
HRQoL is associated with adverse outcomes in disease-specific populations. This 
study examines whether it is also an independent predictor of incident cancer, 
CHD and mortality in the general population.  
The records of adult participants in the SHeS 2003 were linked with hospital 
admissions, cancer registrations and death certificates. Cox proportional hazard 
models were used to explore the associations between quintiles of physical and 
mental component summary scores (PCS and MCS respectively) of the SF-12 and 
adverse outcomes. Higher quintiles of both PCS and MCS indicate better health 
status. 
Among the 5,272 study participants, the mean PCS score was 49 (standard 
deviation (SD) 10.3). Participants were followed-up for a mean of 7.6 years. On 
survival analysis the lowest quintile of PCS was a strong predictor of all-cause 
death HR 2.81, 95% CI 1.76, 4.49), incident cancer (HR 1.63, 95% CI 1.10, 2.42), 
and CHD events (HR 1.99, 95% CI 1.00, 3.96), compared to the highest quintile. 
This association was independent of potential confounders. The mean MCS score 
was 52 (SD 8.8). MCS quintile was not associated with incident cancer, CHD and 
all-cause death. 
Physical HRQoL is a significant predictor of a range of adverse outcomes, even 
after adjustment for potential confounders. This study highlights the importance 
of subjective well-being in the general population. 
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3.2 Introduction 
Studies have shown that overall HRQoL is associated with adverse outcomes, 
such as hospitalisation and death, in several disease-specific populations 
including: patients receiving haemodialysis (Kalantar-Zadeh et al. 2001) and 
patients with diabetes (Li CL et al. 2013), pulmonary diseases (Nishiyama et al. 
2012), CHD (Zuluaga et al. 2010), stroke (Grool et al. 2012), cancer (Sehlen et 
al. 2012), arthritis (Michaud et al. 2012), and liver disease (Kanwal et al. 2009). 
However, results have conflicted in relation to the associations with the physical 
and mental components of HRQoL. Some studies have shown that physical HRQoL 
is significantly associated with adverse outcomes (Li Chang et al. 2013), but 
others have reported no association (Nishiyama et al. 2012). Similar 
contradictory findings have been reported for mental HRQoL (Hayashino et al. 
2009; Osthus et al. 2012). There is a general paucity of studies that have 
examined the associations between overall, physical or mental HRQoL and 
adverse outcomes in the general population (Haring et al. 2011). 
SF-12 is a validated and widely used tool for measuring generic HRQoL (Ware Jr. 
et al. 1996). It is a shorter version of SF-36, takes only one-third of the time to 
complete and is, therefore, used in many large surveys (Burstrom & Fredlund 
2001). The 12 questions of SF-12 are combined to form summary scores for 
physical and mental HRQoL, called PCS and MCS. These summary scores are 
closely correlated with those produced using the SF-36 (Wee et al. 2008). 
In Chapter 2, I conducted a retrospective cohort study of 20,000 Scottish adults 
with 17 years follow-up. I found that poor SRH at baseline was an independent 
predictor of all-cause death, incident cancer, psychiatric hospitalisations and 
CHD events (Chapter 2, Ul-Haq et al. 2014a). In contrast, there was no 
independent association between poor mental health (measured by GHQ-12) and 
these adverse outcomes.  
In this study I investigate whether physical and mental HRQoL (derived from the 
SF-12) were independent predictors of incident cancer, CHD events, and all-
cause deaths, and whether the associations varied by sex among a large 
representative sample from the Scotland adult population, after adjusting for 
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potential confounding factors including: demographic and life-style factors, 
socio-economic status and medical comorbidity.  
3.3 Material and methods 
3.3.1 Data sources  
I used an extract of data from the SHeS 2003.  
(http://www.scotland.gov.uk/Topics/Statistics/Browse/Health/scottish-health-
survey). Unlike, the earlier two SHeS’s, which were conducted in 1995 and 1998, 
the SHeS 2003 had no age limitation and it is the only SHeS which included the 
SF-12 questionnaire to measure the physical and mental HRQoL. The details of 
the SHeS have been described previously in Chapter 2. In brief, participants 
were interviewed face to face by trained staff who collected information on 
demographics (including age and sex), socio-economic status (including area of 
residence and level of education) and lifestyle behaviours (including smoking 
habits and alcohol consumption) as well as completing the SF-12 questionnaire. 
The data collectors also measured the weight and height of study participants. In 
a follow-up visit, a qualified nurse measured blood pressure and collected saliva 
and urine samples. The overall response rate was around 60%. Furthermore, over 
90% of SHeS participants consented to passive follow-up via record linkage to the 
Scotland-wide routine administrative databases held by the Information Services 
Division including: admissions to acute hospital (Scottish Morbidity Record 
SMR01), cancer registrations (Scottish Morbidity Record SMR06) and death 
certificates (Gray et al. 2010). The SMR data undergo regular quality assurance 
checks and have been shown to be 99% complete and 94% accurate (NHS 
Scotland 2010). The linkage provided follow-up data up to a censor date of 31 
December 2011.  
3.3.2 Inclusion criteria and definitions 
SF-12 questionnaires were completed by SHeS participants aged ≥20 years. 
Therefore analysis was restricted to this age-group. Participants with a history of 
cancer or CHD at the time of the baseline interview were excluded from the 
study. Study participants were categorized into 20-44, 45-64 and ≥65 years of 
age. BMI was categorized, using WHO standardized cut-off points, into 
underweight (<18.5 kg/m2), normal weight (18.5-24.9 kg/m2), overweight (25.0-
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29.9 kg/m2), and obese (≥30 kg/m2). Obese was further categorized into class I 
(30.0-34.9 kg/m2), class II (35.0-39.9 kg/m2) and class III obese (≥40 kg/m2). The 
level of education was treated as four categories from level 1 (less than O level 
grade C) to level 4 (degree level or above). SIMD was used as the measure of 
socio-economic status. SIMD is a validated and widely used area-based measure 
of multiple deprivations and is derived from participants’ postcodes of 
residence. SIMD is calculated using 31 indicators across 6 domains: income, 
employment, housing, health, education, skills and training, and area based 
access to the services (http://www.scotland.gov.uk/Topics/Statistics/SIMD). 
Self-reported smoking status was categorized into never, previous or current, 
and alcohol consumption was categorized as never, previous, within limits and 
excessive. Hypertension was defined as ≥140/90 mmHg or use of anti-
hypertensive medication. Presence of diabetes was based on self-report of a 
physician diagnosis. PCS and MCS were calculated from the 12 responses to the 
SF-12 questionnaire. Higher scores indicate better physical and mental health 
status respectively. PCS and MCS score quintiles were used in the analyses. 
Cancer was defined using ICD-10 codes C00-C97. CHD event was defined as death 
or hospitalisation due to CHD. The latter was defined as first hospitalisation 
using ICD-10 code I20-I25 in the primary position of diagnosis. 
3.3.3 Statistical analyses 
The characteristics of participants by quintile of PCS and MCS were analysed 
using chi-square tests or chi-square tests for trend for binary and ordinal data 
respectively. Separate Cox proportional hazard models were used to examine 
the associations between PCS and MCS quintile and three outcomes: all-cause 
deaths, cancer registrations, and CHD events (hospitalisations or death). The 
highest quintile (best HRQoL) was used as the referent category. The models 
were first adjusted for age only (model 1), followed by further adjustment for 
sex, SIMD, education level, smoking status, BMI, alcohol consumption and 
medical comorbidity (hypertension and diabetes) (model 2). Global test was 
used to check the proportional-hazards assumption of the survival models 
(StataCorp 2011). I tested for statistical interactions between HRQoL summary 
scores and sex. All statistical analyses were performed using Stata version 12.1 
(StataCorp, College Station, Texas). Statistical significance was defined as 
p<0.05. 
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3.4 Results 
Of the 5,272 participants, 2,889 (54.8%) were women, 1,392 (26.4%) were 
current smokers, 1,096 (20.8%) consumed excessive amounts of alcohol and 
1,316 (25%) had either hypertension, diabetes or both. Their mean age at 
recruitment was 50 years (SD 16 years). The mean BMI was 27.5 kg/m2 (SD 5.1 
kg/m2); 59 (1.1%) were underweight, 1,689 (32%) normal-weight, 2,152 (40.8%) 
overweight, and 1,372 (26%) obese. Of the obese, 940 (17.8%) were class I, 297 
(5.6%) were class II, and 135 (2.6%) were class III obese (Table 3.1). Participants 
were followed-up for a maximum of 8 years (median 7.8 years), providing a total 
of 40,067.2 person years of follow-up. Incident events included 391 (7.4%) all-
cause deaths, 368 (7.0%) cancer registrations, and 134 (2.5%) CHD 
hospitalisations or deaths. I found no evidence that my specification violates the 
proportional-hazards assumption (p=0.246). 
Overall, the mean PCS score was 49 (SD 10.3). The lowest quintile equated to < 
42 and the highest to >56. Compared to the participants who were in the highest 
quintile of PCS (better physical HRQoL), those in the lowest quintile were older 
and more likely to be obese, male, socio-economically deprived, smoke and have 
hypertension or diabetes, but were less likely to consume excessive amounts of 
alcohol or have a higher degree (Table 3.1). Overall, the mean MCS score was 52 
(SD 8.8). The lowest quintile equated to <47 and the highest quintile to >58. 
Compared to the participants who were in the highest quintile of MCS (better 
mental HRQoL), those in the lowest quintile were younger and more likely to be 
morbidly obese, female, well educated, smoke and consume excessive amounts 
of alcohol, but were less likely to have hypertension or diabetes or be socio-
economically deprived (Table 3.1).  
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Table 3.1 Characteristics of the participants by physical and mental component summary score quintiles of the SF-12 
 
 
Physical component quintile (score) 
 
Mental component quintile (score) 
 
 
1 (<42) 2 (42 - <51) 3 (51 - <55) 4 (55 - <56) 5 (≥56) 
 
1 (<47) 2 (47 - <53) 3 (53 - <56) 4 (56 - <58) 5 (≥58) 
 
 
N=1,055 N=1,054 N=1,057 N=1,068 N=1,038 
 
N=1,055 N=1,054 N=1,057 N=1,068 N=1,038 
 
 
N (%) N (%) N (%) N (%) N (%) P value N (%) N (%) N (%) N (%) N (%) P value 
Body Mass Index       
     
 
Underweight 24 (2.3) 4 (0.38) 9 (0.85) 11 (1.0) 11 (1.1) <0.001 21 (2.0) 4 (0.4) 15 (1.4) 11 (1.0) 8 (0.8) 0.045 
Normal-weight 251 (23.8) 287 (27.2) 330 (31.2) 358 (33.5) 463 (44.6)  338 (31.7) 365 (34.0) 379 (36.0) 358 (32.6) 249 (25.4)  
Overweight 369 (35.0) 416 (39.5) 445 (42.1) 496 (46.4) 426 (41.0)  391 (36.7) 435 (40.5) 441 (41.9) 484 (44.0) 401 (40.9)  
Obese 411 (39.0) 347 (32.9) 273 (25.8) 203 (19.0) 138 (13.3)  315 (29.6) 271 (25.2) 217 (20.6) 247 (22.5) 322 (32.9)  
   Class I  261 (24.7) 222 (21.1) 202 (19.1) 148 (13.9) 107 (10.3)  184 (17.3) 190 (17.7) 162 (15.4) 171 (15.6) 233 (23.8)  
   Class II  95 (9.0) 95 (9.0) 48 (4.5) 34 (3.2) 25 (2.4)  81 (7.6) 54 (5.0) 39 (3.7) 56 (5.1) 67 (6.8)  
   Class III  55 (5.2) 30 (2.9) 23 (2.2) 21 (2.0) 6 (0.6)  50 (4.7) 27 (2.5) 16 (1.5) 20 (1.8) 22 (2.2)  
Sex             
Men 463 (43.9) 476 (45.2) 508 (48.1) 508 (47.6) 428 (41.2) <0.001 419 (39.3) 448 (41.7) 488 (46.4) 532 (48.4) 496 (50.6) <0.001 
Women 592 (56.1) 578 (54.8) 549 (51.9) 560 (52.4) 610 (58.8)  646 (60.7) 627 (58.3) 564 (53.6) 568 (51.6) 484 (49.4)  
Age (years)             
 20-44 201 (19.1) 404 (38.3) 507 (48.0) 527 (49.3) 573 ( 55.2) <0.001 473 (44.4) 508 (47.3) 518 (49.2) 484 (44.0) 229 (23.4) <0.001 
 45-64 419 (39.7) 400 (38.0) 395 (37.4) 403 (37.7) 389 (37.5)  409 (38.4) 422 (39.3) 386 (36.7) 416 (37.8) 373 (38.1)  
 ≥65 435 (41.2) 250 (23.7) 155 (14.7) 138 (12.9) 76 (7.3)  183 (17.2) 145 (13.5) 148 (14.1) 200 (18.2) 378 (38.6)  
SIMD             
 1 (most deprived) 267 (25.3) 197 (18.7) 153 (14.5) 157 (14.5) 105 (10.1) <0.001 246 (23.1) 182 (16.9) 154 (14.6) 145 (13.2) 152 (15.5) <0.001 
 2 247 (23.4) 197 (18.7) 204 (19.3) 179 (16.8) 168 (16.8)  233 (21.9) 187 (17.4) 182 (17.3) 196 (17.8) 197 (20.1)  
 3 238 (22.6) 254 (24.1) 257 (24.3) 220 (20.6) 253 (24.4)  253 (23.8) 235 (21.7) 234 (22.2) 253 (23.0) 247 (25.2)  
 4 189 (17.9) 209 (19.8) 230 (21.8) 248 (23.2) 252 (24.3)  198 (18.6) 240 (22.3) 234 (22.2) 223 (20.3) 233 (23.8)  
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 5 (least deprived) 114 (10.8) 197 (18.7) 213 (20.2) 264 (24.7) 260 (25.1)  135 (12.7) 231 (21.5) 248 (23.6) 283 (25.7) 151 (15.4)  
Education
a
             
Level 1 139 (13.2) 168 (15.9) 170 (16.1) 187 (17.5) 169 (16.3) <0.001 170 (15.7) 185 (17.2) 175 (16.6) 166 (15.1) 137 (14.0) 0.015 
Level 2 143 (13.6) 163 (15.5) 193 (18.3) 198 (18.5) 200 (19.3)  167 (15.7) 175 (16.3) 211 (20.1) 209 (19.0) 135 (13. 8)  
Level 2 32 (3.0) 77 (7.31) 78 (7.4) 92 (8.6) 93 (9.0)  167 (7.8) 175 (6.1) 211 (7.5) 209 (8.3) 135 (5.5)  
Level 4 151 (14.3) 210 (19.9) 290 (27.4) 314 (29.4) 400 (38.5)  224 (21.0) 321 (29.9) 326 (31.0) 289 (26.3) 205 (20.9)  
None of these 590 (55.9) 436 (41.4) 326 (30.8) 277 (25.9) 176 (17.0)  421 (39.5) 329 (30.6) 261 (24.8) 345 (31.4) 449 (45.8)  
Smoking status             
Never 361 (34.2) 441 (41.9) 447 (42.3) 526 (49.3) 541 (52.1) <0.001 390 (36.6) 465 (43.3) 490 (46.6) 536 (48.7) 435 (44.4) <0.001 
Previous 387 (36.7) 317 (30.1) 296 (28.0) 306 (28.7) 258 (24.9)  268 (25.2) 311 (28.9) 318 (30.2) 319 (29.0) 348 (35.5)  
Current 307 (29.1) 296 (28.1) 314 (29.7) 236 (22.1) 239 (23.0)  407 (38.2) 299 (27.8) 244 (23.2) 245 (22.3) 197 (20.1)  
Alcohol consumption           
Never 92 (8.7) 53 (5.03) 36 (3.4) 39 (3.7) 32 (3.1) <0.001 53 (5.0) 41 (3.8) 34 (3.2) 42 (3.8) 82 (8.4) 0.016 
Previous 99 (9.4) 39 (3.7) 36 (3.4) 26 (2.4) 25 (2.4)  75 (7.0) 39 (3.6) 35 (3.3) 37 (3.4) 39 (4.0)  
Within limit 704 (66.7) 739 (70.1) 733 (69.4) 802 (75.1) 721 (69.5)  687 (64.5) 774 (72.0) 748 (71.1) 812 (73.8) 678 (69.2)  
Excessive 160 (15.2) 223 (21.2) 252 (23.8) 201 (18.8) 260 (25.1)  250 (23.5) 221 (20.6) 235 (22.3) 209 (19.0) 181 (18.5)  
Medical comorbidity            
No 576 (54.6) 725 (68.8) 829 (78.4) 886 (83.0) 940 (90.6) <0.001 734 (68.9) 836 (77.8) 859 (81.7) 879 (79.9) 648 (66.1) <0.001 
Yes 479 (45.4) 329 (31.2) 228 (21.6) 182 (17.0) 98 (9.4)  331 (31.1) 239 (22.2) 193 (18.4) 221 (20.1) 332 (33.9)  
 
P values were determined by χ2 test; SIMD, Scottish index of multiple deprivations; 
a
1 (Lower than O level Grade C), 2 (O level or equivalent), 3 (A level/other below 
degree), 4 (Degree level or above)
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The Cox-proportional hazard models revealed that there were inverse dose-
response relationships between baseline PCS and all-cause deaths, cancer 
registrations, and CHD events (Figure 3.1). Compared to those in the highest 
quintile (better physical HRQoL), participants in bottom two quintiles were 
significantly more likely to experience all-cause death, cancer registration 
and CHD events when adjusted for age only (Table 3.2). Further adjustment 
for sex, socioeconomic status, education level, smoking status, BMI alcohol 
consumption, hypertension and diabetes attenuated the associations but the 
participants in the lowest quintile of PCS remained at significantly higher risk 
of all-cause death (HR 2.81, 95% CI 1.76, 4.49), incident cancer (HR 1.63, 95% 
CI 1.10, 2.42), and CHD events (HR 1.99, 95% CI 1.00, 3.96), compared to the 
participants in the highest PCS quintile (PCS score > 56) (Table 3.2). There 
was no significant interaction between PCS quintile and either sex (p=0.968) 
relation to any of the adverse outcomes. 
There were inverse dose response relationships between the two lowest 
quintiles of MCS and all-cause death, but not with CHD events or cancer 
registration. Being in the lowest quintile of MCS was a significant predictor of 
all-cause death after adjustment for age (Table 3.3). When further adjusted 
for sex, socioeconomic status, education level, smoking status, BMI, alcohol 
consumption, hypertension and diabetes the HR became statistically non 
significant (HR 1.25, 95% CI 0.95, 1.65). There was no significant interaction 
between MCS and sex (p=0.062) in relation to any of the adverse outcomes. 
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Figure 3.1 Kaplan-Meier plot of the association between Physical component summary quintile of the SF-12 and adverse outcome   
a. All-cause death (N=391)                                                                                               b. Cancer registration (N=368)                   
           
      c. Coronary heart disease hospitalisation/death (N=134)                                   
   
Higher quintile indicate better perceived physical health; Q1 (worst), quintile 1 (PCS score <42); Q2, quintile 2 (PCS score 42 to 51); Q3, quintile 3 (PCS score 51 to 
55); Q4 quintile 4 (PCS score 55 to 56); Q5 (best) quintile 5 (PCS score >56) 
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Table 3.2 Cox regression models of the association between quintiles of physical 
component summary score (PCS) of the SF-12 and adverse outcomes 
 
 
 
Higher quintile indicate better physical health status; PCS, physical component summary 
quintile (score): 1 (<42), 2 (42 to 51), 3 (51 to 55), 4 (55 to 56), 5 (>56); HR, hazard ratio; 
CI, Confidence interval; Model 1 adjusted for  age; Model 2 adjusted for age, sex, SIMD, 
education  level, BMI, smoking status, alcohol consumption, hypertension and diabetes 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Model 1 Model 2 
 
HR (95% CI) P value HR (95% CI) P value 
All-cause death    
PCS quintile     
  1(worst) 4.23 (2.70, 6.63) <0.001 2.81 (1.76, 4.49) <0.001 
  2  1.97 (1.22, 3.19) 0.005 1.55 (0.95, 2.54) 0.078 
  3  1.45 (0.86, 2.42) 0.160 1.15 (0.68, 1.94) 0.599 
  4  1.06 (0.61, 1.84) 0.826 0.95 (0.55, 1.66) 0.869 
  5 (best) 1.00 - 1.00 - 
Cancer registration    
PCS quintile     
  1(worst) 1.87 (1.29, 2.71) 0.001 1.63 (1.10, 2.42) 0.015 
  2  1.58 (1.07, 2.31) 0.020 1.47 (0.99, 2.19) 0.056 
  3  1.39 (0.93, 2.07) 0.110 1.30 (0.86, 1.95) 0.212 
  4  1.50 (1.01, 2.23) 0.043 1.45 (0.98, 2.17) 0.066 
  5 (best) 1.00 - 1.00 - 
Coronary heart disease hospitalisation/death 
PCS quintile     
  1(worst) 2.57 (1.35, 4.93) 0.004 1.99 (1.00, 3.96) 0.049 
  2  2.23 (1.15, 4.30) 0.017 1.81 (0.92, 3.58) 0.087 
  3  1.61 (0.79, 3.25) 0.187 1.36 (0.66, 2.78) 0.402 
  4  1.36 (0.66, 2.80) 0.405 1.19 (0.57, 2.48) 0.640 
  5 (best) 1.00 - 1.00 - 
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Table 3.3 Cox regression models of the association between quintiles of mental component 
summary score (MCS) of the SF-12 and adverse outcomes 
 
 
Model 1 Model 2 
 
HR (95% CI) P value HR (95% CI) P value 
All-cause death    
MCS quintile     
   1(worst) 1.61 (1.24, 2.10) <0.001 1.25 (0.95, 1.65) 0.117 
   2  1.04 (0.76, 1.41) 0.824 1.00 (0.73, 1.37) 0.998 
   3  0.83 (0.59, 1.15) 0.259 0.88 (0.63, 1.23) 0.463 
   4  0.66 (0.47, 0.91) 0.012 0.76 (0.55, 1.06) 0.104 
   5 (best) 1.00 - 1.00 - 
Cancer registration  
  
MCS quintile     
   1(worst) 0.81 (0.59, 1.10) 0.171 0.75 (0.55, 1.03) 0.079 
   2  0.75 (0.55, 1.03) 0.077 0.74 (0.54, 1.03) 0.071 
   3  0.70 (0.51, 0.97) 0.033 0.72 (0.52, 1.01) 0.054 
   4  0.78 (0.58, 1.06) 0.111 0.82 (0.61, 1.11) 0.206 
   5 (best) 1.00 - 1.00 - 
Coronary heart disease hospitalisation/death 
MCS quintile     
   1(worst) 0.91 (0.56, 1.48) 0.715 0.84 (0.51, 1.38) 0.499 
   2 0.60 (0.35, 1.05) 0.072 0.61 (0.35, 1.06) 0.082 
   3  0.55 (0.31, 0.97) 0.039 0.59 (0.33, 1.05) 0.073 
   4  0.75 (0.46, 1.22) 0.252 0.80 (0.49, 1.30) 0.363 
   5 (best) 1.00 - 1.00 - 
 
Higher quintile indicate better mental health status; MCS, mental component summary 
quintile (score): 1 (<47), 2 (47 to 53), 3 (53 to 56), 4 (56 to 58), 5 (>58); HR, hazard 
ratio; CI, Confidence interval; Model 1 adjusted for  age; Model 2 adjusted for age, sex, 
SIMD, education  level, BMI, smoking status, alcohol consumption, hypertension and 
diabetes 
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3.5 Discussion 
Physical HRQoL was found to be a strong predictor of incident cancer, CHD 
events and all-cause mortality on follow-up. The associations were independent 
of potential confounders, and there was evidence of inverse dose-response 
relationships. In contrast, poor mental HRQoL was not a significant predictor of 
any of the adverse outcomes. There were no statistically significant differences 
in the associations between men and women. 
The majority of previous studies have focused on the association between HRQoL 
and mortality in diseases-specific populations and they have produced 
conflicting results. For example, in patients undergoing haemodialysis some 
studies have reported that both PCS and MCS were strong predictors of mortality 
(Kalantar-Zadeh et al. 2001). Some reported that MCS was a significant predictor 
of mortality, but not PCS (Osthus et al. 2012). Others reported the reverse 
findings with PCS being a significant predictor of mortality, but not MCS 
(Hayashino et al. 2009). In patients with pulmonary fibrosis, HRQoL did not 
predict death (Nishiyama et al. 2012). PCS was associated with higher mortality 
in diabetic patients, but not MCS (Li Chang et al. 2013). In a study of patients 
with heart failure, MCS predicted mortality, but PCS did not (Zuluaga et al. 
2010). Others have reported that both MCS and PCS were associated with higher 
mortality in atherosclerotic patients (Grool et al. 2012). Similarly, only PCS was 
strongly associated with mortality in patients with rheumatoid arthritis (Michaud 
et al. 2012), but both PCS and MCS were in patients with liver cirrhosis (Kanwal 
et al. 2009). One recent study reported that HRQoL was the only psychosocial 
predictor of survival in cancer patients (Sehlen et al. 2012). 
Very few studies have explored the association between HRQoL and adverse 
outcomes in the general population. In a recent German study, 4,259 
participants, aged 20-79 years, completed the SF-12 at baseline and suffered 456 
deaths over a mean of 9.7 years follow-up (Haring et al. 2011). The Cox-
proportional hazard models revealed that the lowest quartile of PCS was an 
independent predictor of mortality (fully adjusted HR 1.64, 95% CI 1.19, 2.27), 
compared to the highest quartile. In contrast, MCS was not a significant 
predictor of mortality (HR 0.97, 95% CI 0.74, 1.28). Other studies conducted in 
general population have been few in number and have focused mainly on people 
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aged 60 years or more. A longitudinal study was conducted in Taiwan, in which 
4,424 individuals, aged 65 years and older were followed over three years and 
221 deaths recorded (Tsai et al. 2007). A 10-point decrease in both PCS and MCS 
scores was associated with higher mortality; RR 1.60, 95% CI 1.39, 1.83, and RR 
1.16, 95% CI 1.01, 1.34, respectively. In a US study 2,166 participants, aged 65 
years or older, completed SF-12 questionnaires at baseline and were passively 
followed-up over 28 months using data from their insurance records (Dorr et al. 
2006). Participants in the lowest quartile of PCS had a higher risk of both all-
cause deaths (HR 5.99, 95% CI 1.90, 18.95) and hospitalisation (HR 2.64, 
p<0.001) than those in the highest quartile. Those in the lowest quartile for MCS 
were also at higher risk of death (HR 2.30, 95% CI 1.64, 3.22) and hospitalisation 
(HR 1.40, p<0.001). A Spanish study followed 2,343 participants, aged 60 years 
and above for six years and recorded 212 deaths (Otero-Rodriguez et al. 2010). A 
five-point decrease in baseline PCS score was found to be a significant predictor 
of mortality (HR 1.28, 95% CI 1.17, 1.40) but this was not true for MCS (HR 1.05, 
95% CI 0.97, 1.13). My model 2 results are consistent with these previous studies.  
In Chapter 2, I demonstrated that after full adjustment, poor baseline SRH was 
an independent predictor of all-cause death (HR 2.48 95% CI 2.16, 2.85), 
incident cancer (HR 1.32, 95% CI 1.09, 1.58), and CHD events (HR 2.26, 95% CI 
1.79, 2.84) (Chapter 2;Ul-Haq, Z 2014a). In contrast, after full adjustment, 
mental health (measured by GHQ-12) was not a significant predictor of these 
adverse outcomes. Similarly, in this study I showed independent associations 
between lowest quintile of baseline PCS (poor physical HRQoL) and all-cause 
death (HR 2.81, 95% CI 1.76, 4.49), incident cancer (HR 1.63, 95% CI 1.10, 2.42), 
and CHD events (HR 1.99, 95% CI 1.00, 3.96). In contrast, MCS was not associated 
with these adverse outcomes after adjustment for potential confounders.  
Commonly, population health is measured in terms of morbidity and mortality. 
My results further strengthen the growing evidence that subjective well-being 
provides additional information and is predictive of future morbidity and 
mortality. It should be considered when undertaking both individual and 
community health assessments. It has been suggested that subjective well-being 
may be a stronger predictor of adverse outcomes than many objective measures 
of health (Idler & Benyamini 1997).  
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3.6 Strengths and limitations 
I used data from a large representative sample of Scottish general population, 
and adjusted my analyses for a series of potential confounders. The 
“representativeness” of a health survey is generally determined by the higher 
number of responses which is based on the updated and correct sampling frame, 
study design and non-responses (Gray et al. 2013). The estimates from a 
representative sample which has strong external validity in association with the 
population of interest can be generalized in confidence to that particular 
population. The SHeS has rigorous methodology and maintains the overall higher 
response rate of 60% or above from the eligible households 
(http://www.scotland.gov.uk/Topics/Statistics/Browse/Health/scottish-health-
survey). The age and sex proportion of the SHeS adult respondents is externally 
validated with the General Registrar Office for Scotland mid-year population 
estimates. The SHeS used weighting to take account of the underrepresentation 
of the large households responses and non-response biases. SHeS is also 
considered to be representative of the Scottish population in terms of the SIMD 
quintiles (Lawder et al. 2010; Gray et al. 2010). BMI and blood pressure were 
measured by trained individuals using standard operating procedures. The 
presence of diabetes was self-reported but based on physician diagnoses. The 
SF-12 is a very widely used measure of HRQoL in the general population (Ware 
Jr. et al. 1996). The Scottish Morbidity Record (SMR) has pan-Scotland coverage 
undergoes regular quality assurance checks (NHS Scotland 2010). Use of a cohort 
design enabled me to demonstrate a temporal relationship between baseline PCS 
and MCS and incident disease, and all-cause mortality and thereby avoid reverse 
causation. By treating PCS and MCS as ordinal data I was able to examine 
whether there were evidence of a dose relationship.  
3.7 Implications of this research 
Poor physical HRQoL is a strong predictor of all-cause death, cancer incidence 
and CHD events. The association is independent of potential confounders. This 
study adds to the growing evidence that subjective well-being is an important 
predictor of health risk, independent of comorbidity and other confounders, and 
should be considered when assessing the health of individuals and communities.  
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Chapters 2 and 3 have demonstrated the importance of subjective well-being. 
Three measures of subjective well-being were studied and all were associated 
with adverse fatal and non-fatal outcomes. Adiposity is preventable and higher 
in prevalence. Therefore, its relationship with subjective well-being is of 
immense public health importance. Previous studies have been limited in 
number and scope and suggest a complex relationship between adiposity and 
subjective well-being. In the subsequent Chapters (4 to 9, inclusive), I will 
investigate the relationship between adiposity and subjective well-being using 
various measures of both. In chapter 4, I will start by examining the relationship 
between adiposity and HRQoL among adults.     
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4 Chapter 4: Adiposity and health-related quality 
of life among adults  
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4.1 Chapter summary 
Obesity is associated with impaired overall HRQoL but individual studies suggest 
the relationship may differ between mental and physical quality of life. A 
systematic review was conducted using Medline, Embase, PsycINFO and ISI Web 
of Knowledge, and random effects meta-analyses performed.  
Studies were included in the meta-analysis if they were conducted on adults 
(defined as age >16 years), reported physical and/or mental component scores 
using SF-36. Heterogeneity was assessed using I2 statistics and publication and 
small study biases using funnel plots. Eight eligible studies, conducted on a total 
of 43,086 study participants, provided 42 estimates of effect size. Adults with 
higher than normal BMI had significantly reduced physical HRQoL with a clear 
dose-response relationship across all categories. Among class III obese adults, 
the score was reduced by 9.72 points (95% CI 7.24, 12.20, p<0.001). Mental 
HRQoL was also significantly reduced among class III obese (-1.75, 95% CI -3.33, -
0.16, p=0.031), but was not significantly different among classes I and II obese 
individuals, and was significantly increased among overweight adults (0.42, 95% 
CI 0.17, 0.67, p=0.001), compared to normal weight individuals. Heterogeneity 
was high in some categories, but there was no significant publication or small 
study bias.  
Different patterns were observed for physical and mental HRQoL, but both were 
impaired in obese individuals. This meta-analysis provides further evidence on 
the relationship between adiposity and both aspects of HRQoL. 
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4.2 Introduction 
Since 1980, obesity has more than doubled worldwide and, in 2008, 1.5 billion 
adults aged ≥20 years were overweight (World Health Organization 2011). The 
higher prevalence of overweight and obese adults in most parts of the world is of 
public health concern (Gulliford et al. 1992; James et al. 2001). It is widely 
accepted that obesity causes, or aggravates, a number of medical conditions, 
such as cardiovascular and musculoskeletal diseases (Colditz 1992; Must et al. 
1999). Obesity is also associated with reduced life-expectancy (Flegal et al. 
2005; Olshansky et al. 2005; Orpana et al. 2010). Previous studies suggest a 
complex relationship between BMI and HRQoL (Fontaine & Barofsky 2001; 
Friedman & Brownell 1995). Overall HRQoL of life is reduced among obese 
individuals, but increased among those who are overweight (Bentley et al. 2011; 
Lopez-Garcia et al. 2003). HRQoL is comprised of different components, such as 
mental and physical HRQoL. A number of studies have examined the relationship 
between BMI and these separate components. Some studies suggest that the 
relationship may be different for physical and mental HRQoL but the published 
results are inconsistent, especially in relation to the latter. Several studies 
reported significant negative associations between increased BMI and reduced 
mental HRQoL (Scott et al. 2008), but others found no association (De wit et al. 
2009). Two systematic reviews of published studies were published in 1995 
(Friedman & Brownell 1995) and 2001 (Fontaine & Barofsky 2001) but, as yet, no 
meta-analysis has been conducted. The systematic reviews suggested that 
obesity is associated with reduced physical HRQoL but were inconclusive in 
relation to an association with mental HRQoL. The systematic reviews were 
updated and a meta-analysis of the published literature was conducted to 
determine the separate relationships between BMI and mental and physical 
HRQoL.  
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4.3 Materials and methods 
4.3.1 Systematic review 
A systematic review of published studies was conducted in accordance with the 
Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) 
guidelines (http://www.prisma-statement.org/), which consists of 27-items 
checklist, aimed to improve the reporting of systematic reviews and meta-
analysis (Moher et al. 2009). I adhered to most of the PRISMA checklist but not to 
item number 5 which is more relevant to clinical trials, and to item number 27 
which is related to the statement of funding and was irrelevant to my study. I 
also could not adhere to PRISMA checklist items number 16 and 23; additional 
analyses; as these were not feasible due to the small number of underlying 
studies (Appendix 1). The following search terms were applied to the Medline, 
Embase, PsycINFO and ISI Web of Knowledge databases: (obes* OR overweight OR 
BMI OR body mass index) AND (quality of life OR QoL OR HRQoL). The search was 
limited to studies conducted on humans and published in, or translated into, 
English. The last search was undertaken on 31 July 2011. The resultant 
manuscripts were reviewed manually, and their reference lists checked for 
additional relevant studies. Studies were included in the meta-analysis if they 
were conducted on adults (defined as age >16 years). SF-36 was the most 
commonly used index of quality of life. Therefore, inclusion was restricted to 
studies that used SF-36, and reported the overall physical component score, 
overall mental component score or both (Figure 4.1). Information was extracted 
on the study design, size and country, year of publication, representativeness, 
populations, age and sex of participants, as well as the mean SF-36 scores by BMI 
category and their SD. Overweight was defined as a BMI of 25.0-29.9 kg/m2, 
obese as 30.0-39.9 kg/m2 and class III obese as ≥40 kg/m2. Obese was further 
sub-divided into class I, defined as 30.0-34.9 kg/m2 and class II, defined as 35.0-
39.9 kg/m2.  
Risk of bias assessment was conducted for each study that was included in the 
systematic review using a generic validated checklist “QualSyst” for the 
quantitative studies. The QualSyst is designed; “to inform our systematic review 
meet a minimum quality standard” (Kmet et al. 2004), and is widely used in 
previously published systematic reviews and meta-analysis (Wu et al. 2008, Wu 
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et al. 2009). The assessment includes 14 checklists for the quantitative studies, 
which is supported by the recommendations of consensus statement of meta-
analysis reporting of observation studies in epidemiology (Stroup D et al. 2000) 
and NHS Centres for reviews and Dissemination (NHS 2001). The checklist is a 
generic assessment of selected studies, including the clearly defined research 
purpose, appropriate study design, method of participant selection, sufficient 
base-line information, well defined outcome, appropriate sample size, reporting 
of analytic methods, estimate of variance, control of potential confounders, 
detailed description of result, and data supported conclusion. 
4.3.2 Meta-analysis 
A random effects meta-analysis was conducted, of the weighted mean difference 
(WMD) in SF-36 scores for each BMI category referent to the normal weight 
category. The aim of conducting this study or any meta-analysis is to statistically 
combine and critically review the findings from two or more individual studies on 
a particular research question. Meta-analyses are very useful as they provide a 
precise cumulative estimate due to higher power, particularly in the current 
climate where clinicians, public health practitioners and general public are 
bombarded with new research findings. However, if not conducted properly, 
there is a potential danger of providing misleading pooled estimates due to the 
presence of publication and/or individual study biases (Deeks et al. 2008). 
Generally, there are two statistical techniques used in the meta-analysis: the 
fixed effect or random effects model.  
 
The assumption of the fixed effect model is that there is one true effect size in 
all the included studies, and our pooled effect size is the estimate of this shared 
effect size (Borenstein et al. 2009). Therefore, the only source of error in our 
pooled estimate is the random error (sampling or estimation) within-studies. In 
the fixed effect model the weights (share) of the individual studies are assigned 
based on the inverse variance, which is mainly dependent on the sample size and 
thus the smaller studies make little contribution to the pooled estimate and are 
therefore effectively ignored. In effect, the pooled effect size is pulled towards 
the results from the larger studies. This could be more problematic in case of 
the relatively extreme effect size (smaller or larger) in the larger studies. If all 
the factors influencing the effect size are equal in the included studies and our 
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aim is to estimate a pooled effect size for a specific population then the fixed 
effect model could be used (Borenstein et al. 2009). 
 
In random effects model, the studies must have sufficient in common to be 
pooled together but the true effect varies from one study to another, and the 
cumulative effect size is the mean estimate of these different effect sizes. 
Therefore, the assumption of random effects model is that the included studies 
represent the population which vary from each other, such that the effect size 
varies (Borenstein et al. 2009). For instance, the effect size might vary among 
studies; as was measured more reliably or due to difference in age, socio-
economic status, or presence of comorbidity, and so on. Therefore, in the 
random effects model there are two sources of errors to be dealt with; the 
random error (within-studies) and the true variations from study to study 
(between-studies). The fixed effect model uses inverse of variance in assigning 
weight to individual studies but this includes only within-studies variance. 
Similarly, the random effects model uses inverse of variance but this includes 
both within and between studies variance. Thus the relative share of individual 
studies is more balanced in random effects model as it is not only dependent on 
the sample size but also every study is important as it is drawn from a unique 
population. As a result, unlike the fixed effect model, the larger study does not 
have too much influence on the pooled estimate and the smaller study is not 
ignored.  
 
The term heterogeneity is defined as “the variation in true effect sizes 
underlying the different studies” (Higgins 2008). Higgins has argued that 
heterogeneity is inevitable in the meta-analysis as the underlying studies are 
conducted by different researchers, using diverse methods and in different 
places. As such, the use of random effects model may be more justified in most 
cases. However, the random effects models has some disadvantages, including 
the non-realistic assumption that the effect sizes of the individual studies are 
drawn from a larger distribution of effect sizes, the failure of estimating the 
between-study variance in the case of a very small number of studies and if the 
studies are conducted in a particular population then it will not be generalizable 
to a wider population (Kelly GA & Kelly KS 2012). In these scenarios, the fixed 
effect model may be the only realistic option. Furthermore, the decision of using 
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the random effects model should not be based on the presence of statistically 
significant heterogeneity or first trying the fixed effect and then moving to 
random effects but should be based on our objectives and how the underlying 
studies are conducted (Borenstein et al. 2009).  
 
For the meta-analysis the underlying published studies had similar study designs, 
same research questions, and tool of measuring subjective well-being. All 
studies adopted standardized BMI cut-offs but were from very different 
population (countries, ages, general population/disease), and had different level 
of adjustment for potential confounders. Therefore, based on the characteristics 
of the underlying studies I used the random effects model in this study. 
The weighted mean differences (WMD) in SF-36 score was analysed between 
individual BMI categories and the normal weight category. Ι2 statistics were 
calculated to determine the degree of heterogeneity (Higgins et al. 2003). 
Possible publication and small study biases were assessed visually using funnel 
plots of the WMD against their standard errors. 
The funnel plot is widely used for the diagnosis of publication bias and small 
study effects in the meta-analyses. It is basically a scatter plot where usually a 
standard error (as a measure of individual study sample size) is plotted vertically 
on the Y-axis in descending order, and the effect size is plotted horizontally on 
the x-axis i.e., precision versus magnitude of the effect size (Sterne JAC 2009). 
Larger studies are plotted towards the bottom of the funnel (lower y values) 
because they produce smaller standard errors while smaller studies are plotted 
towards the top of the funnel (higher y values) because they produce larger 
standard errors. The results of the smaller studies are more dispersed, producing 
95% confidence intervals, and therefore the funnel shape. 
In the absence of bias or heterogeneity, the plot resembles the shape of a 
symmetric funnel. The asymmetry or other shapes of the funnel plot may 
indicate the reporting bias (publication bias, selective outcome or analysis 
reporting), poor methodology of the underlying studies, heterogeneity, artefact 
or chance (Egger et al. 1997). The diagonal lines in the funnel plots correspond 
to the pseudo 95% CI around the pooled estimate. In the absence of 
heterogeneity, 95% of the underlying studies are expected to lie within these 
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diagonal lines (Sterne & Harbord 2004). In case of small study bias, asymmetry is 
expected due to the wide spread of the smaller studies at the bottom. If there is 
publication bias, there will be a gap, for example, in the right bottom side of 
the funnel plot and so there could be an overestimated pooled estimate (Sterne 
& Harbord 2004).       
The visual assessment of funnel plot may not be occasionally reliable (Sterne et 
al. 2011), and therefore the meta-analysts usually follow it by conducting the 
statistical test, such as Eggers test (based on the linear regression) or Begg’s 
rank correlation test (Deeks et al. 2008). However, it is argued that these funnel 
asymmetry tests are very underpowered and therefore should be used only in 
minority of the cases. Generally, the results of these tests are not considered 
valid if the number of underlying studies is less than 10 (Higgins & Green 2011). 
All statistical analyses were performed using Stata version 11.2 (Stata 
Corporation, College Station, Texas, USA). 
4.4 Results 
The electronic search identified 968 publications. I used four different databases 
and when these were combined 396 duplicates were found and excluded. An 
additional 32 publications were identified from the reference lists. The abstracts 
of the 540 articles were reviewed, 466 articles were found not to fulfil the 
inclusion criteria and were excluded. Seventy four were deemed relevant, and 
the full manuscripts were reviewed. Of these, 53 were excluded because they 
did not fulfil the inclusion criteria. Among the remaining 21 publications that 
have used the SF-36 index, only eight studies reported the physical and mental 
summary scores and thus were included in the meta-analyses (Bentley et al. 
2009; de Petersen et  al. 2009; Doll et al. 2000; Hopman et al. 2007; Larsson et 
al. 2002; Mond & Baune 2009; Renzaho et al. 2010; Yancy et al. 2002). The eight 
studies were all cross-sectional (Table 4.1). They were published between 2000 
and 2011 inclusive. Four (50%) of the studies were conducted in Europe (de 
Petersen et  al. 2009; Doll et al. 2000; Larsson et al. 2002; Mond & Baune 2009), 
three (38%), in North America (Bentley et al. 2011; Hopman et al. 2007; Yancy et 
al.2002), and one (12%) in Australia (Renzaho et al. 2010). One study was 
conducted on only male participants (Yancy et al. 2002);  the remainder 
included both sexes. The number of participants ranged from 640 (De wit et al. 
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2009) to 9,771 (Renzaho et al. 2010), with a total of 43,086 participants. Overall 
23,097 (54%) participants were either overweight or obese. The eight studies all 
reported results for both the physical and mental health components of SF-36, 
and they provided a total of 42 estimates of effect size for each of these 
components. Overall, the majority of included studies were of good quality and 
fulfilled the quality satisfying criteria (Figure 4.2). The main limitations were 
the failure of reporting sufficient baseline information, appropriate description 
of analysis and controlling for confounders. 
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Figure 4.1 PRISMA flowchart of the SF-36 studies 
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Figure 4.2 Results of quality assessment for all studies included in the review 
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Table 4.1 Characteristics of studies examining the association between BMI and SF-36 
physical and mental health scores. 
 
 
Author  
 
Year 
 
Country 
 
N 
 
Sex 
 
Age 
(years) 
 
Mean BMI 
 
Overweight or 
obese (%) 
 
Bentley 2011 USA 3,710 M&F 35-89 27.6 (28.1 M, 27.0 F) 68.9 
Renzaho 2010 Australia 9,771 M&F ≥ 21 26.8 (27.1 M, 26.4 F) 65.9 M, 52.3 F 
De ZM 2009 Germany 640 M&F ≥ 21 37.3 73.9 
Johanthan 2009 Germany 4,181 M&F 18-65 26.3 (26.7 M, 25.9 F) 65.5 M, 48.3 F 
Hopman  2007 Canada 9,094 M&F ≥25 26.8 (26.9 M, 26.6 F) 69.0 M, 60.4 F 
Larsson   2002 Sweden 5,633 M&F 16-64 23.6 (24.1 M, 23.0 F) 31.6 M, 23.1 F 
Yancy  2002 USA 1,168 M 48-60 - 79 
 
Doll  
 
2000 England 8,889 M&F 18-64 24.9 44 
N number; BMI body mass index; USA United States of America; M male; F female 
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4.4.1 Mental health-related quality of life 
Of the 42 individual estimates of the effect of BMI on mental HRQoL, only six 
achieved statistical significance (Figure 4.5). Of these, two suggested a higher 
score among overweight individuals (Doll et al. 2000; Mond et al. 2009), and one 
a reduced score among class III obese individuals (Hopman et al. 2007). The 
results for obese (class I and II) was different from the results of either class 
separately but all remained not significant. The Class I obese had not 
significantly better mental health similar to the overweight individuals. Studies 
have reported that people my underestimate their BMI (Krul et al. 2011; 
Madrigal et al. 2000), and therefore the Class I obese may consider themselves 
as overweight but not obese. Whereas, class II obese had not significant lower 
mental health than normal-weight individuals. Among obese individuals, two 
suggested a reduced score (Doll et al. 2000; Larsson et al. 2002) and one an 
increased score (Mond et al. 2009). On meta-analysis, overweight individuals had 
a significantly higher mental health score compared with normal weight 
individuals, and class III obese individuals had a significantly lower mental health 
score (Table 4.2). Between-study heterogeneity was low for the overweight 
category and moderate for the obese category. The funnel plots appeared 
reasonably symmetrical (Figure 4.3).  
Figure 4.3 Funnel plot of the studies examining the association between adiposity and MCS 
score of SF-36 
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4.4.2 Physical health-related quality of life 
Of the 42 individual estimates of the effect of BMI on physical HRQoL, 33 
achieved statistical significance with all of these suggesting reduced scores 
among individuals with higher than normal BMI (Figure 4.6). On meta-analysis, 
compared with normal weight individuals, physical health scores were 
significantly lower in all raised BMI categories (Table 4.2). Furthermore, there 
was evidence of a dose-response relationship across the categories from normal 
weight to class III obese. Between studies heterogeneity was moderate in the 
overweight category and high in the other categories (Table 4.2). The funnel 
plots appeared reasonably symmetrical (Figure 4.4).  
Figure 4.4 Funnel plot of the studies examining the association between adiposity and PCS 
score of SF-36 
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Table 4.2 Pooled estimates of the weighted mean difference in SF-36 physical and mental 
health scores by body mass index category referent to normal weight 
 
 
  
Mental health 
 
Physical health 
 
 Pooled estimate 
 
Heterogeneity Pooled estimate Heterogeneity 
 WMD (95% CI) 
 
P value I
2
 (%) P value WMD (95% CI) P value I
2 
(%) P value 
 
Overweight 
 
0.42 (0.17, 0.67) 
 
0.001 
 
3.1  
 
0.416 
 
-1.40 (-1.82, -0.98) 
 
<0.001 
 
64.3  
 
0.001 
 
Obese -0.98 (-1.98, 0.03) 0.058 28.2  0.233 -3.73 (-5.54, -1.92) <0.001 83.6  <0.001 
 
       Class Ι 0.03 (-0.78, 0.83) 0.951 66.5 0.004    -2.54 (-3.93, -1.16) <0.001 89.9 <0.001 
 
       Class II -0.04 (-1.06, 0.99) 0.945 51.3  0.045 -3.91 (-5.10, -2.72) <0.001 68.6 0.002 
 
       Class III  -1.75 (-3.33, -0.16) 0.031 59.6  0.016 -9.72 (-12.20, -7.24) <0.001 87.3  <0.001 
 
 
WMD weighted mean difference; CI confidence interval  
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Figure 4.5 Forest plots of the mental health scores 
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   e. Class ΙΙΙ Obese 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
NOTE: Weights are from random effects analysis
Overall  (I-squared = 59.6%, p = 0.016)
Renzaho (M)
Study
Renzaho (F)
Larsson (MF) 16-64
Doll (MF)
De ZM (MF)
Hopman (M)
ID
Hopman (F)
Yancy (M)
-1.75 (-3.33, -0.16)
-0.40 (-3.47, 2.67)
-1.50 (-3.54, 0.54)
-4.00 (-8.33, 0.33)
-1.95 (-4.58, 0.68)
-1.70 (-3.78, 0.38)
-16.80 (-25.58, -8.02)
WMD (95% CI)
0.30 (-1.48, 2.08)
-1.10 (-4.88, 2.68)
100.00
12.48
%
16.92
8.53
14.29
16.74
2.87
Weight
18.11
10.06
  
0-25.6 25.6
 
 
 
Chapter 4 Adiposity and HRQoL among adults  
 
107 
 
Figure 4.6 Forest plots of the physical health scores 
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   e. Class ΙΙΙ Obese 
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4.5 Discussion 
Different patterns were observed for physical and mental HRQoL. Compared with 
normal weight adults, those with higher BMI had significantly reduced physical 
HRQoL with clear evidence of a dose relationship across all the BMI categories. 
Mental HRQoL was also significantly reduced among class III obese adults, but 
was not significantly different among obese individuals and was significantly 
increased among overweight adults, compared to normal weight adults.   
It has been shown that obese adults are at increased risk of a number of 
conditions, such as CVD (Bray 1992; Trakas et al. 1999; Visscher & Seidell 2001), 
have shorter life expectancy (Peeters et al. 2003), and have reduced overall 
HRQoL (Brown et al. 2000; Ford et al. 2001; Huang et al. 2006). There is now 
sufficient evidence to demonstrate that while physical HRQoL was reduced in 
both overweight and obese adults, mental HRQoL was only reduced among the 
class III obese. A between-groups difference of 5 points in individual SF-36 
domains (Ware 1993), or 2-3 points in the overall physical and mental 
component is generally considered  clinically significant (Ware 1994). Therefore, 
the reduction in physical HRQoL demonstrated for all above normal weight 
categories was clinically significant, as well as statistically significant. The 
reduction in mental HRQoL was only clinically and statistically significant in the 
class III obese. There is some evidence that BMI may be more negatively 
associated with mental HRQoL among women than men (Bentley et al. 2011).  
Previous studies have suggested that overweight individuals have increased 
overall HRQoL (Bentley et al. 2011; Vasiljevic et al. 2008). This meta-analysis 
suggests that this is driven by an increase in the mental HRQoL component. The 
finding that mental HRQoL was higher in overweight than normal-weight 
individuals is consistent with some previous studies. The underlying reason is not 
yet clearly understood (Carpenter et al. 2000). Therefore I can only speculate. 
One possible reason is that generic measures of HRQoL might not be sensitive to 
the type of impairment in the mental HRQoL which is likely to be associated 
with overweight (Mond & Baune 2009). In some cultures overweight is still 
accepted as a symbol of a happy life (Huang et al. 2006). Also as the prevalence 
of overweight increases, perceptions may be changing such that being 
overweight is perceived as normal. Overeating may console some individuals, 
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especially those who are socioeconomically deprived (Crisp & McGuiness 1976). 
However, their physical HRQoL is reduced. This result is consistent with the 
increased risk of many conditions, such as CVD, diabetes, hypercholesterolemia, 
gallstones, osteoarthritis and musculoskeletal disease, demonstrated in 
overweight individuals (Field et al. 2001; Manson et al. 1995; Wyatt et al. 2006). 
4.6 Strengths and limitations 
There have been two previous systematic reviews, published in 1995 and 2001, 
of studies examining the association between BMI and physical and mental 
HRQoL (Fontaine & Barofsky 2001; Friedman & Brownell 1995) but, to my 
knowledge, this is the first meta-analysis of their results. Most of the published 
literature has reported a significant association between obesity and impairment 
in the physical domain of HRQoL but a comprehensive quantitative analysis is 
lacking. In particular, the results of published studies have not been consistent 
in relation to the association between the mental component of HRQoL and BMI. 
Some have reported a significant dose-response relationship between increasing 
BMI and decline in mental health (Friedman & Brownell 1995; Kim et al. 2007; 
Sullivan et al. 1987), while others have reported very weak or no association (de 
Petersen et al. 2009; Hopman et al. 2007; Le et al. 1998). This study was 
conducted in accordance with PRISMA guidelines and I searched four databases 
to ensure that I identified all relevant studies. My pooled estimates were derived 
from eight studies that comprised a total of 43,086 participants. Random effects 
meta-analyses were used to take account for heterogeneity in study design and 
populations and provide more conservative estimates of pooled effect sizes.  
Of the 21 selected studies, only eight reported the physical and mental summary 
scores and were thus included in the quantitative analysis. Since I did not have 
access to individual level data I could not adjust for potential confounders at 
this level. The extent to which individual studies measured and adjusted for 
potential confounders varied. Many studies reported only unadjusted results. 
This might be a potential source of heterogeneity. Only published studies 
reporting SF-36 scores were included but there was no evidence of significant 
publication bias or small study bias as assessed by both funnel plots. SF-36 has 
been translated into and validated in more than 50 countries (http://www.sf 
36.org/tools/sf36.shtml) and was the most commonly used measure. Since all of 
Chapter 4 Adiposity and HRQoL among adults  
 
111 
 
the studies were cross-sectional, it was not possible to determine the temporal 
relationship and therefore exclude the possibility of reverse causation.  
4.7 Implications of this research 
Both physical and mental HRQoL were impaired among class III obese individuals. 
There was a significant positive association between overweight and mental 
HRQoL. Physical HRQoL was impaired among overweight and obese, whereas 
mental HRQoL was only significantly impaired among individuals who were 
classified as class III obese. This meta-analysis provides further evidence to 
support the injurious effects of obesity on all aspects of health and supports the 
need to take action to reverse the higher prevalence of obesity.   
In this Chapter, I collated the published evidence on the relationship between 
adiposity and HRQoL. The prevalence of adiposity is high, not only among adults, 
but also in children. Childhood obesity is important because obese 
children/adolescents are more likely to become obese adults (Cunningham et al. 
2014). In the next chapter I will explore whether it is also important in its own 
right, in terms of an adverse effect on subjective well-being during childhood. A 
previous systematic review was published in 2009 (Tsiros et al. 2009), but that 
mainly focused on the impact of weight loss on HRQoL and, as yet, no meta-
analysis has been conducted. Therefore, in the next Chapter (Chapter 5), I will 
update the systematic review and conduct a meta-analysis of the published 
studies to determine the association between childhood/adolescent adiposity 
and HRQoL. 
Chapter 5 Adiposity and HRQoL among children  
 
112 
 
 
 
 
 
 
 
5 Chapter 5: Adiposity and health-related quality 
of life among children 
 
 
 
 
 
 
 
Published in; 
Ul-Haq Z, Mackay DF, Fenwick E, Pell JP (2013). Meta-analysis of the association 
between body mass index and health-related quality of life among children and 
adolescents assessed, using the pediatric quality of life inventory index. J 
Pediatr 162(2):280-286. 
 
 
Chapter 5 Adiposity and HRQoL among children  
 
113 
 
5.1 Chapter summary 
To explore the relationships between BMI and overall, physical and psychosocial 
HRQoL in children and adolescents, a systematic review was conducted, in 
accordance with PRISMA guidelines. Medline, Embase, PsycINFO and the Web of 
Knowledge were used to search for relevant articles.  
Inclusion was restricted to participants under 20 years of age, who had been 
assessed using the PedsQL index. Random effects meta-analysis was conducted. 
Heterogeneity was assessed using the I2 statistic, and potential publication and 
small study bias using funnel plots.   
Eleven eligible studies provided 35 estimates of effect size, derived from 13,210 
study participants. Based on self-report, children and adolescents with higher 
than normal BMI had significantly reduced total, physical and psychosocial 
HRQoL with a clear dose relationship across all categories. Among obese 
children/adolescents, the overall score was reduced by 10.6 points (95% CI 14.0, 
7.2, p<0.001). Parents reported the same pattern but a larger effect size. The 
overall parental score for obese children/adolescents was reduced by 18.9 points 
(95% CI 26.6, 11.1, p<0.001). No significant publication or small study bias was 
observed.  
Parents over-estimate the impact of obesity on the HRQoL of their children. 
Nonetheless, obese children/adolescents themselves report reduced overall, 
physical and psychosocial HRQoL.  
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5.2 Introduction 
Recent estimates suggest that around 43 million children under five years of age 
are overweight, including 35 million in developing and 8 million in developed 
countries (World Health Organization 2011). The prevalence of overweight and 
obesity in children and adolescents is high (Ogden et al. 2002; Wang & Lobstein 
2006; Waxman & Norum 2004). Obesity in childhood predisposes to obesity in 
adulthood which, in turn, increases the risk of ill-health and reduced life 
expectancy (Guo et al. 2000; Whitaker et al. 1997). The relationship between 
adult obesity and HRQoL is complex. Physical HRQoL demonstrates a dose 
relationship, decreasing steadily as BMI increases from the normal range to 
obese (Chapter 4; Ul-Haq Z et al.  2013b). In contrast, mental HRQoL is 
significantly reduced in obese adults, but not in overweight adults. The 
relationship between childhood obesity and HRQoL is currently unclear. 
Individual studies have used a mixture of self and parental reporting, and have 
produced conflicting results. A systematic review was published in 2009 (Tsiros 
et al. 2009) and suggested that HRQoL improves with weight loss. The pooled 
results suggested that children’s HRQoL can be predicted from parent-proxy 
reports, although parents tend to perceive HRQoL to be worse than their 
children. No meta-analysis has previously been conducted. I undertook an 
updated systematic review and meta-analysis of published studies to determine 
the association between childhood/adolescent BMI and overall, physical and 
psychosocial HRQoL. 
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5.3 Materials and methods 
5.3.1 Systematic review 
A systematic review of published articles was performed in accordance with the 
PRISMA guidelines (http://www.prisma-statement.org), which consists of 27-
items checklist, aimed to improve the reporting of systematic reviews and meta-
analysis (Moher et al. 2009). I adhered to most of the PRISMA checklist but not to 
item number 5 which is more relevant to clinical trials, and to item number 27 
which is related to the statement of funding and was irrelevant to my study. I 
also could not adhere to PRISMA checklist items number 16 and 23; additional 
analyses; as these were not feasible due to the small number of underlying 
studies (Appendix 1). The relevant search terms (obes* OR BMI OR body mass 
index OR overweight) AND (HRQoL OR quality of life OR QoL) were applied to 
four electronic databases: Embase, Medline, ISI Web of Knowledge and 
PsycINFO. The last search was undertaken on 1 August 2011. The electronic 
search was limited to studies conducted on humans and written, or translated 
into, English. The identified articles were then reviewed manually, and their 
reference lists checked for any additional relevant studies. Articles were 
included in the meta-analysis if they were conducted on children or adolescents; 
defined as <20 years of age. The PedsQL was the most frequently used index. 
Therefore, inclusion in the meta-analysis was limited to studies that used the 
PedsQL Inventory, and reported the overall, physical and psychosocial summary 
scores or both. PedsQL is a generic HRQoL index developed for self-reporting by 
study participants aged 5-18 years, as well as parent-proxy reporting for 
participants aged 2-18 years (Varni et al. 1999; Varni et al. 2003). It comprises 
23 items that encompass physical, emotional, social and school functioning 
(Schwimmer et al. 2003). It produces standardized scores for overall, physical 
and psychosocial HRQoL, ranging from 0 to 100, with higher scores indicating 
better HRQoL (Varni et al.1999). BMI was categorised, using the International 
Obesity Task Force (IOTF) (Cole et al. 2000) age-sex specific BMI cut-off values, 
into normal weight, overweight, obese and severely obese. Where studies used 
the CDC definition, I treated the normal, at risk of overweight, overweight and 
very overweight as equivalent to these four IOTF categories, respectively 
(Kuczmarski et al. 2000). The information collated from individual studies 
included study design, age, sex, region, year of publication, number of 
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participants and the mean PedsQL scores and SD by BMI category. No additional 
or individual level data were obtained from the study investigators. Risk of bias 
assessment was conducted for each study that was included in the systematic 
review using a generic validated checklist “QualSyst” for the quantitative studies 
(Kmet et al. 2004). 
5.3.2 Meta-analysis  
A random effects meta-analysis was conducted, of the weighted mean WMD in 
PedsQL scores for each BMI category referent to the normal weight category. 
Based on the characteristics of the underlying studies I used the random effects 
model in this study. As they were very different population (countries, ages, 
general population/disease), and had different level of adjustment for potential 
confounders.  Ι2 statistics were calculated to assess the degree of heterogeneity 
(Higgins et al. 2003). All statistical analyses were performed using Stata version 
11.2 (STATA Corporation, College Station, Texas, USA). 
5.4 Results 
Electronic searching of the four databases identified 968 potentially eligible 
studies, of which 460 were excluded as duplicates. An additional 32 articles 
were identified from the reference lists (Figure 5.1). After reviewing the 
abstracts of the resultant 540 articles, 74 were considered relevant and the full 
articles were studied. Fifty two studies did not meet the inclusion criteria. Of 
the remaining 22 studies that have used the PedsQL index, only 11 provided the 
overall, physical and psychosocial summary scores by BMI category and were thus 
included in the meta-analysis. The 11 studies comprised a total of 13,210 
children or adolescents (range of 93 to 5,543 participants per study), of whom 
1,370 (10%) were either overweight or obese. The studies were published 
between 2003 and 2011 (Table 5.1). Five (45%) were conducted in North America 
(Schwimmer et al. 2003; Tyler et al. 2007; Varni et al. 2007; Zeller et al. 2006; 
Zeller & Modi 2006), three (27%) in Europe (de wit et al. 2007; Hughes et al. 
2007; Riazi et al. 2010), two (18%) in Australia (Williams et al. 2005; Williams et 
al. 2011) and one (9%) in Asia (Pinhas-Hamiel et al. 2006). Nine studies were 
cross-sectional (de wit et al 2007; Hughes et al. 2007; Pinhas-Hamiel et al. 2006; 
Riazi et al. 2010; Schwimmer et al. 2003; Tyler et al. 2007; Varni et al. 2007; 
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Williams et al. 2005; Zeller et al. 2006) and two were cohort studies (Williams et 
al. 2011; Zeller & et al. 2006). All studies included both sexes and all reported 
results obtained from child-self assessment. Eight of the studies also reported 
results obtained from parent-proxy assessment (Hughes et al. 2007; Schwimmer 
et al. 2003; Tyler et al. 2007; Varni et al. 2007; Williams et al. 2005; Williams et 
al. 2011; Zeller et al. 2006; Zeller & Modi 2006).  
Overall, the majority of included studies were well performed and fulfilled the 
quality satisfying criteria (Figure 5.2). However, there were some weaknesses 
such as lack of sufficient baseline information, patient selection, sample size, 
detailed reporting of results, inappropriate description of analysis and 
adjustment for potential confounders. 
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Figure 5.1 PRISMA flowchart of the PedsQL studies 
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Figure 5.2 Results of quality assessment for all studies included in the review 
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Table 5.1 Characteristics of studies examining the association between body mass index in children and adolescents and health-
related quality of life   
 
Author 
 
Year Country Sex Age 
(years) 
Sample size 
all (OW/obese) 
Sample Comparison groups Child-self 
report 
Parent-proxy 
report 
Williams1 2011 Australia M&F* 08-18 851 (199) From schools 
Normal-weight vs
†
 overweight 
& obese 
Yes Yes 
Riazi  2010 England M&F 05-16 540 (96) Obese (clinic), control (schools) 
Healthy control vs obese 
clinical 
Yes No 
Varni  2007 USA M&F 15-18 5,543 (63) Obese (clinic), healthy (community) 
Healthy control vs obese 
clinical 
Yes Yes 
De beer 2007 Netherland M&F 12-18 93 (31) Obese (clinic), healthy (community) Normal-weight vs obese Yes No 
Hughes  2007 Scotland M&F 05-11 197 (126) Obese (clinic), control (schools) Control vs obese 
Yes Yes 
Tyler  2007 USA M&F 02-18 175 (105) From school 
Normal vs overweight, obese & 
very obese 
Yes No 
Pinhas  2006 Israel M&F 02-18 182 (88) Obese (clinics) & Healthy (OPD) Normal-weight vs obese 
Yes Yes 
Zeller 2006 USA M&F 08-18 1,843 (166) Obese (clinics), healthy (published) 
Healthy control vs obese 
clinical 
Yes Yes 
Williams2  2005 Australia M&F 09-12 1,569 (357) From schools 
Normal-weight vs overweight 
& obese 
Yes Yes 
Zeller2  2005 USA M&F 13-18 1,710 (33) Obese (clinics), healthy (published) Normal-weight vs obese 
Yes Yes 
Schwimer  
 
2003 USA M&F 05-18 507 (106) Obese (clinics), healthy (published) Normal-weight vs obese Yes Yes 
*M: male, F: female     †vs: versus     Yes: provided;     No: not provided
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5.4.1 Child-self reporting 
The 11 studies provided 35 estimates of the effect of obesity, of which 28 
achieved statistical significance (p<0. 05) (Figure 5.4). Three studies provided 9 
estimates of the effect of overweight and one achieved statistical significance. 
In comparison with normal weight children, obese children had significantly 
reduced overall HRQoL, as well as both significantly reduced physical and 
psychosocial HRQoL (Table 5.2). In relation to overall HRQoL, there was a clear 
dose relationship, whereby overall HRQoL was reduced slightly in overweight 
children and much more among obese children (Table 5.2). Similar patterns were 
observed for both physical and psychosocial HRQoL, although the reduction in 
psychosocial HRQoL in overweight children did not reach statistical significance. 
The reduction in physical HRQoL was slightly greater than that in psychosocial 
HRQoL but the differences were not statistically significant. Visual inspection of 
the funnel plots did not suggest asymmetry (Figure 5.3). 
Figure 5.3 Funnel plot of the studies examining the association between adiposity and 
PedsQL score 
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5.4.2 Parent-proxy reporting 
Eight studies provided 23 estimates of the effect of obesity, of which 22 
achieved statistical significance (p<0.005) (Figure 5.5). Two studies provided 6 
estimates of the effect of being overweight and two achieved statistical 
significance. Consistent with children’s reports, the parents of obese children 
reported that they had significantly reduced overall, physical and psychosocial 
HRQoL (Table 5.2). There was a dose effect whereby HRQoL was reduced in 
overweight children but to a much lesser extent than among obese children 
(Table 5.2). As with children’s reports, the reduction in psychosocial HRQoL 
reported by the parents of overweight children did not reach statistical 
significance. Across all three measures, parents consistently rated their 
overweight and obese children as suffering greater reductions in their HRQoL 
than that reported by the children themselves. Compared with children, parents 
tended to report a greater reduction in physical, compared with psychosocial, 
HRQoL for both overweight and obese. However, the differences were not 
statistically significant. There was no evidence of asymmetry in the Funnel plots. 
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Table 5.2 Pooled estimates of the weighted mean difference in health-related quality of life score among obese and overweight children and adolescents 
referent to normal weight. 
 
  
                            Child-self report 
 
                               Parent-proxy report 
 
 Pooled estimate 
 
Heterogeneity Pooled estimate Heterogeneity 
 WMD* (95% CI
¶
) 
 
P value I
2
 (%) P value WMD (95% CI) P value I
2 
(%) P value 
Obese 
 
Total Score 
 
 
-10.63 (-14.03, -7.24) 
 
 
<0.001 
 
 
87.1 
 
 
<0.001 
 
 
-18.87 (-26.60, -11.14) 
 
 
<0.001 
 
 
96.3 
 
 
<0.001 
 
Physical Summary -11.93 (-15.13, -8.74) <0.001 81.8 <0.001 -21.73 (-30.12, -13.35) <0.001 95.4 <0.001 
 
Psychosocial Summary 
 
-9.99 (-13.98, -6.01) 
 
<0.001 
 
88.1 
 
<0.001 
 
-17.37 (-25.89, -8.85) 
 
<0.001 
 
96.4 
 
<0.001 
 
Overweight 
 
Total Score 
 
 
 
-1.43 (-2.55, -0.32) 
 
 
 
0.012 
 
 
 
00.0 
 
 
 
0.690 
 
 
 
-2.60 (-4.00, -1.19) 
 
 
 
<0.001 
 
 
 
00.0 
 
 
 
0.322 
 
Physical Summary -1.47 (-2.67, -0.28) 0.015 04.4 0.351 -4.16 (-6.57, -1.74) 0.001 45.1 0.177 
 
Psychosocial Summary -1.15 (-2.46, 0.16) 
 
0.084 00.0 0.774 -1.32 (-2.79, 0.16) 0.080 00.0 0.748 
      
*
WMD weighted mean difference; ¶CI confidence interval  
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Figure 5.4 Forest plots of the child-self reports from the obese participants compared with 
normal-weight participants. 
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c. Psychosocial summary
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Figure 5.5 Forest plots of the parent proxy reports from the obese participants compared 
with normal-weight participants. 
a. Total score
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c. Psychosocial summary
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5.5 Discussion 
The evidence from published studies suggests that obese children and 
adolescents have significantly reduced overall HRQoL. The impact on physical 
HRQoL is non-significantly greater than the impact on psychosocial HRQoL but 
both are significantly reduced. Parents tend to over-estimate the extent to 
which their children’s HRQoL is reduced. Nonetheless, there is a significant 
effect when based on child self-reporting. There is also evidence of a dose 
relationship whereby HRQoL decreases as BMI increases from normal weight, 
through overweight to obesity. 
Childhood obesity is significantly associated with various morbidities (Ebbeling et 
al. 2002), including noninsulin-dependent diabetes mellitus (Scott et al. 1997), 
hypertension (Figueroa-Colon et al. 1997), dyslipidemia (Williams et al. 1992), 
sleep apnoea (Riley et al. 1976), gall bladder diseases (Acalovschi et al. 1997) 
and depression (Zeller et al.2006). There has been one previous systematic 
review of the effect of childhood BMI on HRQoL (Tsiros 2009) but, to my 
knowledge, this is the first meta-analysis to have been conducted in children. In 
the previous Chapter of meta-analysis of adults (Chapter 4; Ul-Haq Z et al. 
2013b), I found a similar dose relationship whereby physical HRQoL fell with 
increasing BMI above normal weight. However, psychosocial HRQoL was only 
reduced significantly in morbidly obese adults. It was not significantly reduced in 
obese adults and it was significantly increased in overweight adults. In contrast, 
psychosocial HRQoL was significantly reduced in obese children and non-
significantly reduced in overweight. This suggests that the psychosocial sequelae 
of increased BMI may be greater in children than in adults.     
Parental over-estimation of the adverse effect on HRQoL is not restricted to 
obesity. Previous studies have shown that parents over-estimate the adverse 
effect on HRQoL of other conditions, such as cystic fibrosis (Modi & Quittner 
2003; Verrips et al. 2000). The reasons that parents over-estimate the impact of 
childhood obesity are not known but may include parental distress (Vance et al. 
2001), and greater awareness of future complications (Ingerski et al. 2007) and 
conversely, children have a short-term perspective (Eiser & Morse 2001). Also, 
the parents of obese children are more likely to be obese themselves (Lake et 
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al. 1997), and their own experiences of being obese may impact on their 
reporting.  
5.6 Strengths and limitations 
This meta-analysis was conducted in accordance with PRISMA guidelines and four 
major databases were searched to ensure that all relevant studies were 
identified. The pooled estimates were derived from eleven studies that 
comprised a total of 13,210 study participants. The majority of the individual 
studies were cross sectional which are inferior to cohort studies at inferring 
causality. The included studies were conducted on both clinical and community 
based samples. The former might be expected to over-estimate the association, 
but previous studies have demonstrated no significant differences in HRQoL 
between the two groups (Pinhas-Hamiel et al. 2006). I found no evidence of 
significant publication or small study bias but, because the individual studies 
were not conducted under identical conditions, I used the more conservative 
approach of random effects meta-analysis. I used the published results from 
individual studies and did not approach the investigators for access to individual 
level data. Some of the studies used IOTF and others used CDC classification of 
BMI which could be one of the reasons of the significant heterogeneity among 
the studies.  The 10% prevalence of overweight and obese children in the 
underlying studies is very low than the general population. The corresponding 
prevalence in the UK is 30.6% (Figure 1.5). This may be because the majority of 
the included studies did not draw sample from the general population but from 
schools or OPD. 
There was statistical heterogeneity among studies in both the chapters (4&5), as 
shown by the funnel plots (some of the studies are lying outside the pseudo 95% 
CI) (Figure 4.3, 5.3), forest plots (the confidence intervals of studies do not 
overlap well) and the standard chi-square statistics (Figure 4.5, 5.4). The level 
of heterogeneity was also explored using the Higgins I2 statistics. This useful 
measure gives the percentage of inconsistency in the underlying studies effect 
size which cannot be explained by sampling error or chance (Higgins et al. 2003). 
In general, the findings of I2 statistics are interpreted as; might not be important 
(I2 = 0% to 40%), moderate (I2 = 30% to 60%), substantial (I2 = 50% to 90%), and 
considerable (75% to 100%) heterogeneity (Higgins & Green 2011). The advantage 
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of I2 is that it is easy to measure and interpret, is accompanied by uncertainty 
level, and importantly not dependent on the sample size (number of underlying 
studies). The moderate to substantial significant heterogeneity in the pooled 
effect sizes were expected; as all of the individual studies are observational 
which are prone to confounding and selection bias and conducted by different 
researchers at different population and different places (Higgins 2008). 
However, all of the underlying studies had similar objectives, all used cross-
sectional study designs, and had reasonably good quality and a same 
standardized cut-off for measuring both adiposity and HRQoL. Furthermore, 
there was significant heterogeneity but no inconsistency in the direction of the 
effect size was observed.  
I conducted a robust search, quality assessments of the included studies, used 
the random effects meta-analysis, and produced funnel plots. However, the 
underlying heterogeneity has resulted in a wider confidence interval of the 
pooled effect size and due to the power issue I could not further explore the 
reasons of heterogeneity by cumulative meta-analysis or meta-regression, and so 
the conclusion of these meta-analyses should be interpreted with caution.   
Heterogeneity can be further explored by using various plots, such as cumulative 
meta-analysis, L’Abbé funnel and re-ordering studies on forest plot (Sterne JAC 
2009, L’Abbé et al. 1987). Cumulative meta-analyses plots could be used to 
explore changes over time in the pooled estimates of effect size. L’Abbé 
proposed a method of presenting the variations in the effect size by plotting the 
control group on the x-axis and the intervention group on the Y-axis. Between-
study heterogeneity may be explored by sub-group analysis (Naggara at al. 
2011), and regression method (Sterne JAC 2001).  
Meta-analysis of a subset of a studies or subset of participants within studies is 
allowed, and the effect size of various sub-groups can be informally compared 
by considering each sub-group independently. However, it could result in 
misleading conclusion if not commenced carefully. The clear definitions of sub-
group are crucial and should be pre-specified based on a scientific rationale. If 
the overall result of one sub-group is significant, and the other is not, it does not 
mean that there is a statistically significant difference between the two sub-
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groups, as they are not directly compared (Borenstein et al. 2009). It should be 
restricted to a hypothesis-generating tool. 
In the presence of significant heterogeneity, the meta-regression may be a 
useful tool for exploring the cause of heterogeneity (Borenstein et al. 2009). In 
simple terms, the outcome variable (WMD in this case) from each underlying 
study is regressed on the independent variable of interest. The variable which is 
significantly associated with effect size is assumed to be the major cause of 
heterogeneity. In meta-analysis, the unit of analysis is the study, and thus the 
validity of a meta-regression is dependent on the number of studies (≥ 10). 
5.7 Implications of this research 
Overweight children are more likely to develop into overweight adults (Whitaker 
et al.1997) and are at increased risk of many conditions. This study suggests that 
they also suffer from impaired HRQoL. Therefore, childhood obesity is an 
important public health problem and effective interventions are needed urgently 
to stem the higher prevalence. These findings will enable clinicians, public 
health physicians and others to educate children and their parents about the 
potential adverse effect of obesity on their HRQoL. 
 
In Chapters 4 and 5, I collated the existing literature. In the subsequent 
chapters, I will undertake a series of primary data studies in which I can address 
a number of the limitations of previous studies, including adjustment for 
potential confounders, testing for interactions with comorbidity and sex, and 
checking the robustness of the relationship using a variety of measures of 
adiposity and subjective well-being. 
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6.1 Chapter summary  
The prevalence of obesity is rising in Scotland and globally. Overall, obesity is 
associated with increased morbidity, mortality and reduced health HRQoL. 
Studies suggest that “healthy obesity” (obesity without metabolic comorbidity) 
may not be associated with morbidity or mortality. Its impact on HRQoL of life is 
unknown.   
Data from the SHeS were extracted on self-reported HRQoL, BMI, demographic 
information and comorbidity. SF-12 responses were converted into a utility score 
(indicating the overall HRQoL of the individuals ranges from 0 “death” to 1 “full 
health). Linear regression analyses were used to explore the association between 
BMI and health utility, stratified by the sex and presence or absence of 
metabolic comorbidity (diabetes, hypertension, hypercholesterolemia or CVD), 
and adjusted for potential confounders (age, sex, deprivation quintile and 
smoking, drinking status).    
Of the 5,608 individuals, 3,744 (66.8%) were either overweight or obese and 921 
(16.4%) had metabolic comorbidity. There was an inverted U-shaped relationship 
whereby health utility was highest among overweight individuals and fell with 
increasing BMI. There were significant interactions of BMI with sex (p<0.001) and 
with metabolic comorbidity (p=0.007). Being overweight was associated with 
significantly higher utility scores in men only. In contrast, being underweight and 
obese was associated with significantly lower utility score in women only.  
Individuals with metabolic comorbidty had lower utility scores and a steeper 
decline in utility with increasing BMI (morbidly obese, adjusted coefficient: -
0.064, 95% CI -0.115, -0.012, p=0.015 for metabolic comorbidity versus -0.042, 
95% CI -0.067, -0.018, p=0.001 for no metabolic comorbidity).     
Overall, the negative association between obesity and HRQoL is greater among 
individuals with metabolic comorbidity. However, increased BMI is associated 
with reduced HRQoL even in the absence of metabolic comorbidity, casting 
doubt on the notion of “healthy obesity”. 
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6.2 Introduction 
In Scotland, around two-thirds of adult men and more than one-half of adult 
women are either overweight or obese 
(http://www.scotland.gov.uk/Topics/Statistics/Browse/Health/TrendObesity). 
Overall, obesity is associated with an increased risk of many conditions including 
hypertension, hypercholesterolemia, type II diabetes and CVD (Bray 1992; 
Colditz 1992; Rippe et al. 1998; Trakas et al. 1999). It is also associated with 
reduced life-expectancy (Flegal et al. 2005; Hu et al. 2004; Olshansky et al. 
2005; Peeters et al. 2003). There is growing evidence that the association 
between obesity and fatal or non-fatal events is mediated via these other 
conditions and that isolated obesity may not be injurious to health.  In the 
United States of America, around 29% of obese men and 45% of obese women 
(totalling 19.5 million individuals) do not have metabolic comorbid conditions 
(Wildman et al. 2008). They do not appear to be at increased risk of 
cardiovascular events (Wildman 2009), and it has been suggested that weight 
loss will not be beneficial and may even increase their risk of cardio-metabolic 
outcomes (Iacobellis et al. 2005; Sims 2001; Stefan et al. 2008; Velho et al. 
2010; Wildman et al. 2008; Wildman 2009). This had led to the term “healthy 
obesity.”  
There is growing evidence that the association between obesity and fatal or non-
fatal events is mediated via these other conditions and that isolated obesity may 
not be injurious to health. In the United States of America, around 29% of obese 
men and 45% of obese women (totalling 19.5 million individuals) do not have 
metabolic comorbid conditions (Wildman et al. 2008). They do not appear to be 
at increased risk of cardiovascular events (Wildman 2009), and it has been 
suggested that weight loss will not be beneficial and may even increase their risk 
of cardio-metabolic outcomes (Iacobellis et al. 2005; Sims 2001; Stefan et al. 
2008; Velho et al. 2010; Wildman et al. 2008; Wildman 2009). This had led to the 
term “healthy obesity”.  
However, there is no standardized definition for categorizing an individual in this 
unique category of obesity. Generally, it is defined as the absence of cardio-
metabolic disease such as type 2 diabetes, hypercholesterolemia and 
hypertension in an obese individual (Pataky et al. 2010). In addition, the 
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associations of cardio-metabolic risk factors and insulin sensitivity are also used 
to determine it, but different studies have used different cut-off value of these 
factors. The lack of a harmonized definition and standardized cut-off values 
have made the between studies comparison difficult (Van et al. 2014). The other 
factors such as age, sex, family history, and ethnicity can also influence the 
prevalence of healthy obesity (Velho et al. 2010). Consequently, due to the 
variation in definition and cut-off values, different studies have given different 
prevalence of “healthy obese”, ranges from 6% (Kuk & Ardern 2009) to as high as 
35% (Aguilar et al. 2008). To know the prevalence of healthy obesity, one recent 
study used a harmonized definition across the 10 cohort studies from 7 European 
countries, including the UK with a total of 163,517 participants (Van et al. 
2014). The study revealed significant variations in the prevalence of healthy 
obesity in different cohorts even after the use of uniform definitions and cut-off 
values; from 7% to 28% among women, and 2% to 19% in men. Overall, the total 
of 3,387 (12%) obese participants had no metabolic comorbidity. The prevalence 
was significantly higher in woman than men. Among all the 10 cohorts, the 
prevalence decreases with increasing age. 
The mechanisms that delay or protect obese people from developing 
comorbidties are not exactly known. Very recently a study which is published in 
“Cell” demonstrated the anti-inflammatory role of heme oxygenase-1 (HO-1) in 
the development of metabolic disease (Jais et al. 2014). HO-1 was the strong 
independent predictor of developing comorbidity in humans and its deletion in 
mice showed promising results of preventing the secondary diseases. This 
development could have important implications for the stratification of obesity 
with and without comorbidity, and may lead to the therapeutic role of HO-1 
inhibition in obese individuals (Jais et al. 2014).  
 However, a recently published meta-analysis suggest that “healthy obese” is a 
“myth” as they are at significantly higher risk of developing CVD events and 
death on a longer follow-up (Kramer eta l 2013). The pooled estimate of the 
included studies showed that obese individuals with no metabolic comorbidity 
had 24% higher risk of developing CVD events and all-cause mortality on a ten 
year follow-up (RR 1.24, 95% CI 1.02, 1.55), compared to normal-weight 
individuals without metabolic comorbidity. The corresponding risk for unhealthy 
obese was also significantly higher (RR 2.65, 95% CI 2.18, 3.12). It is argued that 
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the “healthy” obese might have subclinical disease which could emerge with 
time (Hill & Wyatt 2013). It is also premature to claim that weight loss in not 
beneficial in healthy obese group, as to date there are very few studies to 
support this (Pataky et al. 2010). The lack of weight loss effect may be 
explained as; the cardio-metabolic and inflammatory parameters of healthy 
obese group are already in normal range. 
Overall, obesity is associated with anxiety, depression and impaired HRQoL 
(Fontaine & Barofsky 2001; Jia & Lubetkin 2005; Kolotkin et al. 2001; Morrison et 
al. 2011). Previous research suggests that deterioration in HRQoL in overweight 
and obese individuals may be due to the presence of comorbidity (Doll et al. 
2000). It is currently unknown whether isolated or “healthy” obesity is 
associated with HRQoL. In this study, I used data from a Scotland-wide survey to 
compare HRQoL across BMI categories in the presence and absence of metabolic 
comorbidity. 
6.3 Material and methods 
6.3.1 Data source 
The SHeS has been conducted at regular intervals, of 3-5 years, since 1995. The 
Survey uses multi-stage, stratified probability sampling to ensure a 
representative sample of the general population. The trained staff collected 
data via face to face interview (including age, sex, postcode of residence, 
lifestyle risk factors, medication, past medical history and current health) and 
measured weight, height and blood pressure and obtained blood samples for 
assays (including total cholesterol concentrations) 
(http://www.esds.ac.uk/government/shes/). I used an extract of data from the 
2003 Survey, the focus of which was CVD and risk factors.  
6.3.2 Inclusion criteria and definitions 
The analyses were restricted to participants aged 20 years and those included 
were categorised into three age groups: 20-44, 45-64 and ≥65 years. Postcode of 
residence was used to allocate individuals to a socioeconomic quintile of the 
general population using the 2004 SIMD 
(http://www.scotland.gov.uk/Publications/2005/01/20458/49127). The index is 
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derived from 31 markers of deprivation relating to health, education, housing, 
current income, employment access and crime, that are applied to each 
postcode data zones. There are 6,505 data zones in Scotland with a mean 
population of 750. BMI was categorised according to the WHO (World Health 
Organization 2000): underweight (BMI <18.5 kg/m2), normal weight (BMI 18.5-
24.9 kg/m2), overweight (BMI 25.0-29.9 40 kg/m2), and obese (BMI 30.0-39.9 
kg/m2), with the addition of a category for morbidly obese (BMI ≥40 kg/m2). 
Metabolic comorbidity was defined as the presence of one or more of the 
following conditions known to be associated with obesity: diabetes, 
hypertension, CVD or hypercholesterolemia. CVD was defined as angina or a past 
history of stroke or myocardial infarction and was based on participants 
reporting diagnosis by a doctor. Hypertension was defined as a blood pressure 
measurement of ≥140/90 mmHg, or anti-hypertensive medication. 
Hypercholesterolaemia was defined as a total cholesterol concentration 
≥5.2mmol/L, or lipid-lowering medication. Diabetes was self-reported of doctor 
diagnosis or on blood glucose lowering agents. Smoking status was self-reported 
and classified as never, ex- or current smoker. Alcohol consumption was self-
reported and categorised as never, ex-, sensible and excessive, with the cut-off 
between sensible and excessive drinking defined as more than 14 units/week for 
women and 21 units/week for men. The responses obtained from the SF-12 
questionnaires were converted into a single utility score using an algorithm 
developed by Brazier and colleagues at the University of Sheffield 
(http://www.shef.ac.uk/scharr/sections/heds/mvh/sf-6d/revisions.html) 
(Brazier et al. 2002). 
6.3.3 Statistical analyses 
All statistical analyses were performed using Stata version 11.2 (Stata 
Corporation, College Station, Texas, USA). Categorical data were summarized 
using frequencies and percentages and groups were compared using chi-square 
tests, or chi-square tests for trend for ordinal data. I used univariate and 
multivariate linear regression models to examine the association between BMI 
category and utility score, adjusting for the potential confounding effects of 
age, sex, deprivation quintiles, smoking status and alcohol consumption. Normal 
weight was used as the referent category. I tested whether there were 
statistically significant interactions by applying likelihood ratio test between BMI 
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and both sex and metabolic comorbidity and stratified the analyses accordingly. 
The utility score was skewed, so the robustness of standard errors was checked 
using the bootstrapping method (Figure 6.1). 
 
 
 
Figure 6.1 Kerned density plot of the utility score  
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6.4 Results 
Of the 10,470 individuals who participated in the SHeS, 7,097 were aged ≥20 
years. Of these 6,559 (92%) had sufficient data to calculate a utility score. 
Participants who completed the SF-12 instrument were not significantly different 
in terms of BMI category (p=0.225) and sex (p=0.197), but were younger 
(p<0.001), less socioeconomically deprived (p<0.001), and more likely to have 
metabolic comorbidity (p<0.001). Among the 6,559 participants with a utility 
score, 5,608 (86%) also had BMI recorded and they comprised the study 
population. These individuals were not significantly different in term of 
metabolic comorbidity (p=0.582) but were younger (p<0.001), more likely to be 
male (p<0.001) and less socioeconomically deprived (p=0.020).  
Of the 5,608 individuals, 2,531 (45.1%) were men and the mean age was 50 years 
(standard deviation 16 years). Nine hundred and twenty one (16.4%) had 
metabolic comorbidity and the mean utility score was 0.80 (standard deviation 
0.14). One thousand seven hundred and ninety seven (32.0%) were normal 
weight, 2,276 (40.6%) overweight, 1,319 (23.5%) obese, 149 (2.7%) morbidly 
obese, and 67 (1.2%) underweight. There were significant differences between 
the BMI categories in terms of age and sex (Table 6.1). The percentage belonging 
to the most deprived quintile increased significantly from normal weight to 
morbidly obese, as did the percentage with metabolic comorbidity (Table 6.1).  
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Table 6.1 Characteristics of participants by body mass index category 
 
                                                                                                                                                                            
¶chi-square tests for trend,  *< 21 units/week for men, <14 units /week for women , deprivation 
quintile; 1 least deprived; 5 most deprived 
 
 
 
 
 
 
 
 Underweight Normal-weight Overweight Obese Morbidly obese p-value¶ Overall 
 N=67 N=1,797 N= 2,276 N=1,319 N=149  N= 5, 608 
 N (%) N (%) N (%) N (%) N (%)  N (%) 
Age (years)        
   20-44 32 (47.8) 937 (52.1) 858 (37.7) 440 (33.4) 54 (36.2) <0.001 2,321 (41.4) 
   45-64 21 (31.3) 562 (31.3) 916 (40.3) 549 (41.6) 75 (50.3)  2,123 (37.9) 
    ≥65 14 (20.9) 298 (16.6) 502 (22.1) 330 (25.0) 20 (13.4)  1, 164 (20.8) 
Sex        
  Men 26 (38.8) 688 (38.3) 1,183 (52.0) 598 (45.3) 36 (24.2) <0.001 2,531 (45.1) 
 Women 41 (61.2) 1,109 (61.7) 1,093 (48.0) 721 (54.7) 113 (75.8)  3,077 (54.9) 
Deprivation quintile 
  1 14 (20.9) 389 (21.7) 498 (21.9) 218 (16.5) 16 (10.7) <0.001 1,135 (20.2) 
  2 11 (16.4) 413 (23.0) 537 (23.6) 258 (19.6) 30 (20.1)  1,249 (22.3) 
  3 9 (13.4) 385 (21.4) 503 (22.1) 337 (25.6) 29 (19.5)  1,263 (22.5) 
  4 14 (20.9) 322 (17.9) 427 (18.8) 276 (20.9) 26 (17.6)  1,065 (19.0) 
  5 19 (28.4) 288 (16.0) 311 (13.7) 230 (17.4) 48 (32.2)  896 (16.0) 
Metabolic comorbidity 
  No 59 (88.1) 1,632 (90.8) 1,899 (83.4) 990 (75.0) 107 (71.8) <0.001 4,687 (83.6) 
  Yes 8 (12.0) 165 (9.2) 377 (16.6) 329 (25.0) 42 (28.2)  921 (16.4) 
Smoking status 
  Never 21 (31.3) 748 (41.6) 1, 002 (44.0) 599 (45.4) 60 (40.3) <0.001 2, 430 (43.3) 
  Ex 7 (10.5) 409 (22.8) 737 (32.4) 447 (33.9) 56 (37.6)  1, 656 (29.5) 
  Current 39 (58.2) 640 (35.6) 537 (23.6) 273 (20.7) 33 (22.2)  1, 522 (27.1) 
Drinking status 
Never 12 (17.9) 89 (5.0) 106 (4.7) 72 (5.5) 8 (5.4) 
<0.00
1 
287 (5.1) 
Ex 5 (7.5) 83 (4.6) 85 (3.7) 62 (4.7) 14 (9.4)  249 (4.4) 
Sensible* 39 (58.2) 1, 266 (70.5) 1, 560 (68.5) 936 (70.9) 100 (67.1)  3, 901 (69.5) 
Excessive 11 (16.4) 352 (19.7) 522 (23.0) 246 (18.7) 27 (18.1)  1, 158 (20.7) 
Missing 0 (0) 7 (0.39) 3 (0.13) 3 (0.23) 0 (0)  13 (0.23) 
Chapter 6 Adiposity, comorbidity and HRQoL 
141 
 
In relation to the association between BMI category and utility score, there was 
a significant interaction with metabolic comorbidity (p=0.007). In every BMI 
category, the utility score was lower among those with metabolic comorbidity 
(Figure 6.2). Among both individuals with and without metabolic comorbidity, 
there was an inverted U-shaped relationship whereby health utility was highest 
among overweight individuals and fell with increasing BMI, with the decline 
steepest among those with metabolic comorbidity (Figure 6.2). HRQoL was 
significantly reduced among obese individuals regardless of the presence or 
absence of metabolic comorbidity.  
 
Figure 6.2 Mean utility score by body mass index category and presence of metabolic 
comorbidity (unadjusted). 
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After adjustment for the potential confounding effects of age, sex, deprivation 
smoking status and alcohol consumption, the utility score was not significantly 
higher among overweight than normal weight individuals, irrespective of the 
presence of metabolic comorbidity (Table 6.2). Compared with normal weight 
individuals, utility scores were significantly lower among both morbidly obese 
and underweight individuals in both groups (Table 6.2).  
In the association between BMI category and utility score, there was also a 
significant interaction with sex (p<0.001). Being overweight was associated with 
significantly higher utility scores in men only. In contrast, being underweight and 
obese was associated with significantly lower utility score in women only (Figure 
6.3). 
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Table 6.2 Characteristics of studies examining the association between body mass index and health-related quality of life   
  Univariate Multivariate 
  No metabolic comorbidity With metabolic comorbidity No metabolic comorbidity With metabolic comorbidity 
  Coefficient (95% CI) P Coefficient (95% CI) P Coefficient (95% CI) P Coefficient (95% CI) P 
BMI category Underweight -0.051 (-0.084, -0.018) 0.002 -0.167 (-0.275, -.059) 0.002 -0.036 (-0.069, -0.004) 0.027 -0.141 (-0.245, -0.037) 0.008 
  Normal-weight* - - - - - - - - 
  Overweight 0.008 (-0.000, 0.016) 0.059 0.032 (0.004,  0.060) 0.023 0.001 (-0.008, 0.009) 0.900 0.026  (-0.002, 0.053) 0.064 
  Obese -0.012 (-0.022, -0.002) 0.015 -0.012 (-0.041, 0.015) 0.380 -0.016 (-0.026, -0.006) 0.001 -0.015 (-0.043, 0.013) 0.290 
  Morbidly obese -0.054(-0.079, -0.029) <0.001 -0.085 (-0.137, -0.034) 0.001 -0.045 (-0.069, -0.020) <0.001 -0.077 (-0.128, -0.026) 0.003 
Age (yrs) 20-44 0.002 (-0.005, 0.010) 0.500 0.001 (-0.036, 0.039) 0.924 0.005 (-0.002, 0.013) 0.190 0.007 (-0.030, 0.043) 0.714 
  45-64 - - - - - - - - 
  ≥65 -0.007 (-0.018, 0.003) 0.191 0.004 (-0.016, 0.025) 0.663 -0.009 (-0.020, 0.002) 0.106 0.004 (-0.017, 0.024) 0.718 
Sex Men* - - - - - - - - 
  Women -0.020 (-0.028, -0.013) <0.001 -0.009 (-0.029, 0.010) 0.357 -0.020 (-0.027, -0.013) <0. 001 -0.005 (-0.025, 0.015) 0.629 
Deprivation quintiles         
 1 - - - - - - - - 
  2 -0.012 (-0.023, -0.001) 0.030 -0.016(-0.048, 0.015) 0.313 -0.008 (-0.019, 0.002) 0.132 -0.009 (-0.040, 0.021) 0.546 
  3 -0.026 (-0.037, -0.015) <0.001 -0.053(-0.085, -0.021) 0.001 -0.019 (-0.030, -0.008) 0.001 -0.036 (-0.068, -0.004) 0.027 
  4 -0.036 (-0.047, -0.024) <0.001 -0.070(-0.103, -0.038) <0.001 -0.026 (-0.038, -0.015) <0.001 -0.050 (-0.082, -0.017) 0.003 
 5 -0.070 (-0.082, -0.058) <0.001 -0.117(-0.150, -0.084) <0.001 -0.052 (-0.064, -0.040) <0.001 -0.084 (-0.117, -0.051) <0.001 
Smoking  Never smoker* - - - - - - - - 
 Ex-smoker -0.012 (-0.021, -0.004) 0.005 -0.031 (-0.053, -0.009) 0.006 -0.008 (-0.016, 0.001) 0.095 -0.031 (-0.053, -0.009) 0.006 
 Current smoker -0.051 (-0.060, -0.042) <0.001 -0.085 (-0.113, -0.058) <0.001 -0.041 (-0.050, -0.032) <0.001 -0.067 (-0.095, -0.038) <0.001 
Drinking  Never* - - - - - - - - 
 Ex -0.058 (-0.083, -0.033) <0.001 -0.066 (-0.118,  -0.013) 0.014 -0.050 (-0.075, -0.026) <0.001 -0.043 (-0.094, 0.008) 0.098 
 Sensible¶ 0.010 (-0.008, 0.028) 0.281 0.033 (-0.002, 0.069) 0.067 0.003 (-0.014, 0.021) 0.710 0.032 (-0.02, 0.067) 0.068 
 Excessive  0.005 (-0.014, 0.024) 0.623 0.056 (0.015, 0.097) 0.007 -0.001 (-0.020, 0.018) 0.925 0.052 (0.010, 0.093) 0.014 
 Missing -0.059 (-0.136, 0.018) 0.133 0.029 (-0.186, 0.244) 0.793 -0.054 (-0.130, 0.021) 0.156 0.033 (-0.173, 0.239) 0.754 
*Referent category, CI confidence interval, ¶<21 units/week for men, <14 units /week for women, deprivation quintiles 1 least deprived, 5 most deprived                          
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Figure 6.3 Adjusted* coefficient for the association between utility score (overall HRQoL) 
and body mass index category by sex.   
 
a. men 
 
 
b. women 
 
Utility score; SF-12 response *adjusted by age, deprivation quintile, comorbidity, smoking and 
drinking status. 
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6.5 Discussion 
Overweight men had better overall HRQoL than normal-weight men whereas 
being underweight and obese is associated with significantly lower overall HRQoL 
in women only. Individuals with metabolic comorbidity have a poorer HRQoL 
than those without, irrespective of their BMI. However, HRQoL is significantly 
reduced among obese individuals even in the absence of metabolic comorbidity, 
suggesting that “healthy obesity” is a misnomer.  
My findings are consistent with previous studies that have demonstrated reduced 
HRQoL among obese individuals (Castres et al. 2010; Fontaine & Barofsky 2001; 
Ford et al. 2001; Garcia-Mendizabal et al. 2009; Hassan et al. 2003; Hopman et 
al. 2007; Kolotkin et al. 2001; Yan et al. 2004). However, these studies have only 
considered obese individuals as a whole. Historically, normal weight was 
associated with the lowest risk of CVD and type II diabetes, and the highest 
HRQoL (Fontaine & Barofsky 2001; Friedman & Brownell 1995). This has changed 
over time, and my finding of significantly better overall HRQoL among 
overweight men is consistent with other recent studies (Bentley et al. 2011; 
Hopman et al. 2007; Lopez-Garcia et al. 2003; Vasiljevic et al. 2008). Previous 
studies have also shown poorer HRQoL among individuals with a low BMI 
(Hopman 2007; Sach et al. 2007; Wee et al. 2008). This is likely to be due, in 
part, to reverse causation due to conditions other than those that I included in 
my definition of metabolic comorbidity. 
There is a growing consensus that the increased risk of cardiometabolic events 
associated with obesity is mediated, largely, via the increased risk of 
intermediate conditions such as hypertension, hypercholesterolemia and type II 
diabetes (World Health Organization 2000). A number of studies have identified 
a sub-group of obese individuals who do not develop these intermediate 
conditions (Wildman 2009). They are not at significantly increased risk of 
cardiometabolic events, and weight loss does not improve their natural history 
(Iacobellis et al 2005; Sims 2001; Stefa et al. 2008; Velho et al. 2010;Wildman et 
al. 2008; Wildman 2009). These findings have led to the label “healthy” obesity.  
Health extends beyond clinical events, to encompass psychological well-being. A 
number of studies have shown that HRQoL is reduced among obese individuals 
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(Fontaine & Barofsky 2001; Friedman & Brownell 1995; Kushner & Foster 2000; 
Sarlio-Lahteenkorva et al. 1995). It was not previously known whether, as with 
clinical events, this risk was specific to obese individuals with metabolic 
comorbidity. This study demonstrated that, whilst HRQoL was lower among 
individuals with metabolic comorbidity, it was nonetheless significantly reduced 
among obese individuals with no metabolic comorbidity.       
6.6 Strengths and limitations 
The study used data from a large pan-Scotland survey that was representative of 
the general population. Due to incomplete data on BMI or utility score in 14% of 
participants, the study population was younger, more affluent and healthier 
than the overall survey population. However, this is unlikely to affect the 
generalisability of the results. Access to information on metabolic comorbidity 
enabled me to undertake sub-group analyses. BMI and blood pressure 
measurements were made by trained fieldworkers using standard operating 
procedures and the presence of hypercholesterolemia was based on blood 
assays. Presence of diabetes and CVD were based on clinician diagnosis but 
reported by participants. Since the study was conducted retrospectively, this is 
unlikely to have led to reporting bias, because certain information such as use of 
medications, current exposure to risk factors or the eliminated exposure factors 
may be recorded more accurately at the time of interview than a personal 
interview. In a cross-sectional study, a temporal relationship cannot be 
established. Therefore, reverse causation is possible. This is particularly so 
among individuals who are below normal weight in whom other conditions may 
be causing both poor HRQoL and weight loss. Survival bias may also occur in 
cross-sectional studies. These findings should be corroborated within the context 
of a cohort study.  
6.7 Implications of this research 
This study suggests that obesity is not only a risk for fatal and non-fatal clinical 
events but also reduced HRQoL, even in the absence of comorbid conditions. 
These findings cast doubt on the notion of “healthy” obesity and reinforce the 
need for population and individual interventions to reverse the higher 
prevalence of obesity. 
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In this Chapter I have shown that obesity is associated with reduced overall 
HRQoL. However, overall HRQoL covers physical and mental domains. The 
adverse impact of obesity on physical HRQoL is much clearer than before, as 
demonstrated in my two meta-analyses (Chapter 4 and 5). In contrast, the 
relationship between BMI and mental health is not well understood. There are 
inconsistencies in the existing evidence and whether the associations vary by 
sex, and there is a paucity of studies using the full spectrum of BMI. I am going 
to address these questions in the next Chapter (Chapter 7) 
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7.1 Chapter summary 
The evidence is conflicting as to whether BMI is associated with mental health 
and, if so, to what extent it varies by sex. I studied mental health across the full 
spectrum of BMI among the general population, and conducted subgroup 
analyses by sex.  
I undertook a cross-sectional study of a representative sample of the Scottish 
adult population. The SHeS provided data on mental health, measured by the 
GHQ, BMI, demographic and lifestyle information. Good mental health was 
defined as a GHQ score <4, and poor mental health as a GHQ score ≥4. Logistic 
regression models were applied.  
Of the 37,272 participants, 5,739 (15.4%) had poor mental health. Overall, 
overweight participants had better mental health than the normal-weight group 
(adjusted OR 0.93, 95% CI 0.87, 0.99, p=0.049), and individuals who were 
underweight, class II or class III obese had poorer mental health (class III obese 
group: adjusted OR 1.26, 95% CI 1.05, 1.51, p=0.013). There were significant 
interactions between BMI and sex (p=0.013). Being overweight was associated 
with significantly better mental health in men only. In contrast, being 
underweight and obese was associated with significantly poorer mental health in 
women only.   
The adverse associations between adiposity and mental health are specific to 
women. Underweight women who are obese have poorer mental health. In 
contrast, overweight men have better mental health.  
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7.2 Introduction 
There is a higher prevalence of both obesity and depression in the UK (Low et al. 
2009; Olfson & Marcus 2009; Reid & Barbui 2010; Rennie & Jebb 2005). In 
Scotland, 28% of adults are obese, and a further 36% are overweight (Keenan et 
al. 2011). Around one in six adults in the United Kingdom experience common 
mental disorders (Adult psychiatric morbidity in England 2009). More than 50% of 
these have mixed depression and anxiety disorder, and one in three has 
generalised anxiety disorder or depression. According to the WHO “there is no 
health without mental health” (World Health Organization 2013). 
Both overweight and obesity predispose to a number of physical conditions, 
including CVD (Lavie et al. 2009; Wannamethee et al. 2005), type II diabetes 
(Mokdad et al. 2003), hypertension (Jarvinen et al. 2007), musculoskeletal 
diseases (Janke et al. 2007; Lohmander et al. 2009), and many cancers (Renehan 
et al. 2008). All-cause mortality is higher among classes II and III obese 
individuals but reduced among adults who are overweight (Flegal et al. 2013). 
Increased BMI has also been shown to be associated with reduced overall HRQoL 
(Chapters 4, 5 & 6; Ul-Haq Z et al. 2012; Ul-Haq Z et al. 2013b; Ul-Haq Z et al. 
2013c). However, overall HRQoL covers different domains; physical and mental. 
The adverse impact of increased BMI on physical HRQoL is now relatively clear, 
as demonstrated in my meta-analyses (Chapter 4; Ul-Haq, Z et al. 2013b; 
Chapter 5 Ul-Haq, Z et al. 2013c). In contrast, the relationship between BMI and 
mental health remains inconclusive. Some studies have reported that increased 
BMI is associated with poor mental health (Baumeister & Harter 2007; Luppino et 
al. 2010; Ohayon 2007; Petry et al. 2008; Strine et al. 2008), whereas others 
have reported no association or a protective role (Crisp & McGuiness 1976; 
Goldney et al. 2009; Jorm et al. 2003; Palinkas et al. 1996).   
In Chapter 4, I conducted a meta-analysis of the association between BMI and 
HRQoL, assessed using the SF-36, among adults (Chapter 4; Ul-Haq, Z 2013b). 
The pooled estimate for the mental health component of SF-36 demonstrated 
significantly reduced mental HRQoL among class III obese individuals and 
increased mental HRQoL among overweight adults. However, many of the 
individual studies included in the meta-analysis had not been adjusted for 
potential confounders, such as socio-economic status, marital status, smoking 
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and alcohol consumption. Also, many population based studies could not be 
included in the meta-analysis because they categorised BMI into two groups only: 
obese (≥30 kg/m2) and non-obese (<30 kg/m2), rather than examining the 
relationship across the whole range from underweight to class III obese. 
Underweight, in particular, has been associated with poor mental health, and it 
has been highlighted that it should be included as a separate category but, as 
yet, very few studies have done so (Mond et al. 2011). In addition to the 
conflicting findings in relation to the overall association between BMI and mental 
health, there is also a lack of consensus on whether the relationship varies by 
sex. Studies commonly do not test or report interactions. Some studies have 
reported no significant interaction with sex and, in those that have, the 
direction of effect has not been consistent (McCrea et al. 2012). For instance, 
one recent study found significant association between BMI and poor mental 
health among women (Brandheim et al. 2013). In contrast, others have reported 
significant associations among men (Carroll et al. 2010; Rosmond & Bjorntorp 
2000).   
In summary, there are inconsistencies in the existing evidence in relation to the 
overall associations between BMI and mental health, and whether the 
associations vary by sex, and there is a paucity of studies using the full spectrum 
of BMI. In this study I investigate the relationship between BMI (across its whole 
range) and mental health (measured using the GHQ-12), and whether it varies by 
sex among a representative sample of Scottish adults, after adjustment for a 
range of potential confounding factors.  
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7.3 Material and methods 
7.3.1 Data source 
The SHeS was undertaken periodically in 1995, 1998 and 2003, and annually from 
2008 (http://www.scotland.gov.uk/Topics/Statistics/Browse/Health/scottish-
health-survey). Each survey recruited a representative sample of the Scottish 
general population from different households. Different samples were drawn for 
each survey using identical methodology. Household response rate was 81% in 
1995, 76% in 1998, 68% in 2003, and 61-64% in SHeS 2008-2010. For the current 
study, I combined data from the six surveys conducted up to, and including, 
2010. Participants under 16 years of age were excluded from the study. As part 
of the surveys, face to face interviews were conducted in participants’ homes to 
collect information on demographics (including age, sex, marital status and 
postcode of residence) and health-related behaviours (including smoking status 
and alcohol consumption), as well as measurements (including height and 
weight). Participants were asked to complete a GHQ-12. During a second visit, a 
survey nurse collected self-reported information on diagnosis, by a doctor, of 
medical conditions (including diabetes, hypertension, CHD, CVD, musculoskeletal 
diseases and cancer) and obtained urine, saliva and blood samples for 
biochemical analyses.  
7.3.2 Definitions 
Age was categorised into four groups: 16-29, 30-44, 45-59, and ≥60 years. BMI 
was categorised into underweight (<18.5 kg/m2), normal weight (18.5-24.9 
kg/m2), overweight (25-29.9 kg/m2), class I obese (30-34.9 kg/m2), class II obese 
(35-39.9 kg/m2), and class III obese (>40 kg/m2) (World Health Organization 
1995). Hypertension was defined as greater than >140/90 mmHg or 
administration of anti-hypertensive therapy. Medical comorbidity was defined as 
the presence of one or more of the following conditions: diabetes, hypertension, 
CHD (angina or myocardial infarction), CVD (CHD or stroke), musculoskeletal 
disease or cancer. Smoking status was categorized as never-smoker, ex-smoker 
or current smoker. Alcohol consumption was classified as never-drinker, ex-
drinker, drinker within limits (<21 units/week for men; <14 units/week for 
women) or excessive-drinker. Marital status was categorized as married, 
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cohabitees, single/never married, married but living separate, divorced or 
widowed. GHQ-12 is a validated and widely-used measure of mental health 
suitable for use in the general population (Goldberg et al.1997). The 12 
questions ask about relevant experiences over the previous few weeks (including 
sleep disturbance, feelings of tension, anxiety, stress, depression, lack of 
confidence and failure to cope). The responses to each question are summated 
producing an overall score ranging from 0 to 12. Good mental health was defined 
as a GHQ-12 score <4 and poor mental health as a score ≥4 (Goldberg et al. 
1998). This definition has been validated, and is strongly linked with different 
mental health disorders such as anxiety and depression (Aalto et al. 2012; Holi 
et al. 2003). Scotland is divided into 6,505 datazones using postcode of 
residence; each contains around 350 households and has a mean population of 
800. The SIMD for each datazone is constructed using information on seven 
domains: income, employment, health, education (including skills and training), 
housing, crime, and access to services. The SIMD is used to derive quintiles of 
socioeconomic status for the Scottish population; ranging from 1 (most deprived) 
to 5 (least deprived) (http://www.scotland.gov.uk/Topics/Statistics/SIMD). 
7.3.3 Statistical analyses 
Differences in the characteristics of participants by BMI category were analysed 
using the χ² test for categorical data and χ² test for trend for ordinal data. I 
examined the association between BMI category and mental health using 
univariate and multivariate logistic regression models with adjustment for age, 
sex, deprivation quintile, presence of medical comorbidity, marital status, study 
year, smoking status and alcohol consumption. I tested whether there were 
statistically significant interactions by applying likelihood ratio test between BMI 
and sex, conducting sub-group analyses accordingly. All statistical analyses were 
performed using Stata version 12.1 (StataCorp, College Station, Texas). 
Statistical significance was defined as p<0.05. 
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7.4 Results 
Of the 37,272 participants, 530 (1.4%) were underweight, 13,176 (35.4%) normal-
weight, 14,161 (38%) overweight, 6,560 (17.6%) class I obese, 2,060 (5.5%) class 
II obese, and 785 (2.1%) class III obese. Overall, the mean age was 47 years 
(standard deviation 16 years), 16,727 (44.9%) were men, 4,673 (12.5%) had at 
least one medical comorbidity, 11,010 (29.5%) were current smokers and 8,233 
(22.1%) drank excessively. All of these characteristics varied significantly by BMI 
category (Table 7.1). There were no statistically significant differences in 
participant demographic characteristics between individual surveys.  
Overall, 5,739 (15.4%) participants had poor mental health (GHQ≥4) but the 
prevalence differed significantly by BMI category. It was lowest (13.6%) among 
overweight participants and highest among the underweight (25.3%) and class III 
obese (23.3%) groups (Table 7.1). There was also a U-shaped relationship 
between BMI category and mean GHQ-12 score (Figure 7.1). The percentage with 
poor mental health varied significantly by sex (12.8% of men versus 17.6% of 
women, p<0.001).  
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Table 7.1 Characteristics of the participants by body mass index category 
 
 
 
Underweight Normal-weight Overweight Class І 
Obese 
Class ІІ 
Obese 
Class ІІІ 
Obese 
‡
P-
value 
 N = 530 N = 13176 N = 14161 N = 6560 N = 2060 N = 785 
 
 
 N (%)                                                N (%) N (%)          N (%)                   N (%)              N (%)    
Mental health             
Good                                                                                            396 (74.7) 11078 (84.1) 12237(86.4) 5563 (84.8) 1657 (80.4) 602 (76.7) <0.001 
Poor  134 (25.3) 2098 (15.9) 1924 (13.6) 997 (15.2) 403 (19.6) 183 (23.3)  
Age (Years)             
16-29 231 (43.6) 3578 (27.1) 1 749 (12.4) 619 (9.5) 213 (10.3) 80  (10.2) <0.001 
30-44 113 (21.3) 4280 (32.5) 3972 (28.1) 1648 (25.1) 545 (26.5) 228 (29.0)  
45-59 84 (15.9) 2940 (22.3) 4280 (30.2) 2031 (31.0) 642 (31.2) 288 (36.7)  
≥60 102 (19.3) 2378 (18.1) 4160 (29.4)   2262 (34.4) 660 (32.1) 189 (24.1)  
Sex              
Men 173 (32.6) 5190 (39.4) 7277 (51.4)  3180 (48.5) 731 (35.5) 176 (22.4) <0.001 
Women 357 (67.4) 7986 (60.6) 6884 (48.6) 3380 (51.5) 1329 (64.6) 609 (77.6)  
Deprivation quintile       
1  150 (28.3) 2520 (19.1) 2542 (18.0) 1267 (19.3) 472 (22.9) 201 (25.6) <0.001 
2 101 (19.1) 2657 (20.1) 2808 (19.8) 1322 (20.2) 452 (21.9) 164 (20.9)  
3 97 (18.3) 2656  (20.2) 3108 (20.0) 1510 (23.0) 453 (22.0) 174 (22.2)  
4 92 (17.4) 2704 (20.5) 3000  (21.2) 1368 (20.9) 424  (20.6) 158 (20.1)  
5  90 (17.0) 2639 (20.0) 2703 (19.1) 1093  (16.7) 259 (12.6) 88 (11.2)  
Smoking status       
Never  199 (37.6) 5726  (43.5) 6224 (44.0) 2899 (44.2) 959  (46.7) 372 (47.4) <0.001 
Ex 43  (8.1) 2602 (19.8) 4223(29.8) 2112 (32.2) 662 (32.1) 241 (30.7)  
Current  288  (54.3) 4848  (36.8) 3714  (26.2) 1549  (23.6) 439  (21.3) 172 (22.0)  
Drinking status           
Never  68 (12.8) 686 (5.2) 638 (4.5) 376  (5.7) 146 (7.1) 56  (7.1) <0.001 
Ex 45 (8.5) 591 (4.5) 682 (4.8) 412 (6.3) 149 (7.2) 73 (9.3)  
Sensible* 333 (62.8) 8921 (67.7) 9467 (66.9) 4426 (67.4) 1410 (68.4) 560 (71.3)  
Excessive 84 (15.9) 2978 (22.6) 3374 (23.9) 1346 (20.6) 355 (17.2) 96 (12.2) 
 
Medical comorbidity        
No 482 (90.9) 12416 (94.3) 12397 (87.7) 5262 (80.3) 1509  73.3) 533 (68.0) <0.001 
Yes 48  (9.0) 760  (5.7) 1764 (12.4) 1298 (19.8) 551  (26.7) 252 (32.0)  
Marital status           
Married 146 (27.6) 5969 (45.3) 8563 (60.5) 3926  (59.9) 1208 (58.6) 395 (50.3) <0.001 
Cohabitees 34 (6.4) 1007 (7.6) 947 (6.7) 420 (6.4) 137 (6.7) 51 (6.5)  
Single 245 (46.2) 3909 (29.7) 2188 (15.5) 956 (14.6) 311 (15.1) 157 (20.0)  
Separated 27 (5.1) 571 (4.3) 492 (3.5) 260 (4.0) 63  (3.1) 43 (5.5)  
Divorced 35 (6.6) 939  (7.1) 922 (6.5) 413  (6.3) 162  (7.9) 81 (10.3)  
Widowed 43 (8.1) 778 (5.9) 1047 (7.4) 584 (8.9) 179  (8.7) 58 (7.4) 
 
GHQ; General Health Questionnaire-12 score; 
‡
P-value; chi-square tests; *<21 units/week for men, 
<14 units /week for women; Deprivation quintile: 1 most deprived, 5 least deprived 
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Figure 7.1 Mean GHQ-12 score by body mass index category 
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On univariate logistic regression analysis, there was a significant association 
between BMI category and poor mental health (p<0.001). After adjusting for the 
potential confounding effects of age, sex, deprivation quintile, medical 
comorbidity, marital status, smoking and drinking status, the overall association 
remained statistically significant (p<0.001). Specifically, overweight participants 
had significantly reduced odds of having poor mental health in comparison with 
normal-weight participants, whilst individuals who were underweight, class II or 
class III obese had significantly increased odds of having poor mental health 
(Table 7.2).  
There were significant interactions of BMI with sex (p=0.013). When the overall 
interaction term was disaggregated I observed that it was mainly driven by 
overweight, possibly due, in part, to larger numbers in this sub-group. The sex 
differences in underweight and class I obesity were also statistically significant. 
The sex difference in class II and class III obese were in the same direction as 
class I obese but failed to reach statistical significance, possibly due to smaller 
numbers in these sub-groups; OR (95% CI); underweight*female 1.77 (1.10, 2.85, 
p=0.018), overweight*female 1.24 (1.08, 1.42, p=0.002), class I obese*female  
1.18 (1.00, 1.40, p=0.052), class II obese*female 1.24 (0.96, 1.60, p=0.104), and 
class III obese*female 1.05 (0.69, 1.61, p=0.823), compared to the sex difference 
in the normal-weight group. 
The sub-group analyses by sex demonstrated that overweight men had a 
significantly lower risk of poor mental health than men of normal-weight 
(adjusted OR 0.85, 95% CI 0.75, 0.95, p=0.004) (Figure 7.2). The overall 
increased risk of poor mental health among class III obese individuals did not 
reach statistical significance in men (adjusted OR 1.25, 95% CI 0.84, 1.86, 
p=0.277).  
In contrast, overweight women did not differ significantly from normal-weight 
women (adjusted OR 1.01, 95% CI 0.93, 1.11, p=0.778), while underweight, class 
II and class III obese women had a significantly higher risk of poor mental health 
(class III obese women relative to normal weight women: adjusted OR 1.37, 95% 
CI 1.11, 1.68, p=0.003) (Figure 7.2).  
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Table 7.2 Multiple logistic regression analysis of the participant characteristics associated 
with having poor mental health (GHQ≥4)  
 
 
   
Univariate 
 
Multivariate 
 
   Odds ratio (95% CI) P-value Odds ratio (95% CI) P-value 
 
BMI category Underweight 1.79 (1.46, 2.19) <0.001 1.46 (1.18, 1.80) <0.001 
  Normal-weight 1 - 1 - 
  Overweight 0.83 (0.78, 0.89) <0.001 0.93 (0.87, 0.99) 0.049 
  Class І Obese  0.95 (0.87, 1.03) 0.187      0.99 (0.92, 1.09) 0.984 
  Class ІІ Obese 1.29 (1.14, 1.45) <0.001 1.22 (1.07, 1.38) 0.002 
  Class ІІІ Obese 1.61 (1.35, 1.91) <0.001 1.26 (1.05, 1.51) 0.013 
Age (years) 16-29 1 - 1 - 
  30-44 1.07 (0.99, 1.17) 0.098 1.12 (1.02, 1.23) 0.017 
  45-59 1.13 (1.04, 1.23) 0.004 1.07 (0.96, 1.18) 0.214 
  ≥60 0.76 (0.69, 0.83) <0.001 0.57 (0.50, 0.64) <0.001 
Sex Men 1 - 1 - 
  Women 1.46 (1.37, 1.54) <0.001 1.41 (1.32, 1.49) <0.001 
SIMD 1(Most deprived)  1 - 1 - 
 2 0.72 (0.66, 0.78) <0.001 0.81 (0.75, 0.89) <0.001 
  3 0.64 (0.59, 0.70) <0.001 0.76 (0.70, 0.83) <0.001 
  4 0.54 (0.49, 0.59) <0.001 0.68 (0.62, 0.75) <0.001 
  5(Least deprived) 0.61 (0.56 0.67) <0.001 0.79 (0.72, 0.87) <0.001 
Smoking status Never smoker 1 - 1 - 
 Ex-smoker 1.03 (0.95, 1.11) 0.468 1.03 (0.95, 1.11) 0.489 
 Current smoker 1.94 (1.82, 2.07) <0.001 1.63 (1.52, 1.74) <0.001 
Drinking status Never drinker 1 - 1 - 
 Ex-drinker 1.77 (1.51, 2.06) <0.001 1.56 (1.33, 1.84) <0.001 
 Within limits* 0.81 (0.72, 0.92) 0.001 0.84 (0.74, 0.95) 0.008 
 Excessive drinker 0.91 (0.80, 1.04) 0.165 0.95 (0.82, 1.09) 0.435 
Comorbidity No  1 - 1 - 
 Yes 1.99 (1.85, 2.14) <0.001 2.49 (2.28, 2.72) <0.001 
Marital status Married 1 - 1 - 
 Cohabitees 1.28 (1.14, 1.44) <0.001 1.12 (0.99, 1.26) 0.070 
 Single 1.50 (1.39, 1.61) <0.001 1.34 (1.23, 1.46) <0.001 
 Separated 2.92 (2.59, 3.30) <0.001 2.27 (2.0, 2.58) <0.001 
 Divorced 2.35 (2.13, 2.60) <0.001 1.81 (1.63, 2.0) <0.001 
 Widowed 1.70 (1.53, 1.88) <0.001 1.68 (1.49, 1.89) <0.001 
 
GHQ: General health questionnaire 12, CI; confidence interval, BMI; body mass index *<21 
units/week for men, <14 units /week for women.  
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Figure 7.2 Adjusted* odds ratio for the association between poor mental health and body 
mass index category by sex.   
 
a. men 
 
b. women 
 
GHQ: General health questionnaire-12; *adjusted by age, deprivation quintile, medical comorbidity, 
marital status, survey year, smoking and drinking status. 
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7.5 Discussion 
Overall, compared with normal weight individuals, overweight participants were 
significantly less likely to have poor mental health, and those who were 
underweight or severely obese were significantly more likely to have poor 
mental health, even after adjustment for potential confounders. However, the 
relationship between BMI and mental health varied by sex. The protective role 
of overweight was confined to men. There was no evidence of a protective 
effect among women. Furthermore, neither underweight nor obesity was 
associated with poor mental health in men. In contrast, underweight and obese 
women had higher risk of poor mental health, compared to normal-weight 
women. 
There is now a substantial body of evidence suggesting an adverse effect of both 
overweight and obesity on physical HRQoL with a dose-relationship (Chapters 4, 
5 & 6; Ul-Haq, Z et al. 2012; Ul-Haq, Z et al. 2013b; Ul-Haq, Z et al. 2013c). In 
contrast, the published evidence is conflicting in relation to the association 
between BMI and mental health. A meta-analysis, conducted in 1995, found no 
association between obesity and depression in adults (Friedman & Brownell 
1995a). In 2010, Wit et al published a meta-analysis of 17 population studies 
comprising a total of 204,507 participants (de wit et al. 2010). The majority of 
the included studies used self-reported BMI dichotomised into obese (≥30 kg/m2) 
and non-obese (<30 kg/m2). None used the GHQ as an indicator of mental health 
and none were conducted in United Kingdom. The meta-analysis reported a 
significant overall association between obesity and depression (pooled OR 1.18, 
95% CI 1.01, 1.37). On sub-group analysis, the association was statistically 
significant among women (pooled OR 1.31, 95% CI 1.27, 1.40) but not men 
(pooled OR 1.12, 95% CI 0.96, 1.30).  
In Chapters 4 and 5, I conducted two meta-analyses of the association between 
BMI and HRQoL; one in children and adolescents (Chapter 4; Ul-Haq Z et al. 
2013c), and the other in adults (Chapter 5; Ul-Haq, Z et al. 2013b). The meta-
analysis of children and adolescents used the PedsQL, and demonstrated that 
physical HRQoL was significantly reduced in both overweight and obese children 
but mental HRQoL was only impaired in obese children. The meta-analysis of 
adults used the SF-36 index, and demonstrated that there was an inverse dose-
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response relationship with physical HRQoL across the BMI categories from normal 
weight to obese. In contrast, mental HRQoL was significantly reduced only in 
class III obese adults and was increased in overweight adults. The overall results 
of this current study corroborate these findings, using a different measure of 
mental health, and suggest that the relationship cannot be explained by 
confounding since the associations persisted after statistical adjustment.   
This current study demonstrated a significant interaction with sex; such that 
obesity impacts adversely on mental health among women but not men. This 
finding is consistent with some previous individual studies (Palinkas et al. 1996; 
Scott et al. 2008). Whilst both men and women compare their bodies with the 
“ideal,” women are more likely to feel dissatisfied with their bodies (Sheldon 
2010). The female body has more socio-cultural importance than the male body, 
and women report feeling greater external pressure to conform to media-
portrayed ideals (Cattarin & Thompson 1994; Connor-Greene 1998; Harrison & 
Cantor 1997; Sheldon 2010). 
I found a significant dose-response relationship with poor mental health across 
classes I, II and III obese women (adjusted ORs 1.20, 1.38 and 1.63 respectively) 
(Table 7.3). Similarly, McCrea et al recently reported that there was a linear 
relationship between level of obesity and common mental disorder; classes I and 
class II obese had adjusted odd ratios for common mental disorder of 1.38 and 
1.40 respectively (McCrea et al. 2012). A recent Swedish study of 68,000 adults 
from the general population reported a significant linear relationship with poor 
mental health (based on GHQ 12) among classes I and II obese women (ORs 2.58 
and 2.71 respectively). Another larger study based on the World Mental Health 
Survey conducted in 13 different countries found a significantly higher risk 
among obese women but not men (Scott et al. 2008, Heo et al. 2006). 
Conversely, other studies have reported no significant interactions with sex 
(Morris et al. 2010, Scott et al. 2008) in relation to the association between BMI 
and mental health.  
In the current study overweight participants had better mental health than 
normal-weight participants but, on further scrutiny, the association was 
confined to men. This corroborates previous studies on the association between 
body weight and subjective well-being (Linna et al. 2013). The overall finding of 
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improved mental health among overweight people is consistent with my previous 
studies in Chapters 4 and 6. A study conducted in Goteborg, Sweden, exclusively 
on middle aged men, reported that overweight participants had better 
psychosocial health but worse physical health than normal-weight (Rosmond & 
Bjorntorp 2000).  
There is evidence that some overweight people may underestimate their BMI and 
classify themselves as normal weight (Krul et al. 2011; Madrigal et al. 2000). 
Also, it is possible that as the BMI distribution in the general population has 
shifted to the right over time, people’s belief as to what constitutes “normal” 
weight has changed. In this obesogenic environment maintaining a healthy 
weight might be stressful, and thus mental health may be better in overweight 
men. BMI is a poor measure of adiposity in individuals with a high muscle mass 
and some men in the overweight category may have a low lean body mass. 
Whereas women feel pressure to reduce weight, men are more likely to feel 
pressure to increase their BMI, by increasing their muscle mass (Harrison & 
Cantor 1997; Sheldon 2010). There is also growing evidence that being 
overweight may not, necessarily, be associated with reduced mortality 
compared to normal-weight individuals (Flegal et al.2013). 
In this study, being underweight was associated with significantly poorer mental 
health overall, but the sub-group analysis showed that this relationship was 
driven by women, and was not significant in men. The majority of previous 
studies have focused on the association between increased BMI and mental 
health, and either excluded underweight individuals or included them in the 
normal-weight category (Mond et al. 2011). These findings support a U-shaped 
association between BMI and poor mental health, even after controlling for 
potential confounders, particularly in women (de Wit et al. 2009). My findings 
highlight the importance of studying the full-spectrum of BMI, as merging or 
excluding the underweight category might not only increase the risk of 
weakening the association between BMI and mental health but also missing the 
valuable information associated with being underweight. Mond et al recently 
reported that underweight women had significantly reduced mental health 
compared to normal-weight women (Mond et al. 2011). They have further shown 
that this association was not because of increased body dissatisfaction or eating 
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disorders, and argued that the notion of “underweight associated with body 
dissatisfaction or eating disorders” is not supported by enough evidence.  
7.6 Strengths and limitations 
This study examined the association with mental health across the full spectrum 
of BMI categories in a large, nationally representative sample of adults in the 
general population, taking account of obvious confounders such as age, sex, 
deprivation, smoking status, drinking status, marital status and medical 
comorbidity. Many of the published studies have not reported appropriately 
adjusted results. Where statistical adjustment has been undertaken, it has 
usually been restricted to only age and sex. Most previous studies have examined 
overall associations only. I tested for interactions with sex, demonstrating 
differences in the relationship between BMI and mental health between men and 
women. The SHeS is a large, representative sample of the Scottish population. 
Height, weight and blood pressure were measured by trained staff using 
standard operating procedures. BMI is a poor measure of adiposity in individuals 
with a high muscle mass. Presence of medical comorbidity was self-reported but 
based on physician diagnoses. Availability of various potential confounders 
including demographic data, deprivation, smoking and drinking status, marital 
status and medical comorbidity enabled me to do the adjustment and subgroup 
analysis. The GHQ-12 is the most widely-used measure of mental health in UK. It 
is intended and validated for adults aged 16 years and above in both clinical and 
general population (Goldberg et al. 1997). Notable limitations of the study 
include the use of cross-sectional data with BMI and recent experiences of 
mental health recorded at the same time and, thus it is impossible to detect 
causation. There is possibility of reverse causation that poor mental health 
might lead to increased weight among women. Over the course of clinical 
treatment, a psychotropic drug may cause 2-17 kg increase in body weight 
(Nihalani et al. 2011). These findings should be confirmed within the context of 
a cohort study. GHQ is a short screening tool, not a detailed assessment of 
mental health. There were fewer people in underweight and class III obese 
category compared to the other BMI groups, so my statistical power to detect 
differences in these groups is less. Furthermore, I have adjusted my analysis for 
several confounders but there is always a possibility of unobserved 
heterogeneity. Further research is needed to look for the incidence of BMI 
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related diseases in overweight participants who have better mental health and 
vice versa.  
7.7 Implications of this research 
Having a BMI well above normal values is associated with significantly poorer 
mental health in women only. Being underweight is associated with poor mental 
health among women, but not men. Conversely, the apparently protective role 
of overweight was confined to men only, and was not significant in women. This 
study further supports the need to consider sex variation and use the full 
spectrum of BMI (from underweight to class III obese) in future studies of BMI 
and mental health. These findings suggest that health care providers should be 
aware that obese and underweight women are more likely to suffer poor mental 
health and may require intervention.  
In this Chapter, I focused on the association between adiposity and mental 
health. However, I used GHQ as a measure of mental health which is a short 
screening tool, not a detailed assessment of mental health. There was also lack 
of information regarding the use of psychotropic drugs. In the next Chapter 
(Chapter 8), I am going to explore this association further, examining the 
relationship between adiposity and mood disorder adjusting for various 
confounders, including the use of psychotropic drugs.  
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8.1 Chapter summary 
Previous studies on the association between adiposity and mood disorder have 
produced contradictory results, and few have used measurements other than 
BMI. I examined the association between several measurements of adiposity 
(BMI, WC, WHR, and BF%) and probable major depression. 
A cross-sectional study was conducted using baseline data on the sub-group of 
UK Biobank participants who were assessed for mood disorder. Multivariate 
logistic regression models were used, adjusting for potential confounders 
including: demographic and life-style factors, comorbidity and psychotropic 
medication. 
Of the 140,564 eligible participants, evidence of probable major depression was 
reported by 30,145 (21.5%). The fully adjusted OR for obese participants were: 
1.16, 95% CI 1.12, 1.20 using BMI; 1.15, 95% CI 1.11, 1.19 using WC; 1.09, 95% CI 
1.05, 1.13 using WHR and 1.18, 95% CI 1.12, 1.25 using BF% (all p<0.001). There 
was a significant interaction between adiposity and sex (p=0.001). Overweight 
women were at increased risk of depression with a dose response relationship 
across the adiposity categories: fully adjusted ORs of 1.14, 1.20, 1.29 and 1.48 
for overweight and obese I, II and III respectively (all p<0.001). In contrast, only 
obese III men had significantly increased risk of depression (OR 1.29, 95% CI 
1.08, 1.54, p=0.006).  
Adiposity was associated with probable major depression, irrespective of the 
measurement used. The association was stronger in women than men. Physicians 
managing overweight and obese women should be alert to this increased risk. 
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8.2 Introduction 
Both depression and obesity are major public health problems. Worldwide, more 
than 350 million individuals suffer from depression (World Health Organisation 
2013). As a contributor to the burden of morbidity, it is ranked third globally and 
first in middle and high income countries, with morbidity expected to rise 
further (World Health Organisation 2008). In the United Kingdom alone, around 1 
in 20 adults experience an episode of depression annually, and it is the third 
most common reason for patients to consult their general practitioner (National 
Institute for Health and Clinical Excellence 2013). Major depression carries a 
significant economic and health burden (Stewart et al. 2001; Wang et al. 2003). 
It is associated with increased physical comorbidity (Moussavi et al. 2007), 
reduced HRQoL (Strine et al. 2008), and impaired function in work, school and 
family life (Cox et al. 1987), as well as increased mortality (Abas et al. 2002), 
including suicides (Miret et al. 2013). The prevalence of obesity is high both in 
the UK and worldwide (Rennie & Jebb 2005), leading to suggestions of an 
“obesity pandemic” or “globesity”. In common with depression, adiposity is 
associated with reduced physical well-being (Canoy et al. 2013), higher societal 
costs (Tigbe et al. 2013) and, as shown in Chapters 4,5, and 6, poorer HRQoL 
(Chapter 4, 5, 6; Ul-Haq, Z et al. 2012; Ul-Haq, Z et al. 2013b; Ul-Haq, Z et al. 
201c). 
The relationship between these two important public health problems has been 
the focus of an increasing number of studies over recent years, but these studies 
have produced inconsistent results (Mcelroy et al. 2004; Stunkard et al. 2003). I 
have reported positive associations (Chapter 7; Ul-Haq et al. 2013a) whilst 
others have reported negative (Goldney et al. 2009) or no associations (John et 
al. 2005). In Chapters 4 and 6, I showed that adiposity was significantly 
associated with poor overall HRQoL, but this was largely due to reductions in the 
physical component of HRQoL, with the mental component reduced only among 
morbidly obese and increased among overweight (Chapter 4 Ul-Haq, Z et al. 
2013b). Furthermore, in Chapter 7, I found that poor mental health was confined 
to obese women, and the apparent protective role of being overweight was 
confined to men (Chapter 7; Ul-Haq, Z et al. 2013a).  
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 A meta-analysis of population studies reported a pooled OR of 1.26 (95% CI 1.17, 
1.36) for the association between obesity and depression (Luppino et al. 2010). 
This association was only significant in women (OR 1.32). Of the 17 studies 
included, 16 used BMI as a measure of obesity. Another recent meta-analysis 
reported a pooled OR of 1.38 (95% CI 1.22, 1.57) for the association between 
central obesity and depression (Xu Q et al. 2011). A total of 15 studies were 
included in this review, of which 14 used WC as the measure of central obesity. 
Several studies, including my study in Chapter 7, have shown that the 
association between obesity and depression is stronger in women (Chapter ; Ul-
Haq, Z et al. 2013a; Wild et al. 2012). In contrast, a recent large study 
demonstrated that adiposity was a significant predictor of depression but only in 
men (Gariepy et al. 2010). 
In these two recent meta-analyses, most investigators used self-reported 
adiposity measurements, and many were not adjusted for important potential 
confounders such as socio-economic status, physical comorbidity, and the use of 
psychotropic medications. Only BMI and WC have been used as measures of 
adiposity, and they were simply dichotomized into obese and not obese, thereby 
losing information on the relationship across the spectrum of adiposity such as 
whether there is a dose relationship. There is some evidence that the 
relationship between adiposity and depression varies according to the level of 
adiposity (Onyike et al. 2003), and that WHR and BF% may also be associated 
with depression (Wyshak 2011). One recent, comparatively smaller German study 
(N=4,907) examined the association between obesity and depression, using BMI, 
WC and WHR as continuous variables, but did not have data on BF% (Wiltink et 
al. 2013). Overall, there is a paucity of larger studies that have used measures 
other than BMI in exploring this association.  
The study included in this chapter aimed to investigate the association between 
probable major depression and four different measurements of adiposity (BMI, 
WC, WHR and BF%), measured by trained staff using standard procedures and 
tools, across the whole range of adiposity (from underweight to class III obese). 
It is also to explore whether the associations varied by sex among a very large 
sample from the UK middle to old aged population, after adjusting for potential 
confounding factors, including medical comorbidity, use of psychotropic drugs, 
social deprivation and ethnicity.  
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8.3 Material and methods 
8.3.1 Data source  
I conducted a cross-sectional study using baseline data collected on UK Biobank 
participants. NHS UK maintains the records of almost all individuals of the 
general population through general practitioners. Based on these records, about 
5 million primary invitations were sent to the eligible individuals who were living 
within a reasonable travelling distance from the assessment centres. UK Biobank 
recruited 502,682 participants, aged 40-69 years, via 22 assessment centres 
across the United Kingdom between 2006 and 2010 (Figure 8.1). The assessment 
of mood disorders was included only in the last two years, during which 172,751 
participants were recruited (UK Biobank 2007). 
Figure 8.1 Schematic of UK biobank invitation and appointment system 
 
 
Source: from UK Biobank website:  http://www.ukbiobank.ac.uk/wp-content/uploads/2011/11/UK-
Biobank-Protocol.pdf 
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8.3.2 Data collection 
Participants completed a series of computer based questionnaires followed by a 
face to face interview with trained research staff. The information collected 
included demographics (including sex, age, ethnicity, employment status, and 
postcode of residence), lifestyle factors (including smoking status and alcohol 
consumption), self-reported physician-diagnosed comorbidities (CVD, 
hypertension, diabetes and cancer), current medication and past or current 
experience of depressive and manic symptoms.  
Anthropometric measurements (including height, weight, WC, hip circumference 
and BF%) were measured by trained data collectors, using standard operating 
procedures. BF% was calculated using a Tanita BC-418MA body composition 
analyser. WHR was derived by dividing WC (measured by a Wessex non-
stretchable sprung tape at the level of the umbilicus) by hip circumference 
(measured at the widest point using the same device). BMI was derived by 
dividing weight in kilograms (measured after removal of shoes and heavy outer 
clothing using a Tanita BC-418MA device) by the square of height in metres 
(measured without shoes using the Seca 202 device) (UK Biobank 2007).  
8.3.3 Definitions 
BMI was classified using WHO cut-offs as; underweight (<18.5 kg/m2), normal-
weight (18.5-24.9 kg/m2), overweight (25.0-29.9 kg/m2), and obese (≥30 kg/m2). 
Obesity was further classified as class I (30.0-34.9 kg/m2), class II (35.0-39.9 
kg/m2) or class III obese (≥40 kg/m2). Among men, WC was classified as normal-
weight (<94 cm), overweight (94-101 cm), and obese (≥102 cm). The 
corresponding cut-off values for women were <80, 80-87 and ≥88 cm, 
respectively. WHR was classified among men as; normal weight (<0.90), 
overweight (0.90-0.99) or obese (≥1) and the corresponding cut-off values for 
women were <0.80, 0.80-0.84 and ≥0.85, respectively. BF% was classified among 
men as; normal weight (<18%), overweight (18-25%) and obese (>25%). The 
equivalent cut-off values for women were <25, 25-32 and >32, respectively. 
Age was categorised into three groups; 39-49, 50-60, and 61-70 years. Townsend 
score quintile (from 1 least deprived to 5 most deprived) was used as an 
indicator of the participant’s socio-economic status. This is a validated measure 
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which is determined on the basis of postcode of residence, and is derived from 
the following household information collected in the most recent census; car 
ownership, the number of people living in a house, home ownership, and 
employment status (Townsend 1987). The census based deprivation index, 
including Townsend index score are validated using ill health and income 
(Gordon D 1995, ONS 2012). Frequency of alcohol consumption (daily/almost 
daily, 3-4 times/week, 1-2 times/week, 1-3 times/month, special occasions and 
never), smoking status (never, former and current), ethnic group (white, mixed, 
Asian/Asian British [Indian, Pakistani, Bangladeshi and other Asian background], 
black/black British, Chinese and other) and employment status (in paid 
employment, retired, looking after home, unemployed, not working due to 
sickness or disability and student) were all self-reported. Comorbidity was 
defined as self-report of a doctor’s diagnosis of one or more of the following 
conditions; CVD (CHD or stroke), hypertension, diabetes or cancer. Text 
information on all current medications was used to identify participants taking 
“any psychotropic medication” based on a list of 125 eligible generic and 
proprietary names. Text information on all current medications was used to 
identify participants taking “any psychotropic medication” based on a list of 125 
eligible generic and proprietary names. This information was provided by the UK 
Biobank mental health group (Smith et al. 2013). 
 My classification of depression was based on criteria published previously by UK 
Biobank mental health group (Smith et al. 2013). Briefly, depression was defined 
using information collected via the Patient Health Questionnaire (PHQ) (Spitzer 
et al. 1999) on past help-seeking behaviour for mental health, and specific 
questions on the severity and duration of both depressed mood and anhedonia. 
Participants were classified as having probable major depression if they had ever 
seen a general practitioner or psychiatrist for ‘nerves, anxiety, depression” and 
had either ever had mood that was depressed/down for at least two weeks or 
had been unenthusiastic/disinterested for at least two weeks. I included 
participants who reported one or more eligible episode but participants with 
probable bipolar I or II disorders were excluded from this study.  
This study was conducted under generic approval from the NHS National 
Research Ethics Service (17th June 2011, Ref 11/NW/0382). Participants provided 
electronic consent for the baseline assessments, biochemical samples and future 
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linkage to routine databases. Participants are not provided with individual level 
information nor benefit from any future commercial developments. 
8.3.4 Statistical analyses 
The differences in depression and other covariates by adiposity were analysed 
using the χ² test for categorical data, and χ² test for trend for ordinal data. I 
examined the associations between anthropometric measurements (BMI, WC, 
WHR and BF%) and probably major depression, as the outcome, using 
multivariate logistic regression models. The association was first adjusted for 
age, sex, socio-economic status and ethnicity (model 1), and was then further 
adjusted for employment, alcohol consumption, smoking, presence of 
comorbidity (CVD, hypertension, diabetes, cancer) and use of psychotropic 
medications (model 2). I tested whether there were statistically significant 
interactions by applying likelihood ratio test between adiposity and sex, and 
conducted sub-group analyses accordingly. The logistic regression model was 
repeated using BMI, WC, WHR and sex-specific deciles of BF%. All statistical 
analyses were performed using Stata version 12.1 (StataCorp, College Station, 
Texas). Statistical significance was defined as p<0.05. 
8.4 Results 
Of the 172,751 UK Biobank participants who were recruited during the last two 
years, complete information on mood disorders was available for 140,564 
(81.4%). Overall, the mean age was 57 years (SD 8 years), and 75,093 (53.4%) 
were women. 30,145 (21.5%) participants satisfied the criteria for probable 
major depression: 19,493 (26.0%) women and 10,652 (16.3%) men. Based on BMI, 
33,857 (24.1%) were obese. Using the other measures, the percentage classified 
as obese were 46,504 (33.1%) for WC, 33,049 (23.5%) for WHR, and 91,166 
(64.9%) for BF%. Depression was significantly more prevalent among women than 
men (19,493 [25.7%] versus 10,652 [16.3%], p<0.001). 
Those with probable major depression were more likely to be obese and were 
more likely to be women, younger, deprived, unemployed, white, smoke, report 
comorbidity, and use psychotropic medication, but they consumed alcohol less 
frequently (all p<0.001) (Table 8.1). There was a positive association whereby 
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major depression was less common in the lower deciles of adiposity and more 
common in the higher deciles, and this was more marked among women (Figure 
8.2). In women, the prevalence of depression in the top decile of adiposity was 
very consistent across the different anthropometric measurements; 31.6%, 
33.5%, 31.2% and 30.6% using BMI, WC, WHR, and BF% respectively. The 
corresponding proportions for men were 20.4%, 20.2%, 18.6% and 24.3%, 
respectively (Figure 8.2).  
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Table 8.1 Characteristics of the participants by body mass index category 
    
 
Obese 
 
 Underweight Normal-weight Overweight Overall Class I  Class II  Class III  P-value 
 N= 654 N= 46,121 N= 59,932   N=  33,857 N= 24,458 N= 6,852 N=  2,547  
 N (%) N (%) N (%) N (%) N (%) N (%) N (%)  
 
Probable major depression 
       
No 508 (77.7) 36,622 (79.4) 47,641 (79.5) 25,648 (75.8) 18,912 (77.3) 5,022 (73.3) 1,714 (67.3) <0.001 
Yes 146 (22.3) 9,499 (20.6) 12,291 (20.5) 8,209 (24.3) 5,546 (22.7) 1,830 (26.7) 833 (32.7)  
Sex         
Women 517 (79.1) 29,748 (64.5) 27,380 (45.7) 17,448 (51.5) 11,634 (47.6) 4,089 (59.7) 1,725 (67.7) <0.001 
Men 137 (21.0) 16,373 (35.5) 32,552 (54.3) 16,409 (48.5) 12,824 (52.4) 2,763 (40.3) 822 (32.3)  
Age (years)         
39-49 170 (26.0) 12,200 (26.5) 12,958 (21.6) 7,119 (21.0) 4,970 (20.3) 1,478 (21.6) 671 (26.3) <0.001 
50-60 283 (43.3) 16,955 (36.8) 21,091 (35.2) 12,652 (37.4) 8,937 (36.5) 2,654 (38.7) 1,061 (41.7)  
61-70 201 (30.7) 16,966 (36.8) 25,883 (43.22) 14,086 (41.6) 10,551 (43.1) 2,720 (39.7) 815 (32.0)  
Townsend score quintile        
1  107 (16.4) 8,289 (18.0) 10,552 (17.6) 4,795 (14.2) 3,718 (15.2) 818 (11.9) 259 (10.2) <0.001 
2 108 (16.5) 9,580 (20.8) 12,377 (20.7) 6,115 (18.1) 4,632 (18.9) 1,126 (16.4) 357 (14.0)  
3 111 (17.0) 9,563 (20.7) 12,795 (21.4) 6,734 (19.9) 4,956 (20.3) 1,314 (19.2) 464 (18.2)  
4 160 (24.5) 10,541 (22.9) 13,232 (22.1) 7,828 (23.1) 5,578 (22.8) 1,646 (24.0) 604 (23.7)  
5  168 (25.7) 8,148 (17.7) 10,976 (18.3) 8,385 (24.8) 5,574 (22.8) 1,948 (28.4) 863 (33.9)  
Employment status        
Employed 339 (51.8) 27,597 (59.8) 34,155 (57.0) 18,733 (55.3) 13,651 (55.8) 3,704 (54.1) 1,378 (54.1) <0.001 
Retired 186 (28.4) 14,798 (32.1) 21,733 (36.3) 11,743 (34.7) 8,676 (35.5) 2,333 (34.1) 734 (28.8)  
Look after home 56 (8.6) 1,796 (3.9) 1,350 (2.3) 813 (2.4) 530 (2.2) 190 (2.8) 93 (3.7)  
Unemployed 32 (4.9) 1,113 (2.4) 1,509 (2.5) 1,031 (3.1) 673 (2.8) 245 (3.6) 113  (4.4)  
Not working  39 (6.0) 681 (1.5) 1,041 (1.7) 1,431 (4.2) 854 (3.5) 355 (5.2) 222 (8.7) <0.001 
Student  2 (0.3) 136 (0.3) 144 (0.2) 106 (0.3) 74 (0.3) 25 (0.4) 7  (0.3)  
Alcohol consumption        
Daily 139 (21.3) 10,604 (23.0) 13,137 (21.9) 5,337 (15.8) 4,296 (17.6) 846 (12.4) 195 (7.7) <0.001 
3-4 times/week 127 (19.4) 11,283 (24.5) 14,456 (24.1) 6,528 (19.3) 5,122 (20.9) 1,077 (15.7) 329 (12.9)  
1-2 times/week 123 (18.8) 11,419 (24.8) 15,411 (25.7) 8,677 (25.6) 6,398 (26.2) 1,720 (25.1) 559 (21.6)  
1-3 times/month 71 (10.9) 4,775 (10.4) 6,345 (10.6) 4,643 (13.7) 3,152 (12.9) 1,065 (15.5) 426 (16.7)  
Special occasions  94 (14.4) 4,587 (10.0) 6,270 (10.5) 5,306 (15.7) 3,299 (13.5) 1,358 (19.8) 649 (25.5)  
Never 100 (15.3) 3,453 (7.5) 4,313 (7.2) 3,366 (9.9) 2,191 (9.0) 786 (11.5) 389 (15.3)  
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Smoking status         
Never 387 (59.2) 27,887 (60.5) 32,729 (54.6) 17,652 (52.1) 12,614 (51.6) 3,652 (53.3) 1,386 (54.4) <0.001 
Previous 151 (23.1) 13,590 (29.5) 21,537 (35.9) 13,154 (38.9) 9,575 (39.2) 2,638 (38.5) 941 (37.0)  
Current 116 (17.7) 4,644 (10.1) 5,666 (9.5) 3,051 (9.0) 2,269 (9.3) 562 (8.2) 220 (8.6)  
Ethnicity         
White 591 (90.4) 42,911 (93.0) 55,312 (92.3) 30,838 (91.1) 22,382 (91.5) 6,191 (90.4) 2,265 (88.9) <0.001 
Mixed 10 (1.5) 377 (0.8) 381 (0.6) 235 (0.7) 161 (0.7) 47 (0.7) 27 (1.1)  
Asian 28 (4.3) 1,426 (3.1) 1,893 (3.2) 863 (2.6) 653 (2.6) 162 (2.4) 48 (1.9)  
Black 3 (0.5) 651 (1.4) 1,521 (2.5) 1,451 (4.3) 926 (3.8) 355 (5.2) 170 (6.7)  
Chinese 6 (0.9) 291 (0.6) 169 (0.3) 38 (0.1) 34 (0.1) 3 (0.0) 1 (0.0)  
Other 16 (2.5) 465 (1.0) 656 (1.1) 432 (1.3) 302 (1.2) 94 (1.4) 36 (1.4)  
Comorbidity         
No 503 (76.9) 35,056 (76.0) 38,488 (64.2) 16,354 (48.3) 12,551 (51.3) 2,920 (42.6) 883 (32.7) <0.001 
Yes 151 (23.1) 11,065 (24.0) 21,444 (35.8) 17,503 (51.7) 11,907 (48.7) 3,932 (57.4) 1,664 (65.3)  
Psychotropic medication        
No 605 (92.5) 43,487 (94.3) 56,091 (93.6) 30,475 (90.0) 22,263 (91.0) 6,059 (88.4) 2,153 (84.5) <0.001 
Yes 49 (7.5) 2,634 (5.7) 3,841 (6.4) 3,382 (10.0) 2,195 (9.0) 793 (11.6) 394 (15.5)  
 
BMI: body mass index category (kg/m
2
); underweight (<18.5), normal-weight (18.5-24.9), overweight (25-29.9), obese (≥30), class I (30-34), class II (35-39), class III 
obese (>40), Townsend score, a measure of socio-economic status,
 
p-value; χ² test for categorical data & p-value for test of trend for ordinal data, Comorbidity (CVD, 
hypertension, diabetes, cancer) 
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Figure 8.2 Frequency (%) of probable major depression by measures of adiposity and sex.   
a. Body Mass Index deciles (kg/m2)                                                                             b. Waist Circumference deciles (cm)                                                                                  
                  
c. Waist to hip ratio deciles                                                                                       d. Body fat % deciles                                                    
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In the overall logistic regression analyses, adjusted for age, sex, socio-economic 
status and ethnicity (model 1) there were significant associations between all 
anthropometric measures and major depression (all p-value <0.001) (Table 8.2). 
Being overweight or obese was significantly associated with major depression, 
and the OR of major depression in obese participants was consistent across the 
anthropometric measurements; 1.36 (95% CI 1.32, 1.41), 1.34 (95% CI 1.30, 
1.39), 1.30 (95% CI 1.26, 1.35), and 1.32 (95% CI 1.25, 1.40) for BMI, WC, WHR 
and BF%, respectively (Table 8.2). When further adjusted for the potential 
confounding effects of employment, alcohol consumption, smoking, comorbidity 
(CVD, hypertension, diabetes, and cancer) and use of psychotropic medications 
(model 2), the associations were slightly attenuated. Nonetheless, participants 
classified as overweight or obese (class I, II or III) based on BMI still had 
significantly higher odds of having major depression, compared to normal weight 
participants, with evidence of a linear relationship. The OR of major depression 
were; 1.09 (95% CI 1.06, 1.13), 1.12 (95% CI 1.08, 1.17), 1.21 (95% CI 1.14, 1.29), 
and 1.39 (95% CI 1.27, 1. 53) (all p-value <0.001) for overweight, class I, II and III 
obese, respectively. Similarly, using WC, WHR, and BF%, overweight and obese 
participants had significantly higher odds of major depression than normal-
weight participants, with a dose-response relationship. The OR for the 
association between overweight and major depression compared to normal 
weight remained very consistent across the anthropometric measurements; 1.09 
(95% CI 1.06, 1.13), 1.07 (95% CI 1.03, 1.10), 1.05 (95% CI 1.02, 1.09), and 1.06 
(95% CI 1.00, 1.13) for BMI, WC, WHR and BF% respectively. The corresponding 
OR for obese participants were 1.16 (95% CI 1.12, 1.20), 1.15 (95% CI 1.11, 1.19), 
1.09 (95% CI 1.05, 1.13) and 1.18 (95% CI 1.12, 1.25), respectively (Table 8.2).  
There was a significant interaction between adiposity and sex (p=0.001). Sub-
group analyses by sex showed that the overall associations were largely driven 
by women (Table 8.2). In contrast, men classified as overweight, overall, class I 
or class II obese on the basis of their BMI were not at significantly increased risk 
of with major depression. Only class III obese men had significantly higher odds 
of major depression, compared to normal weight men. Similarly, using WC and 
BF%, there was no association between being overweight and major depression 
in men. Only obese men had significantly higher odds of major depression. In 
contrast, using WHR, both overweight and obese men were at significantly 
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increased risk of major depression (Table 8.2). Underweight individuals were not 
at significantly increased risk of depression either overall or by gender-specific 
sub-group. 
When the logistic regression model was repeated using the BMI, WC, WHR and 
BF% sex-specific deciles, the adjusted OR in women illustrated the similar 
positive association (Figure 8.3) as was observed for the crude frequencies 
(Figure 8.2). The adjusted OR for the top decile of BMI, WC, WHR and BF% were; 
1.38, 1.35, 1.16 and 1.67, respectively. In contrast, among men, other than the 
top decile of BMI (>33 kg/m2), there was a straight line indicating no significant 
relationship with major depression in all anthropometric measurements. 
 
 
 
 
 
 
Chapter 8       Adiposity and probable major depression 
179 
 
Table 8.2 Logistic regression analysis of the adiposity measurements associated with major depression.  
 
 
 
Overall Women Men 
Model 1 Model 2 Model 1 Model 2 Model 1 Model 2 
 
OR (95% CI) P-value OR (95% CI) P-value OR (95% CI) P-value OR (95% CI) P-value OR (95% CI) P-value OR (95% CI) P-value 
BMI category 
            
Underweight 1.00 (0.83, 1.20) 0.972 0.93 (0.77, 1.13) 0.480 0.92 (0.74, 1.13) 0.428 0.89 (0.71, 1.10) 0.281 1.47 (0.98, 2.21) 0.061 1.25 (0.82, 1.93) 0.302 
Normal-weight 1 - 1 - 1 - 1 - 1 - 1 - 
Overweight 1.15 (1.11, 1.18) <0.001 1.09 (1.06, 1.13) <0.001 1.20 (1.15, 1.24) <0.001 1.14 (1.10, 1.19) <0.001 1.07 (1.01, 1.12) 0.018 1.02 (0.97, 1.08) 0.480 
Obese (overall) 1.36 (1.32, 1.41) <0.001 1.16 (1.12, 1.20) <0.001 1.43 (1.37, 1.50) <0.001 1.24 (1.19, 1.30) <0.001 1.24 (1.17, 1.32) <0.001 1.05 (0.99, 1.12) 0.134 
    Class I  1.29 (1.24, 1.34) <0.001 1.12 (1.08, 1.17) <0.001 1.35 (1.29, 1.42) <0.001 1.20 (1.14, 1.26) <0.001 1.18 (1.11, 1.26) <0.001 1.02 (0.96, 1.10) 0.489 
Class II  1.47 (1.38, 1.56) <0.001 1.21 (1.14, 1.29) <0.001 1.51 (1.41, 1.63) <0.001 1.29 (1.20, 1.40) <0.001 1.38 (1.25, 1.53) <0.001 1.10 (0.99, 1.23) 0.081 
Class III  1.82 (1.66, 1.98) <0.001 1.39 (1.27, 1.53) <0.001 1.84 (1.66, 2.04) <0.001 1.48 (1.32, 1.65) <0.001 1.76 (1.50, 2.08) <0.001 1.29 (1.08, 1.54) 0.006 
WC category 
            
Normal-weight 1 - 1 - 1 - 1 - 1 - 1 - 
Overweight 1.13 (1.10, 1.17) <0.001 1.07 (1.03, 1.10) <0.001 1.15 (1.10, 1.20) <0.001 1.09 (1.04, 1.14) <0.001 1.11 (1.05, 1.17) 0.096 1.04 (0.98, 1.10) 0.161 
Obese 1.34 (1.30, 1.39) <0.001 1.15 (1.11, 1.19) <0.001 1.39 (1.33, 1.44) <0.001 1.21 (1.16, 1.26) <0.001 1.28 (1.22, 1.35) <0.001 1.07 (1.02, 1.13) 0.010 
WHR category 
            
Normal-weight 1 - 1 - 
 
- 1 - 1 - 1 - 
Overweight 1.14 (1.10, 1.18) <0.001 1.05 (1.02, 1.09) 0.002 1.12 (1.08, 1.17) <0.001 1.05 (1.01, 1.10) 0.024 1.18 (1.13, 1.24) <0.001 1.06 (1.01, 1.12) 0.018 
Obese 1.30 (1.26, 1.35) <0.001 1.09 (1.05, 1.13) <0.001 1.26 (1.21, 1.31) <0.001 1.09 (1.04, 1.13) <0.001 1.46 (1.36, 1.56) <0.001 1.12 (1.04, 1.20) 0.002 
BF%  category 
            
Normal-weight 1 - 1 - 1 - 1 - 1 - 1 - 
Overweight 1.07 (1.01, 1.14) 0.016 1.06 (1.00, 1.13) 0.039 1.08 (1.00, 1.18) 0.061 1.10 (1.00, 1.20) 0.039 1.06 (0.98, 1.14) 0.156 1.03 (0.95, 1.12) 0.469 
Obese 1.32 (1.25, 1.40) <0.001 1.18 (1.12, 1.25) <0.001 1.37 (1.26, 1.48) <0.001 1.26 (1.16, 1.37) <0.001 1.27 (1.17, 1.36) <0.001 1.09 (1.00, 1.18) 0.038 
OR: Odds ratio; CI: Confidence Interval; Model 1: adjusted by age, sex, socio-economic status, and ethnicity; Model 2 (full adjusted): in addition to the variables in 
model-1 below variables were added: employment, alcohol consumption, smoking, comorbidity (CVD, diabetes, hypertension, cancer), and use of psychotropic 
medications. 
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Figure 8.3 Adjusted
¶
 odds ratio of probable major depression by measures of adiposity and sex.   
a. Body Mass Index deciles (kg/m
2
)                                                                            b. Waist Circumference deciles (cm)                               
      
c. Waist to hip ratio deciles                                                                                          d. Body fat % deciles                                                       
          
Reference deciles,  OR; Odds ratio, CI; confidence interval, (W) Women,  (M) Men, ¶Adjusted by age, socio-economic status, employment, ethnicity, alcohol consumption, smoking, comorbidity (CVD, 
hypertension, diabetes, cancer) and psychotropic medication
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8.5 Discussion 
Overall, both overweight and obese individuals were significantly more likely to 
have probable major depression than normal weight participants, irrespective of 
the anthropometric measurement used, and independent of potential 
confounding factors. There was evidence of a dose relationship with the risk of 
depression increasing with the level of adiposity, above normal weight. Being 
underweight was not associated with major depression. The relationship 
between adiposity and depression varied significantly by sex, such that the 
overall association was largely driven by women. In contrast, only men with class 
III obesity were at significantly increased risk of probable major depression.  
In my meta-analyses, increased BMI was associated with significantly reduced 
physical HRQoL (Chapters 4 & 5; Ul-Haq, Z et al. 2013b; Ul-Haq, Z et al. 2013c). 
In contrast, psychological HRQoL was higher among overweight individuals and 
reduced significantly in only class III obese. Two previous meta-analyses have 
reported a significant association between obesity and depression with pooled 
OR of 1.38 for BMI (Luppino et al. 2010) and 1.26 for WC (Xu Q et al. 2011). 
Wiltink et al examined the association between obesity and depression and 
demonstrated a similar positive relationship using BMI, WC and WHR (Wiltink et 
al. 2013). In another study, Wyshak demonstrated a positive association between 
obesity, measured by BF%, and depression, relative to non-obese participants 
(adjusted OR 1.70, 95% CI 1.20, 2.39, p=0.002) (Wyshak 2011). These findings are 
consistent with those of Wiltink et al (Wiltink et al. 2013), in that the magnitude 
of the association between obesity and depression was comparable using a 
number of different measurements: 1.36, 1.34, 1.30, and 1.32 for BMI, WC, WHR 
and BF%, respectively and there was an overall dose response relationship across 
the categories from overweight to obese III. 
I found that the relationship between adiposity and depression was stronger in 
women than men. Previous studies have reported that overweight individuals 
have better mental health than normal-weight individuals (Bentley et al. 2011), 
but I found that this was confined to men (Chapter 7; Ul-Haq, Z et al. 2013a). It 
is plausible that the association may be causal, and stronger in women. Adiposity 
can result in stigma, particularly in women, which is a known risk factor for 
depression (Puhl & Heuer 2010). Print and electronic media portray thin women 
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and larger, muscular men as ideals and may lead to a lower acceptance of 
increased body weight among women (Sheldon 2010). It is also plausible that 
reverse causation may play a role. Depression may lead to both less physical 
activity and over-eating, contributing to obesity (Pan et al. 2012). Physical 
attractiveness is known to be associated with depression, and depression may 
reduce an individual’s general interest in maintaining their appearance (Noles et 
al. 1985). Depressed people are also reported to have more realism or even to 
underestimate their physical attractiveness (Lewinsohn et al. 1980). In contrast, 
feeling attractive may be protective against depression. Depression is also 
known to be associated with neuro-endocrine abnormalities, such as 
hypercortisolaemia, which can contribute to obesity (Bjorntorp 2001). In this 
cross-sectional study, I was unable to establish temporal relationships and, 
therefore, could not determine the most plausible direction of causation.  
8.6 Strengths and limitations 
Only a small number of previous studies have examined the association between 
level of adiposity and depression and, to my knowledge, this is the first study to 
explore the whole range of anthropometric measures (from underweight to class 
III obesity), not rely on self-reported measures and use four different 
anthropometric measurements. I used the recommended sex-specific deciles for 
adiposity (other than BMI). Use of UK Biobank data enabled me to analyze a very 
large number of participants recruited from the general population, and to 
adjust for a wide range of potential confounders. The importance of adjusting 
for medical comorbidity, use of psychotropic medications, ethnicity and socio-
economic status has been highlighted previously (Luppino et al. 2010; Wiltink et 
al. 2013; Xu, Anderson et al. 2011), but this has rarely been carried out.   
Inclusion in this study was limited to the participants who provided complete 
information on mood. Compared with participants who did not provide complete 
information, these individuals were more likely to be of normal-weight, male, 
younger and socioeconomically deprived, non smokers, in employment and 
consume alcohol and less likely to report medical comorbidity. UK Biobank 
recruited middle and old aged individuals (aged 40 to 69 years) from the general 
population and so young people or very old people are underrepresented. Less 
than 10% of invited individuals were recruited into UK Biobank.  
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One of the possible reasons of the very low response rate might be the concerns 
of the general public for participating in the genetic research. This is also 
noticed in the other genetic studies where respondents were less likely to agree 
for storing their blood sample for future research, compared to the non-
genetically clinical data (McQuillan et al. 2003; Schwartz et al. 2001). A 
qualitative study revealed the findings of a focus group discussion among the 
patients and control of genetic study (McGuire et al. 2008). One of the 
participants shared his view about the consent for a genetic study is to, “Let 
them know up-front... keep it simple, keep it correct, and never lie”. Most of 
the participants were concerned about sharing of their genetic information on a 
public database, “I just keep thinking if the entire sequence is out there, one of 
these days the computers are going to catch up with us and they will be able to 
tack it back to us”. The other participant expresses his concern as, “I want to 
share everything ... my total history, whatever... but I want it to be in the 
medical community, not just some guy saying well I didn’t have anything else to 
do so I just went ahead and read this,... I want this information going to help 
people that I am here to help”. The genetic information, such as future risk of 
disease may have serious impact on individuals and their family lives (Baoqi & 
Darryl 2004).  
The potential reasons of participating in the genetic research includes; the 
desire to help current and future generations, family member with a genetic 
condition, hope of development cure for disease through genetic research, ease 
of participating, trust and credibility of the responsible organization, how 
participants will benefit themselves such as receiving personal genetic test 
results, and clarity of information in the consent form (Lemke et al. 2010; 
Sterling et al. 2006; Ormond et al. 2011). Possible reasons of not participating 
includes; the lack of public education about genetic research, fear of the 
“unknown” associated with genetic research, fear of genetic discrimination by 
the insurance company, health department or employer, no direct or immediate 
benefit, fear of breach of confidentiality, or no belief in genetic research or 
genetic determinism (Ormond et al. 2011; Streicher et al. 2011; Schwartz et al. 
2001). 
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This low response could introduce bias to the analysis of this study in terms of 
difference between people who did and did not respond to the study invitation. 
This may affect the generalisability of my results. However, the internal validity 
of mood disorder in the UK Biobank has previously described (Smith et al. 2013).  
 In Chapter 7, I reported an association between being underweight and poor 
mental health, particularly in women (Chapter 7; Ul-Haq, Z et al.2013c). The 
lack of an association with underweight in this study may reflect a lack of 
statistical power due to smaller numbers in this sub-group, or may be due to the 
previously I used the GHQ-12 which is a short screening instrument rather than a 
detailed assessment of mental health. The population of SHeS and UK Biobank 
differ considerably in age range which may perhaps explain differences in 
results. 
The use of many psychotropic medications, such as mood stabilizers, anti-
psychiatric and anti-depressants is associated with weight gain (exposure). These 
drugs may cause 2-17 kg of increase in the individuals’ body weight over the 
period of a clinical treatment (Allison et al. 1999). It may be a potential 
confounder and therefore the analysis was adjusted for the use of psychotropic 
medications. However, the psychotropic drugs may be used by the participants 
with the probable major depression (outcome). Furthermore, adiposity may 
result in the non-compliance of psychotropic drugs and may be associated with 
the relapse of the depression and psychiatric hospitalization (Nihalani et al. 
2011). Therefore, adjustment for it may be “over adjustment” and may 
underestimate or even change the direction of the association between adiposity 
(exposure) and probable major depression (outcome) (Schisterman et al. 2009). 
8.7 Implications of this research 
Overweight and obese women are significantly more likely to suffer from major 
depression, and the risk increases with increasing level of adiposity, even after 
adjusting for a range of potential confounders. Physicians managing overweight 
and obese women should be alert to this increased risk. Further research is 
required into whether the associations are causal, the direction of causality, and 
whether obesity interventions can reduce the risk of depression.  
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In the last five Chapters (Chapter 4 to 8, inclusive) I have explored the 
relationships between adiposity and HRQoL and mental health. In the next 
Chapter (Chapter 9), I explore whether the same relationships are present 
between adiposity and other two measures of subjective well-being: self-rated 
health and unhappiness.  
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9.1 Chapter summary 
Obesity is known to increase the risk of many diseases and reduce overall quality 
of life. This study examines the relationship with SRH and happiness.   
I conducted a cross-sectional study of the 163,066 UK Biobank participants who 
completed the happiness rating. The association between adiposity and SRH and 
happiness was examined using logistic regression. SRH was defined as good 
(excellent, good), or poor (fair, poor). Self-reported happiness was defined as 
happy (extremely, very, moderately) or unhappy (moderately, very, extremely). 
Poor health was reported by 44,457 (27.3%) participants. The adjusted OR for 
poor health were 3.86, 2.92, 2.60 and 6.41 for the highest, compared with 
lowest, deciles of BMI, WC, WHR and BF%, respectively. The associations were 
stronger in men (p<0.001). Overall, 7,511 (4.6%) participants felt unhappy, and 
only class III obese participants were more likely to feel unhappy (adjusted OR 
1.33, 95% CI 1.15, 1.53, p<0.001) than normal-weight but the associations 
differed by sex (p<0.001). Among women, there was a significant association 
between unhappiness and all levels of obesity. By contrast, only class III obese 
men had significantly increased risk and overweight and class I obese men were 
less likely to be unhappy.  
Obesity impacts adversely on happiness as well as health, but the association 
with unhappiness disappeared after adjustment for SRH, indicating this may be 
mediated by health. Compared with obese men, obese women are less likely to 
report poor health but more likely to feel unhappy.  
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9.2 Introduction 
Historically, the main focus of healthcare has been the avoidance of preventable 
mortality. As life-expectancy has increased, attention has focused on the need 
to improve health, as well as longevity. The WHO definition of health 
encompasses mental and social, as well as physical, well-being (World Health 
Organisation 1992) but, when self-reporting health, people give greater 
emphasis to physical well-being than psychological well-being (Smith et al. 
1999). Poor SRH predicts mortality over 2-13 years follow-up overall (Idler and 
Benyamini 1997), but the association is significantly stronger in men (Benyamini 
et al. 2000). This has been attributed to women considering a wider range of 
health-related factors and non-health-related factors in the process of assessing 
their own health (Benyamini et al. 2000). Psychological well-being itself 
comprises several components, including happiness (hedonic well-being) and life 
satisfaction (eudaimonic well-being). In the United Kingdom, 38% of people who 
reported poor health had high levels of life satisfaction, and 20% of those who 
reported good health had low life satisfaction (Beaumont & Thomas 2012). 
Therefore, it is important that study results pertaining to one construct are not 
inappropriately generalised to another.  
High levels of adiposity are associated with many diseases including hypertension 
(Narkiewicz 2006), stroke (Kurth et al. 2002), CHD (Silventoinen et al. 2009), 
diabetes (Hossain et al. 2007) and arthritis (Magliano 2008). Evidence is 
increasing that obesity may also impact adversely on psychosocial well-being. 
There are conflicting results regarding the association between obesity and poor 
SRH. Some studies have reported significant associations (Marques-Vidal et al. 
2012; Trakas et al. 2001) while others have reported no (Kepka et al. 2007) or 
very weak associations (Macmillan et al. 2011). A recent study from the USA that 
found no association, hypothesised that a shift to the right in the BMI 
distribution of the general population had changed societal perspectives of what 
constituted normal weight (Macmillan et al. 2011). Previous studies on obesity 
have tended to use measures of HRQoL which encompass both physical and 
psychosocial well-being. In previous chapters, I demonstrated that obesity was 
associated with significantly reduced overall HRQoL, irrespective of the presence 
of comorbid conditions (Chapter 6; Ul-Haq, Z et al. 2012). The physical 
component of HRQoL was reduced in both overweight and obese adults with 
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evidence of a dose relationship (Chapter 4, 5; Ul-Haq, Z et al. 2013b; Ul-Haq,Z 
et al. 2013c). By contrast, the mental component of HRQoL was reduced only 
among class III obese individuals and was increased among overweight adults. On 
sub-group analyses it was also clear that the overall reduction in the mental 
component among class III obese was present in women only (Chapter 7 Ul-Haq, 
Z et al. 2013a). 
While BMI remains the anthropometric measure of choice for most researchers, 
there is also growing evidence that favours other measures such as WC, WHR and 
BF% (Rothman 2008). Studies have reported associations between WC and WHR 
and perceived stress and higher levels of stress-dependent cortisol (Bjorntorp & 
Rosmond 2000). In some recent studies, abnormally high BF% was significantly 
associated with poor mental health and well-being (Saarni et al. 2009). Obesity 
can lead to stigma and discrimination (Cramer & Steznwert 1998). Compared 
with men, women are more likely to be judged based on physical appearance. 
Therefore, it is plausible that obesity will be associated with unhappiness, 
especially among women. The aim of this study was to explore the relationship 
between adiposity (objectively measured by BMI, WC, WHR and BF%), SRH and 
unhappiness among a large sample of the UK middle-aged population.  
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9.3 Material and methods 
9.3.1 Data source  
UK Biobank is a large, prospective cohort study of 502,682 residents of the 
United Kingdom, aged between 40 and 69 years (Allena et al. 2012; Collins 
2012). The cohort provides one of the largest resources worldwide to study the 
genetic, environmental and lifestyle factors that cause or prevent disease in 
middle and older age (UK Biobank 2007). Recruitment was undertaken over a 4-
year period from 2006 to 2010, but the rating on self-reported happiness was 
only included in the last two years of recruitment. In due course, follow-up 
information will be obtained via record linkage to routine health and 
administrative databases. This cross-sectional study was undertaken using the 
baseline data on those participants who completed the happiness rating.   
9.3.2 Data collection 
Participants attended one of 22 centres located across the United Kingdom 
(Chapter 8, Figure 8.1). Each person completed a touch screen questionnaire 
that collected information on demographics (including age, sex, ethnicity, 
employment status and postcode of residence), health-related behaviours 
(including smoking status and alcohol consumption), doctor-diagnosed 
comorbidity (CVD, hypertension, diabetes and cancer), overall health rating and 
happiness. Trained clinic staff used standard operating procedures to record 
physical measurements; including height, weight, waist and hip circumference 
and BF% (measured by bioimpedance). After removal of shoes and heavy outer 
clothing, weight and BF% were measured using the Tanita BC-418MA body 
composition analyser. Height, without shoes, was measured using the Seca 202 
device. The Wessex non-stretchable sprung tape was used to measure WC at the 
level of the umbilicus and hip circumference at the widest point. WHR was 
derived by dividing WC by hip circumference and BMI was derived by dividing 
weight (measured in kilograms) by the square of height (measured in metres).  
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9.3.3 Definitions 
BMI was categorised as WHO cut-off into underweight (<18.5 kg/m2), normal 
weight (18.5-24.9 kg/m2), overweight (25.0-29.9 kg/m2), class I obese (30.0-34.9 
kg/m2), class II obese (35.0-39.9 kg/m2) and class III obese (≥40 kg/m2), using 
standard cut-point (World Health Organization 2013). Among men, WC was 
categorised into normal weight (<94 cm), overweight (94-101 cm), and obese 
(≥102 cm). The equivalent cut-off values for women were <80, 80-87 and ≥88 cm 
respectively. 
 Among men, WHR was categorised into normal weight (<0.90), overweight 
(0.90-0.99) and obese (≥1). Among women, the equivalent cut-off values were 
<0.80, 0.80-0.84 and ≥0.85 respectively (World Health Organization 2008) BF% 
was dichotomised into normal weight (defined as ≤25% for men and ≤32% for 
women) and obese (defined as >25% for men and >32% for women) (The 
American Council on Exercise 2013)  
Smoking status, level of alcohol consumption, ethnic group and employment 
status were self-reported. Townsend deprivation index is an area-based measure 
of socioeconomic status and is derived from aggregated information collected in 
the census on: car ownership; overcrowding; owner-occupation and 
unemployment (Townsend 1987). The score includes both positive and negative 
values, with positive values indicating higher levels of deprivation. The presence 
of comorbidity was based on self-report of a physician diagnosis. Overall health 
was self-classified, and based on response to the question “In general, how 
would you rate your overall health; excellent, good, fair or poor? In this study, I 
collapsed these into two categories, one comprising excellent and good that I 
labelled good, and a second comprising fair and poor that I labelled poor. 
Overall happiness was self-reported, and based on response to the question: “In 
general, how happy are you; extremely happy, very happy, moderately happy, 
moderately unhappy, very unhappy or extremely unhappy?’ In this study, I 
collapsed these into two categories: happy (extremely happy, very happy, 
moderately happy) and unhappy (moderately unhappy, very unhappy or 
extremely unhappy). UK Biobank used validated questionnaires, particularly for 
lifestyle factors, socioeconomic status and general health (UK Biobank 2007).  
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This study was approved by the NHS National Research Ethics Service (17 June 
2011, Ref 11/NW/0382). Written consent was obtained, including consent to 
collect baseline data, to obtain follow-up information via linkage to medical 
records, and to collect and analyse blood and urine samples. Participants agreed 
that, except for some measurements obtained during the visits, none of their 
results would be provided to them and they will not benefit from any future 
commercial developments. 
9.3.4 Statistical analyses 
Differences in the characteristics of participants by SRH and happiness were 
analysed using the χ² test for categorical data, χ² test for trend for ordinal data, 
and Wilcoxon rank-sum test for Townsend score (non-normally distributed). I 
examined the associations between anthropometric measurements (BMI, WC, 
WHR and BF%) and SRH and happiness using univariate and multivariate logistic 
regression models. Results are presented as OR and 95% CI. In the latter, I 
adjusted for the potential confounding effects of age, sex, socioeconomic and 
employment status, ethnic group, smoking status, frequency of alcohol 
consumption and presence of comorbidity. I tested whether there were 
statistically significant interactions by applying likelihood ratio test between 
anthropometric measurements and both sex; conducting subgroup analyses 
accordingly. All statistical analyses were performed using Stata version 12.1 
(StataCorp, College Station, Texas). Statistical significance was defined as 
p<0.05. 
9.4 Results 
Of the 502,682 UK Biobank participants, 163,066 (32.4%) were recruited 
following inclusion of a happiness rating and were, therefore, eligible for 
inclusion in this study. Their mean BMI was 27.4 (SD 4.8) (men 27.8 (SD 4.2); 
women 27.1 (SD 5.2). Overall, the mean age was 57 years (SD 8 years), and 
74,177 (45.5%) were men. 
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9.4.1 Self-reported health 
Overall, 44,457 (27.3%) participants classified themselves as being in poor 
health. Compared to those with good SRH, those with poor SRH were more likely 
to be women, obese, deprived, unemployed, non-white, smoked and reported 
comorbidity, but consumed less alcohol and were not significantly different in 
terms of age (Table 9.1). There was a J-shaped relationship between several 
anthropometric measures and poor SRH in both men (Figure 9.1), and women 
(Figure 9.2). On both univariate and multivariate logistic regression analysis, 
there were significant associations between all anthropometric measures and 
SRH (all p<0.001) (Table 9.2). In relation to BMI category, those participants who 
were classified as underweight, overweight or obese (class I, II or III) had 
significantly increased odds of having poor SRH in comparison with normal 
weight participants with evidence of a dose relationship among participants with 
above-normal BMI (Table 9.2). Similarly, individuals classified as overweight or 
obese based on the other measures had significantly higher odds of poor SRH 
compared with individuals of normal-weight, with higher odds for obese than 
overweight. There was a significant interaction with gender (p<0.001). Sub-
group analyses by sex demonstrated that the overall patterns of association were 
common to both men and women, but the OR associated with class II and III 
obesity tended to be higher in men (Table 9.2).  
When the logistic regression analyses were re-run entering the anthropometric 
measures as sex-specific deciles, the adjusted OR in both sexes showed the same 
J shaped relationships (Figure 9.1 and 9.2) observed for the crude frequencies 
(Figures 9.3 and 9.4). Men and women in the highest deciles of BMI, WHR and WC 
had fourfold to sixfold higher odds of poor SRH. The magnitude of association 
with BF% was much greater in men than women. Being in the top decile of BF% 
increased the odds of poor SRH ninefold in men (adjusted OR 8.99, 95% CI 5.58, 
14.49, p<0.001) (Figure 9.3) but only threefold in women (adjusted OR 3.33, 95% 
CI 3.09, 3.59, p<0.001) (Figure 9.4).  
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Table 9.1 Characteristics of the participants by self-reported health and happiness. 
 
 
 
Self-reported General Health Self-reported overall Happiness 
 
Good Poor P-value Happy Unhappy P-value 
 
N=118609 
N (%) 
N= 44457 
N (%) 
 
N=155555 
N (%) 
N=7511 
N (%) 
 Sex 
      
Women 66600 (56.15) 22289 (50.14) <0.001 85105 (54.71) 3784 (50.38) <0.001 
Men 52009 (43.85) 22168 (49.86) 
 
70450 (45.29) 3727 (49.62) 
 
Age (years) 
      
39-49 26985 (22.75) 10167 (22.87) 0.134 34714 (22.32) 2438 (32.46) <0.001 
50-60 42930 (36.19) 16274 (36.61) 
 
56076 (36.05) 3128 (41.65) 
 
61-72 48694 (41.05) 18016 (40.52) 
 
64765 (41.63) 1945 (25.90) 
 
BMI category 
      
Underweight 555 (0.47) 241 (0.54) <0.001 729 (0.47) 67 (0.89) <0.001 
Normal-weight 43995 (37.09) 9284 (20.88) 
 
50873 (32.70) 2406 (32.03) 
 
Overweight 51983 (43.83) 17067 (38.39) 
 
66216 (42.57) 2834 (37.73) 
 
Class I obese 17249 (14.54) 11432 (25.71) 
 
27213 (17.49) 1468 (19.54) 
 
Class II obese 3837 (3.23) 4294 (9.66) 
 
7665 (4.93) 466 (6.20) 
 
Class III obese 990 (0.83) 2139 (4.81) 
 
2859 (1.84) 270 (3.59) 
 
WC category 
      
Normal-weight 53223 (44.87) 11257 (25.32) <0.001 61636 (39.62) 2844 (37.86) <0.001 
Overweight 32791 (27.65) 10787 (24.26) 
 
41781 (26.86) 1797 (23.92) 
 
Obese 32595 (27.48) 22413 (50.42) 
 
52138 (33.52) 2870 (38.21) 
 
WHR category 
      
Normal-weight 47874 (40.36) 10293 (23.15) <0.001 55681 (35.80) 2486 (33.10) <0.001 
Overweight 46689 (39.36) 18472 (41.55) 
 
62219 (40.00) 2942 (39.17) 
 
Obese 24046 (20.27) 15692 (35.30) 
 
37655 (24.21) 2083 (27.73) 
 
%BF category 
      
Normal-weight 45812 (38.62) 10479 (23.57) <0.001 53582 (34.45) 2709 (36.07) 0.003 
Obese 72797 (61.38) 33978 (76.43) 
 
101973 (65.55) 4802 (63.93) 
 
‡
Townsend score  median (IQR) 
     
 
-2.07 (3.85) -1.08(4.78) <0.001 -1.87 (4.08) -0.64 (5.05) <0.001 
Employment status 
     
Employed 69946 (58.97) 22014 (49.52) <0.001 87868 (56.49) 4092 (54.48) <0.001 
Retired 41330 (34.85) 15531 (34.93) 
 
55225 (35.50) 1636 (21.78) 
 
Look after home 3517 (2.97) 1354 (3.05) 
 
4589 (2.95) 282 (3.75) 
 
Unemployed 2761 (2.33) 1697 (3.82) 
 
3953 (2.54) 505 (6.72) 
 
Not working 704 (0.59) 3740 (8.41) 
 
3478 (2.24) 966 (12.86) 
 
Student 351 (0.30) 121 (0.27) 
 
442 (0.28) 30 (0.40) 
 
Ethnicity 
      
White 110390 (93.07) 39330 (88.47) <0.001 143128 ( 92.01) 6592 (87.76) <0.001 
Mixed 822 (0.69) 394 (0.89) 
 
1137 (0.73) 79 (1.05) 
 
Asian 3111 (2.62) 2255 (2.62) 
 
4991 (3.21) 375 (4.99) 
 
Black 2641 (2.23) 1562 (3.51) 
 
3927 (2.52) 276 (3.67) 
 
Chinese 413 (0.35) 197 (0.44) 
 
569 (0.37) 41 (0.55) 
 
Other 1232 (1.04) 719 (1.62) 
 
1803 (1.16) 148 (1.97) 
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Alcohol consumption 
Daily 25677 (21.65) 7563 (17.01) <0.001 31720 (20.39) 1520 (20.24 ) <0.001 
3-4 times/week 28685 (24.18) 7880 (17.72) 
 
35292 (22.69) 1273 (16.95) 
 
1-2 times/week 30600 (25.80) 10492 (23.60) 
 
39502 (25.39) 1590 (21.17) 
 
1-2 times/month 13041 (10.99) 5517 (12.41) 
 
17624 (11.33) 934 (12.44) 
 
Special occasions 12394 (10.45) 7321 (16.47) 
 
18506 (11.90) 1209 (16.10) 
 
Never 8212 (6.92) 5684 (12.79) 
 
12911 (8.30) 985 (13.11) 
 
Smoking status 
      
Never 68702 (57.92) 21696 (48.80) <0.001 86586 (55.66) 3812 (50.75) <0.001 
Previous 40452 (34.11) 16039 (36.08) 
 
54113 (34.79) 2378 (31.66) 
 
Current 9455 (7.97) 6722 (15.12) 
 
14856 (9.55) 1321 (17.59) 
 
Comorbidity 
      
No 82923 (69.91) 20394 (45.87) <0.001 98717 (63.46) 4600  (61.24) <0.001 
Yes 35686 (30.09) 24063 (54.13) 
 
56838 (36.54) 2911 (38.76) 
  
‡ 
Townsend score, a measure of socio-economic status; a negative score represents greater 
affluence.
  
P-value; χ² test for categorical data and χ² test for trend for ordinal data, Wilcoxon rank-
sum test for Townsend score (non normally distributed).  
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Table 9.2 Logistic regression analysis of the participant characteristics associated with having poor self-reported health.  
 
  Overall Men Women  
  
Univariate 
 
Multivariate 
 
Univariate 
 
Multivariate 
 
Univariate 
 
Multivariate 
 
  Odds Ratio                               
(95% CI) 
P-  
value 
Odds Ratio                             
(95% CI) 
P-
value 
Odds Ratio                              
(95% CI) 
P-
value 
Odds Ratio                             
(95% CI) 
P-
value 
Odds Ratio                              
(95% CI) 
P-
value 
Odds Ratio                             
(95% CI) 
P-
value 
BMI category 
            
Underweight 2.06 (1.77, 2.40) <0.001 1.67 (1.41, 1.97) <0.001 3.64 (2.67, 4.97) <0.001 2.43 (1.72, 3.45) <0.001 1.85 (1.54,2.21) <0.001 1.49 (1.22, 1.81) <0.001 
Normal-weight 1 - 1 - 1 - 1 - 1 - 1 - 
Overweight 1.56 (1.51, 1.60) <0.001 1.40 (1.35, 1.44) <0.001 1.34 (1.29, 1.40) <0.001 1.29 (1.23, 1.35) <0.001 1.63 (1.57, 1.70) <0.001 1.47 (1.42, 1.54) <0.001 
Class I obese 3.14(3.04, 3.24) <0.001 2.49 (2.40, 2.58) <0.001 2.76 (2.63, 2.90) <0.001 2.32 (2.20, 2.45) <0.001 3.26 (3.12, 3.41) <0.001 2.58 (2.46, 2.70) <0.001 
Class II obese 5.30 (5.05, 5.57) <0.001 3.82 (3.63, 4.03) <0.001 5.22 (4.83, 5.65) <0.001 3.86 (3.55, 4.19) <0.001 5.29 (4.97, 5.64) <0.001 3.75 (3.50, 4.01) <0.001 
Class III obese 10.24 (9.47, 11.08) <0.001 6.45 (5.94, 7.02) <0.001 11.44 (9.86, 13.28) <0.001 7.38 (6.31, 8.63) <0.001 10.15 (9.25, 11.15) <0.001 6.13 (5.55, 6.77) <0.001 
Waist circumference 
           
Normal-weight 1 - 1 - 1 - 1 - 1 - 1 - 
Overweight 1.56 (1.51,  1.60) <0.001 1.47 (1.42,  1.51) <0.001 1.57 (1.51, 1.64) <0.001 1.50 (1.43, 1.56) <0.001 1.52 (1.46, 1.59) <0.001 1.42 (1.35, 1.48) <0.001 
Obese 3.25 (3.17,  3.34) <0.001 2.68 (2.60,  2.76) <0.001 3.28 (3.16, 3.41) <0.001 2.71 (2.60, 2.83) <0.001 3.38 (3.26, 3.51) <0.001 2.60 (2.49, 2.70) <0.001 
Waist to hip ratio 
           
Normal-weight 1 - 1 - 1 - 1 - 1 - 1 - 
Overweight 1.84 (1.79, 1.89) <0.001 1.51 (1.46, 1.55) <0.001 2.01 (1.93, 2.10) <0.001 1.79 (1.72, 1.87) <0.001 1.52 (1.46, 1.58) <0.001 1.34 (1.29, 1.40) <0.001 
Obese 3.04 (2.95, 3.13) <0.001 2.34 (2.27, 2.42) <0.001 4.77 (4.53, 5.02) <0.001 3.48 (3.29, 3.68) <0.001 2.54 (2.45, 2.64) <0.001 1.90 (1.83, 1.98) <0.001 
Body fat Percent 
           
Normal-weight 1 - 1 - 1 - 1 - 1 - 1 - 
Obese 2.04 (1.99, 2.09) <0.001 1.98 (1.92, 2.03) <0.001 2.30 (2.22, 2.37) <0.001 2.0 (1.93, 2.07) <0.001 2.24 (2.15, 2.33) <0.001 1.93 (1.85, 2.02) <0.001 
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9.4.2 Self-reported happiness 
Overall, 7,511 (4.6%) participants reported feeling unhappy. Compared to those 
with good self-reported happiness, those with poor self-reported happiness were 
more likely to be women, obese, deprived, unemployed, non-white, smoked and 
reported comorbidity, but consumed less alcohol and were not significantly 
different in terms of age (Table 9.1). In both men (Figure 9.1) and women 
(Figure 9.2), the odds of being unhappy were higher in only the highest deciles 
of adiposity. There was a significant interaction with gender (p<0.001) but not 
with ethnicity (p=0.366). On logistic regression analysis, women who were 
obese, based on BMI, were more likely to be unhappy (Table 9.3). Adjustment 
for the potential confounding effects attenuated the associations but they 
remained statistically significant (class III obese adjusted OR 1.38, 95% CI 1.16, 
1.65, p<0.001) (Table 9.3). BF% was less discriminatory. Men only had 
significantly higher odds of unhappiness if they were class III obese (adjusted OR 
1.29, 95% CI 1.03, 1.63, p=0.029), and overweight and class I obese men were 
significantly less likely to be unhappy than men of normal weight (Table 9.3).  
Overall, of the 44,457 participants with self-reported poor health, 39,869 
(89.7%) were happy and, of the 7,511 participants who felt unhappy, 2,923 
(38.9%) reported good health. After adjustment for SRH, obesity was no longer 
associated with a significantly increased risk of unhappiness (Table 9.4). In 
women, being underweight was associated with increased odds of being unhappy 
even after adjusting for potential confounders including comorbidity (Table 9.3). 
But when the analyses were stratified according to whether or not participants 
reported themselves as healthy, underweight women who reported themselves 
to be healthy were no longer significantly more likely to be unhappy (adjusted 
OR 1.39, 95% CI 0.86, 2.24, p=0.181) (Table 9.5a) whereas unhealthy 
underweight women were still more likely to feel unhappy (adjusted OR 1.70, 
95% CI 1.14, 2.53, p=0.009) (Table 9.5b). Among men, there was a significant 
univariate association between being underweight and unhappy but this was no 
longer significant following adjustment for potential confounders (Table 9.3).    
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Table 9.3 Logistic regression analysis of the participant characteristics associated with self-reported Unhappiness. 
 
 
 
Overall 
 
Men 
 
Women  
 
 
Univariate 
 
Multivariate 
 
Univariate 
 
Multivariate 
 
Univariate 
 
Multivariate 
 
 
Odds Ratio     
(95% CI) 
P-                  
value 
Odds Ratio    
(95% CI) 
P-                  
value 
Odds Ratio    
(95% CI) 
P-                  
value 
Odds Ratio    
(95% CI) 
P-                  
value 
Odds Ratio    
(95% CI) 
P-                  
value 
Odds Ratio    
(95% CI) 
P-                  
value 
 
            
BMI category             
Underweight 1.94 (1.51, 2.50) <0.001 1.44 (1.11, 1.88) 0.006 1.74 (1.02, 2.97) 0.043 0.93 (0.53, 1.63) 0.798 2.16 (1.62, 2.89) <0.001 1.73 (1.28, 2.33) <0.001 
Normal-weight 1 - 1 - 1 - 1 - 1 - 1 - 
Overweight 0.90 (0.86, 0.96) <0.001 0.89 (0.84, 0.94) <0.001 0.79 (0.73, 0.86) <0.001 0.83 (0.77, 0.90) <0.001 0.94 (0.87, 1.01) 0.105 0.94 (0.87, 1.02) 0.137 
Class I obese 1.14 (1.07, 1.22) <0.001 1.02 (0.95, 1.09) 0.576 0.94 (0.85, 1.04) 0.21 0.89 (0.81, 0.99) 0.029 1.27 (1.16, 1.40) <0.001 1.15 (1.05, 1.27) 0.004 
Class II obese 1.29 (1.16, 1.42) <0.001 1.03 (0.93, 1.15) 0.536 1.10 (0.94, 1.29) 0.221 0.91 (0.77, 1.07) 0.245 1.41 (1.23, 1.61) <0.001 1.15 (1.00, 1.32) 0.057 
Class III obese 2.0 (1.75, 2.28) <0.001 1.33 (1.15, 1.53) <0.001 1.88 (1.51, 2.34) <0.001 1.29 (1.03, 1.63) 0.029 2.11 (1.79, 2.49) <0.001 1.38 (1.16, 1.65) <0.001 
Waist circumference 
           
Normal-weight 1 - 1 - 1 - 1 - 1 - 1 - 
Overweight 0.93 (0.88, 0.99) 0.022 0.96 (0.90, 1.02) 0.218 0.92 (0.84, 0.99) 0.036 0.96 (0.88, 1.05) 0.366 0.94 (0.86, 1.03) 0.193 0.96 (0.88, 1.05) 0.381 
Obese 1.19 (1.13, 1.26) <0.001 1.11 (1.05, 1.17) <0.001 1.15 (1.07, 1.24) <0.001 1.09 (1.01, 1.19) 0.037 1.26 (1.17, 1.36) <0.001 1.12 (1.04, 1.22) 0.004 
Waist to hip ratio            
Normal-weight 1 - 1 - 1 - 1 -   1 - 
Overweight 1.06 (1.0, 1.12) 0.039 0.99 (0.93, 1.05) 0.732 1.0 (0.92, 1.07) 0.9 1.01 (0.93, 1.10) 0.791 1.0 (0.92, 1.09) 0.958 0.97 (0.89, 1.06) 0.507 
Obese 1.24 (1.17, 1.32) <0.001 1.14 (1.07, 1.21) <0.001 1.29 (1.17, 1.43) <0.001 1.16 (1.04, 1.29) 0.008 1.25 (1.16, 1.35) <0.001 1.12 (1.03, 1.21) 0.006 
Body fat Percent 
           
Normal-weight 1 - 1 - 1 - 1 - 1 - 1 - 
Obese 0.93 (0.89, 0.97) 0.004 0.98 (0.93, 1.04) 0.535 0.98 (0.92, 1.05) 0.541 0.98 (0.91, 1.05) 0.505 0.96 (0.89, 1.03) 0.26 0.96 (0.89, 1.04) 0.298 
CI; Confidence Interval, adjusted by age, sex, socio-economic status, employment, ethnicity, alcohol consumption, smoking and comorbidity (CVD, 
hypertension, diabetes and cancer) 
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Figure 9.1 Frequency (%) of self-reported poor health and unhappiness by measures of adiposity in Men 
a. Body Mass Index deciles (kg/m2)                                                                            b. Waist Circumference deciles (cm)         
             
c. Waist to hip ratio deciles                                                                                       d. Body fat % deciles                                                    
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Figure 9.2 Frequency (%) of self-reported poor health and unhappiness by measures of adiposity in Women.   
a. Body Mass Index deciles (kg/m2)                                                                     b. Waist Circumference deciles (cm)                                
        
c. Waist-to-hip ratio deciles                                                                                d. Body fat% deciles          
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Figure 9.3 Adjusted odds ratio of self-reported poor health and unhappiness by measures of adiposity in Men.   
a. Body Mass Index deciles (reference group* 24 to 25kg/m2)                                b. Waist Circumference deciles (reference group* 90.5 to 93cm)                      
     
c. Waist to hip ratio deciles (reference group* 0.87 to 0.90)                                 d. Body fat % deciles (reference group* 21 to 24%)                                                       
        
 OR; Odds ratio, CI; confidence interval, Adjusted by age, socio-economic status, employment, ethnicity, alcohol consumption, smoking, and comorbidity  
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Figure 9.4 Adjusted odds ratio of self-reported poor health and unhappiness by measures of adiposity in Women 
a. Body Mass Index deciles (reference group* 24 to 25kg/m2)                                                               b. Waist Circumference deciles (reference group* 73 to 78cm)                                                     
       
c. Waist to hip ratio deciles (reference group* 0.75 to 0.79)                                                                   d. Body fat % deciles (reference group* 29 to 31%)  
                                               
OR; Odds ratio, CI; confidence interval, Adjusted by age, socio-economic status, employment, ethnicity, alcohol consumption, smoking, and comorbidity  
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Table 9.4 Logistic multivariate regression analysis of the body mass index associated with self-
reported unhappiness after adjustment for self-reported health, in addition to the other 
potential confounding factors. 
 
 
Odds Ratio (95% CI)  P-value  
 
BMI category 
  Underweight 1.24 (0.94, 1.62) 0.123 
Normal-weight 1 - 
Overweight 0.81 (0.77, 0.86) <0.001 
Class I obese 0.78 (0.73, 0.84) <0.001 
Class II obese 0.71 (0.64, 0.79) <0.001 
Class III obese 
 
0.84 (0.73, 0.97) 0.015 
 
CI; Confidence Interval, adjusted by age, sex, socio-economic status, employment, ethnicity, 
alcohol consumption, smoking, comorbidity and self-reported health. 
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Table 9.5 Logistic regression analysis of the women body mass index associated with self-
reported unhappiness after stratification by self-reported health. 
 
a. Self-reported good health women 
  
Odds ratio (95% CI) 
 
P-value 
 
BMI category   
Underweight 1.39 (0.86,2.25) 0.181 
Normal-weight           1     - 
Overweight 0.82 (0.72, 0.91) <0.001 
Class I obese 0.87 (0.74, 1.03) 0.100 
Class II obese 0.77 (0.58, 1.03) 0.075 
Class III obese 0.75 (0.46, 1.23) 0.254 
 
 
 
b. Self-reported poor health women 
 
 Odds ratio(95% CI) P-value  
 
BMI category 
  
Underweight 1.70 (1.14,2.53) 0.009 
Normal-weight           1     - 
Overweight 0.85 (0.75, 0.95)  0.005 
Class I obese 0.84 (0.74, 0.95) 0.007 
Class II obese 0.75 (0.63, 0.89)  0.001 
Class III obese 0.85 (0.70, 1.03) 0.098 
 
CI; Confidence Interval, adjusted by age, socio-economic status, employment, ethnicity, alcohol 
consumption, smoking, comorbidity 
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9.5 Discussion 
In this study I sought to investigate the relationship between obesity, health and 
happiness using a large cross-sectional study of the UK general population. I 
found that there was no association between happiness and self-reported good 
health which suggests that the general population may primarily define their 
health in terms of physical, rather than psychosocial, well-being. Overweight 
and obese individuals were significantly more likely to report poor overall health 
than individuals of normal weight, even after adjustment for potential 
confounders, and irrespective of the anthropometric measure used. The 
association varied by sex such that obesity increased the odds of poor self-rated 
health in men more than in women. In contrast, obesity increased the odds of 
unhappiness in women more than men. Overweight and class I obese men were 
more likely to report being happy than men of normal weight, and men only 
reported feeling unhappy if they were severely obese. Conversely, women 
reported unhappiness at lower levels of obesity. The significant association 
between obesity and unhappiness was lost following adjustment for SRH 
suggesting that the association may be mediated by health. Being underweight 
may occur as a result of ill-health, and underweight women were only at 
increased risk of unhappiness if they also reported themselves as unhealthy.  
Self-reported poor health is a stronger predictor of mortality among men (Idler & 
Benyamini 1997). My findings suggested that the association between poor SRH 
and obesity was also stronger in men. Both may be due to sex differences in the 
range of factors considered when self-reporting health (Benyamini et al. 2000). 
Previous study findings have been inconsistent as to whether SRH is poorer in 
overweight and obese individuals. Studies have reported different results across 
countries (Gray et al. 2012; Macmillan et al. 2011; Marques-Vidal et al. 2012). 
Poor SRH was more prevalent in the UK than other European countries, 
particularly in men (Gray et al. 2012). In contrast, poor mental health was more 
prevalent in women than men, in all the European countries studied (Gray et al. 
2012). There is a paucity of UK studies on the association between body weight 
and SRH, but my findings of higher poor SRH among overweight and obese 
individuals are in line with published international studies (Okosun et al. 2001; 
Trakas et al. 2001).    
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The sex differences I observed in the relationship between adiposity and 
happiness are consistent with the previous studies that have examined overall 
quality of life; as is the finding of greater happiness among overweight men. In 
Chapter 7, I reported sex differences in the relationship between BMI and mental 
health in a cross-sectional study of more than 37,000 Scottish adults (Chapter 7; 
Ul-Haq,Z 2013a). Being overweight was associated with better mental health in 
men only and obesity was associated with significantly worse mental health in 
women only. Greeno et al reported an association between obesity and reduced 
life satisfaction in women only (Greeno et al. 1998). Obese men had significantly 
higher life satisfaction (Greeno at al. 1998). In a recent meta-analysis, HRQoL 
was significantly reduced in class III obese adults and improved in overweight 
adults (chapter 4; Ul-Haq, Z et al. 2013b).  
Health is an important determinant of well-being and happiness; but it is not the 
only determinant. Electronic and print media invariably use thin and muscular 
models and are becoming increasingly unrepresentative of the general 
population in which more than 65% of individuals are either overweight or obese. 
Portrayal of these models as the ideal can promote negative body image and 
disordered eating (Diedrichs et al. 2011). Several studies have reported more 
discriminatory societal attitudes towards obesity in women than men 
(Fabricatore & Wadden 2003). Obesity-related stigma begins very early in life, as 
young as three years of age, and persists through childhood and adolescence into 
adult and later life (Cramer & Steznwert 1998). There is evidence of 
discrimination in recruitment, education, news and the media (Roehling 1999). 
Recurrent stigma, prejudice and discrimination could result in chronic 
psychological stress, reduced mental health and overall happiness.  
9.6 Strengths and limitations 
A small number of previous studies have examined the association between level 
of adiposity and SRH and happiness. To my knowledge, this is the first study to 
examine the relationship across the full spectrum from underweight to class III 
obese, and use multiple anthropometric measurements. Use of UK Biobank 
provided a large sample of middle-aged and old-aged individuals recruited from 
the general population. I was able to adjust for a series of potential 
confounders, but as with any observational study, residual confounding is always 
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possible. Many studies have used only BMI which is a poor measure of adiposity in 
muscular individuals. Having access to three other measures of adiposity (WC, 
WHR and BF%) enabled me to corroborate my findings using BMI. I was able to 
demonstrate interactions by sex and to undertake subgroup analyses 
accordingly. As with any cross-sectional study, it was not possible to establish a 
temporal relationship and exclude reverse causation. Obesity may predispose to 
unhappiness. Conversely, unhappiness may lead to over-eating. A longitudinal 
study reported that after 5 years of follow-up, obesity, predicted unhappiness 
(OR 1.70) and depression (OR 2.16), but depression did not predict obesity 
(Roberts et al. 2002; Roberts et al. 2003). Conversely, another study reported 
that baseline depressive symptoms influenced future adiposity but initial 
adiposity did not influence future depressive symptoms (Richardson et al. 2003).   
One weakness of this study is that it used a condensed rating scale for happiness 
that has been rarely used. However, some previous studies have used a similar 
happiness question using the full range of categories from extremely happy to 
extremely unhappy (Charness & Grosskopf 2001; Lee et al. 2000). Less than 10% 
of invited people participated in UK Biobank. It is representative of the UK 
population in terms of breakdown for age, sex, ethnicity and socioeconomic 
status, but may not be representative in terms of other parameters, such as 
lifestyle. However, my finding of an overall prevalence of 66% for overweight or 
obese (42% and 24% respectively) corresponds closely with national statistics  
(Health and Social Care Information Centre 2013; Keenan at al. 2011). The 27% 
prevalence for poor SRH observed in my study and mean score of 2.177 are 
higher than the UK figures (9.1% and 1.196 respectively) reported in WHO’s 
“2002 World Health Survey” (Subramanian et al. 2010) but this difference is 
likely to be due, in part, to WHO survey participants being younger (mean age of 
45 years compared with 57 years in UK Biobank) since my figures are 
commensurate with UK national figures (Young et al. 2010). Inclusion was 
restricted to participants who had completed the happiness question. They were 
more likely to be older (p<0.001), and deprived (p<0.001) than participants who 
did not complete the happiness question, but were not significantly different in 
terms of sex (p=0.855). The association between BMI and happiness is highly 
significant (p<0.001) but the odds ratios are small. Clinical significance as well 
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as statistical significant should be considered when interpreting the outputs, 
particularly in the high-powered studies. 
9.7 Implications of this research 
High levels of adiposity are associated with unhappiness as well as poor health. 
Compared with obese men, obese women are less likely to report poor health 
but more likely to report unhappiness. However, after adjustment for SRH the 
association between adiposity and unhappiness is lost, suggesting that this 
association may be mediated by health. This study further supports the existing 
evidence that there is an association between adiposity and subjective well-
being, particularly perceived health, regardless of the anthropometric 
measurements used, and independent of various potential confounders, 
including comorbidity. These findings emphasise the need for individual and 
community-level interventions to reverse the higher prevalence of obesity 
because it is a risk to mental, as well as physical, well-being. 
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This chapter describes the inter-linkages between the thesis chapters, summarises 
the key findings, discusses the strengths and limitations of the methodology used, 
and proposes recommendations based on the findings of the research included in 
this thesis. 
10.1 Inter-linkages between thesis chapters 
The terms subjective well-being, life satisfaction and happiness are frequently 
used interchangeably. Correspondingly, the terms quality of life are occasionally 
used as synonym with health status, well-being, life-satisfaction and happiness. 
These are all broad ranging concepts but in simple, these are the scientific term 
relating to how individuals evaluate their own lives. Health is an important 
element of subjective well-being; but there are many other domains, such as 
income, jobs, socio-economic status, education, housing, leisure time, 
neighbourhood, marital status, heredity characters and social belonging (Wilson et 
al. 2003; Subramanian et al. 2005). Findings from the Framingham Heart Study 
social network showed that the people’s happiness depends on the other people’s 
happiness related to them to a 3 degree of separation i.e., to one’s friends’ 
friends’ friends (Fowler & Christakis 2008). The concept of HRQoL, SRH or self-
perceived health corresponds to those aspects of subjective well-being that are 
closely related to health, either physical or mental. According to the WHO, 
worldwide the life-expectancy at birth for both men and women has reached to 70 
years, ranges from 62 years in developing countries to 79 years in the developed 
countries. There is a 6 years of gain, since 1990. Women are living longer by 5 
years (more than 6 years in developed country) and this gap is consistent since 
1990. The developed countries have achieved an adequate level of affluence that 
survival is no more a fundamental factors in individuals’ lives but how good is their 
quality of life. The increasing trend of individualism has also enhanced the 
importance of individual’s well-being and happiness (Ogihara & Uchida 2014). 
Furthermore, the development of valid and more reliable measure of well-being, 
such as the generic measure of SF-36 (Ware Jr. 2000), SF-12 (Wee et al. 2008), 
PedsQL (Varni et al. 2003), SRH (Bowling 2005), and GHQ (Goldberg et al. 1997) 
are the reasons of flourishing the research of well-being over the recent past. Self-
reported physical and mental health and HRQoL are independent predictors of all-
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cause mortality (Nielsen et al. 2008; Haring et al. 2011), but whether they are also 
independent predictors of incident diseases such as cancer, CHD and psychiatric 
hospitalisation is not well-documented. 
 
Adiposity is a significant higher risk factor for the development of many physical 
conditions than other avoidable factors such as smoking, alcohol and poverty 
(Sturm & Wells 2001). The annually direct and indirect health care costs due to 
obesity is in billions of pounds (Vlad 2003). The higher prevalence of obesity is a 
threat to halt and possibly reverse the steady increase in the life expectancy 
(Lavie et al. 2009). Obesity can also spread to three degrees of separation 
(Christakis & Fowler 2007), just like the spread of happiness (Fowler & Christakis 
2008) and smoking behaviour (Christakis & Fowler 2008). The impact of this highly 
prevalent avoidable risk factor on all the aspects of public health is of greater 
importance, not only in terms of objective measurements of health; morbidity and 
mortality but perhaps also in relation to self-perceived health.  
 
The research on the association between adiposity and subjective well-being is in 
an early phase. There is a paucity of existing studies and those conducted, have 
suggested a complex relationship between adiposity and different measures of 
subjective well-being. The aim of this thesis was to first investigate whether self-
reported physical and mental health and HRQoL are independent predictors of 
incident diseases such as cancer, CHD and psychiatric hospitalisation in the general 
population, and then to determine relationships between adiposity and self-
perceived health, and whether any associations varied by sex, and comorbidity. 
The thesis comprises eight complementary studies (Chapters 2 to 9, inclusive) to 
achieve these aims.  
 
Chapters 2 and 3 looked at subjective well-being (exposure) and clinical outcomes, 
whereas the other chapters looked at adiposity (exposure) and subjective well-
being (outcome) (Figure 10-1). This thesis is focused on adiposity and health. 
Health can be defined in many ways. In chapters 2 and 3 I demonstrated that 
subjective well-being (measured in terms of both HRQoL and Self-reported physical 
and mental health) was associated with clinical adverse outcomes, such as cancer, 
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CHD, psychiatric admissions and deaths, thereby demonstrating the importance of 
subjective well-being as a health outcome measure. Therefore, the subsequent 
chapters focus on the association between adiposity (exposure) and subjective 
well-being (outcome).  
 
I initially reviewed the existing literature in both adults and children (chapters 
4&5). I found that previous studies have focused on HRQoL as the measure of 
subjective well-being. Studies of both adults and children, have demonstrated 
negative associations between obesity and HRQoL but highlighted differences 
between men and women. Therefore, it was important that my subsequent 
chapters included exploration of differences by sex.  
 
My reviews in chapters 4&5 demonstrated that there were two main gaps in the 
existing literature. Firstly, it was unclear whether the findings of the previous 
studies were true for the relatively new phenomenon of “healthy” obesity. I 
explored this in chapter 6 and found that the findings were consistent irrespective 
of whether obesity occurred in isolation or with comorbidity.  
 
Secondly, the existing literature had tended to overlook the mental health aspects 
of subjective well-being. Therefore I explored this in chapters 7, 8 and 9 looking at 
a number of measures: mood disorder, happiness and mental, as well as general, 
SRH. Overall, there was dose relationship between obesity and poor mental health, 
mood disorder, poor SRH and unhappiness, and the associations differed by sex. 
 
The highly prevalent rate of adiposity has significantly adverse impact on the 
objective measurements of health in terms of morbidity and mortality. The 
findings of these individual chapters and this thesis as whole may extend our 
existing knowledge about its association with self-perceived health. 
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Figure 10.1 Schematic of thesis chapters 
 
Adverse clinical outcomes 
Subjective well-being (SWB) 
Chapters 4 & 5 reviewed existing evidence on adiposity 
and SWB - focus has been on HRQoL as the measure of 
SWB – evidence of negative association between obesity 
and HRQoL among both children/adolescents and adults 
but interactions with sex that need to be taken into 
account in future chapters. Also gaps identified in the 
literature and therefore addressed in chapters 6-9:  
1. Interaction with comorbidity  
2. Mental health components of SWB  
Chapters 6 – interaction with comorbidity- obese 
individuals had poor HRQoL irrespective of the presence 
or absence of comorbidity casting doubt on the term 
“healthy obesity” 
Chapters 7-9 – adiposity and mental health aspects of 
SWB  
7 – Self-reported mental health  
8 – Mood disorders  
9 – Happiness and SRH (general and mental)  
 
Overall: There was dose-response relationship between 
obesity and different measures of SWB  
 
Women: Compared to obese men, obese women were 
less likely to report poor physical health but more likely 
to report poor mental health and unhappiness.  
 
Men: Only class III obese men reported poorer well-
being, whereas the adverse associations between 
adiposity and well-being were apparent in all groups of 
women with above normal weight.           
Adiposity 
Chapters 2 & 3 established that SWB (in terms of SRH 
and HRQoL) is associated with adverse clinical 
outcomes (cancer, CHD, psychiatric admissions, deaths) 
in men and women – therefore SWB is an important 
outcome in itself – therefore the focus (outcome) of the 
remainder of the thesis  
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10.2 Review of key findings 
This thesis established the importance of subjective well-being as a predictor of 
adverse outcomes and then explored the relationship between adiposity and 
subjective well-being.  
In two long-term, retrospective cohort studies I demonstrated that both SRH and 
HRQoL were significant predictors of a range of fatal and non-fatal adverse 
outcomes in the Scottish adult general population: incident cancer and CHD, 
psychiatric hospitalisations and all-cause mortality. The associations were 
independent of potential confounders and there was evidence of dose 
relationships. These findings demonstrated the importance of subjective well-
being as an indicator of overall health and further strengthened the notion that 
health extends beyond physical well-being, to encompass psychological well-
being.  
I undertook meta-analyses of studies in both adults and children/adolescents to 
collate the existing evidence and then undertook four, complementary cross-
sectional studies to explore the relationship between adiposity and subjective 
well-being in more detail and address some of the limitations of previous 
studies. I was able to study the whole range of anthropometric measurements. I 
also explored whether the relationship was consistent across a variety of 
measures of adiposity (BMI, WC, WHR and BF%) and a variety of measures of 
subjective well-being (SRH, HRQoL [overall, physical and mental/psychosocial]), 
mental health and mood disorder, and whether it varied by sex and the presence 
of comorbidity.  
Overall, obesity was associated with reduced HRQoL, irrespective of the 
presence of comorbidity, suggesting that “healthy obesity” (obesity without 
metabolic comorbidity) is a misnomer. The association differed by sex, such that 
being overweight was associated with significantly better overall HRQoL in men 
only. In contrast, being underweight and obese was associated with significantly 
poor overall HRQoL in women only. 
However, overall HRQoL covers physical and mental domains. On further 
research, I found that both overweight and obesity were significantly associated 
Chapter 10 Conclusion 
 
215 
 
with reduced physical HRQoL in adults, as well as children/adolescents, 
compared with normal weight with evidence of a dose relationship. In contrast, 
mental HRQoL was reduced only in class III obese, and overweight individuals 
had better mental HRQoL than normal-weight individuals. In adults, a between-
groups difference of 5 points in individual SF-36 domains, or 2-3 points in the 
summary scores (PCS, MCS) is generally considered clinically significant (Ware 
1994). The reductions in physical HRQoL among overweight and obese were both 
clinically and statistically significant. In contrast, the reduction in mental HRQoL 
was only clinically and statistically significant in class III obese. 
The adverse impact of adiposity on physical HRQoL I demonstrated is consistent 
with previous research. In contrast, there were inconsistencies in the existing 
literature regarding the relationship between adiposity and mental health, and 
whether the association varied by sex. To address this question, I used data from 
two large population based surveys which enabled me to analyze multiple 
measurements of adiposity (BMI, WC, WHR and BF%) and mental health (GHQ-12 
and mood disorder). I found consistent results, such that overweight participants 
reported better mental health than the normal-weight group, and obese 
individuals had poorer mental health. However, the adverse associations 
between adiposity and mental health were specific to women. In contrast, the 
findings of better mental health in overweight individuals were specific to men, 
and only class III obese men were at significantly increased risk of poor mental 
health. 
In the cohort studies I conducted in Chapters 2 and 3, SRH was a strong predictor 
of adverse clinical outcomes and mortality. Therefore, I explored the 
relationship between four measurements of adiposity (BMI, WC, WHR and BF%) 
and self-reported poor health and unhappiness among the large number of adults 
recruited to UK Biobank from the general population. I found that obesity was 
associated with both unhappiness and poor SRH.  
In summary, the previous literature provided ample evidence that adiposity has 
an adverse impact on physical health conditions and life-expectancy. In 
comparison, there was a relative paucity of studies on the association between 
adiposity and subjective well-being. There had been some previous systematic 
reviews but no meta-analysis had been conducted. The existing literature had 
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some limitations and reported contradictory results. Many of the studies only 
relied on self-reported BMI as a measure of adiposity, and only HRQoL as a 
measure of subjective well-being. 
My thesis demonstrated that poor subjective well-being was a significant 
independent predictor of a range of adverse clinical outcomes and mortality. 
Overall, obesity was consistently associated with a variety of measures of poor 
subjective well-being (overall HRQoL, physical HRQoL, mental/psychosocial 
HRQoL, SRH, mental health and mood disorder) across a series of studies. The 
findings were consistent using different measures of obesity and were apparent 
in all of the subgroups studied: both adults and children/adolescents, men and 
women, and people with and without comorbidity. However, there were sex 
differences, such that both overweight and obesity were associated with poor 
mental health and major depression in women only. In contrast, the better 
mental health in overweight individuals was confined to men. Compared with 
obese men, obese women were less likely to report poor health but more likely 
to feel unhappy.  
10.3 Strengths and limitations  
This thesis comprises eight, complementary studies using three study designs: 
meta-analyses, retrospective cohort studies and cross-sectional studies. The 
meta-analyses were conducted in accordance with PRISMA guidelines. However, 
they have a number of limitations. The adult meta-analysis was limited to the 
use of SF-36, and similarly the children and adolescents meta-analysis used only 
PedsQL as a measure of HRQoL. I did not have access to individual-level data and 
therefore could not adjust for potential confounders consistently across the 
studies. However, there was no evidence of significant publication bias as 
assessed by both funnel plots. The included studies were conducted on both 
clinical and community based samples. The former might be expected to over-
estimate the association, but previous studies have demonstrated no significant 
differences in HRQoL between the two groups (Pinhas-Hamiel et al. 2006). 
Cross-sectional studies are inferior to cohort studies in that they cannot 
establish a temporal relationship between the risk factor/exposure and 
outcome. Possible reverse causation is a particular concern among underweight 
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women. Cross-sectional studies are also more prone to survival bias. Therefore, 
ideally, the cross-sectional studies examining the relationship between adiposity 
and subjective well-being would have been undertaken as cohort studies but this 
was not possible.  
Both the cohort studies and cross-sectional studies comprised secondary analyses 
of existing data. Whilst such an approach provides rapid, low cost access to large 
amounts of data on a large number of participants, a limitation is the inability to 
determine what data are collected and how. For example, the four cross-
sectional studies were undertaken using two existing studies: the Scottish Health 
Survey and baseline data from UK Biobank. An advantage is that I was able to 
demonstrate consistency of the findings across two studies conducted on 
different study populations: Scottish adults aged ≥16 years and UK adults aged 
40 to 69 years. However, a limitation was the inability to ensure that the same 
data were available from both studies. For example, UK Biobank had a very large 
sample size and had certain measurements that SHeS did not have it, such as 
BF% but SHeS did not have any age limits and is linked with Scottish Morbidity 
Record, cancer registry and death records. At the moment UK Biobank linked 
data is not available. Therefore, it was not possible to undertake all of the 
analyses using a single resource. In particular, some studies were limited to BMI, 
which is a poor measure of adiposity in individuals with a high muscle mass. 
UK Biobank recruited individuals, aged 40 to 69 years, from the general 
population and so young people or very old people were excluded. Less than 10% 
of invited individuals were recruited into UK Biobank. UK Biobank is 
representative of the UK population in terms of demographics, but may not be 
representative in terms of other parameters, such as lifestyle. However, whilst 
this might impact on the generalizability of some types of results such as overall 
prevalence it does not, necessarily impact on the generalisability of measures of 
effect size.  
I chose the studies used in this thesis (SHeS and UK Biobank) because they 
provided very large numbers of participants recruited from the general 
population, and multiple measures of both adiposity and subjective well-being. I 
had sufficient power to test for interactions with sex and comorbidity and 
undertake sub-group analyses where appropriate. Other strengths of the thesis 
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include being able to study the whole range of anthropometric measurements 
(from underweight to class III obesity), having access to actual measurements 
rather than having to rely on self-reported adiposity, and using four different 
measurements of adiposity (BMI, WC, WHR and BF%) and several standardized 
measures of subjective well-being. Many previous studies have used binary 
variables for SRH, GHQ, PCS and MCS. By using ordinal data, I was able to 
examine whether there was evidence of a dose relationship. The analyses were 
adjusted for a series of potential confounding factors. However, residual 
confounding is always possible in any observational study.  
In Chapters 2 and 3, I used the measures of subjective well-being; self-reported 
physical and mental health and HRQoL as the exposure variables and the cancer 
incidence, CHD events, psychiatric admissions and overall mortality as the 
outcome variables. In the subsequent chapters (4 to 9), I used the measures of 
adiposity as the exposure variables and that of subjective well-being as the 
outcome variables by using the SHeS and the UK Biobank. The technique of data 
linkage has been used since the second half of the nineteenth century, mostly in 
the health-related research (Karmel & Rosman 2008). In this technique the 
individual’s information from two or more datasets/sources are merged together 
using the personal identifier (name, address, date of birth or a unique ID 
number) into a single source of information (Taylor & Lynch 2010). However, 
worldwide not many population based linked data is available, including the 
Scottish Record Linkage system, Oxford Record Linkage Study and Work & 
Pensions Longitudinal Study in the UK. The other such datasets are; the 
Rochester Epidemiology Project in the USA, British Columbia Linked Health 
Database and Manitoba Population Health Information System in Canada, and 
Western Australia Data Linkage System and NSW Centre for Health record 
Linkage in Australia (Holman et al. 2008).  
Once the data linkages are established then there are many advantages of using 
it including the reduced cost (Flowers & Ferguson 2010) and length of time 
(Gissler & Haukka 2004), compared to the primary study. The linkages of data 
make the better use of the existing data by re-using it for a range of new 
research and can also improve its quality by removing the duplicates and other 
errors (Christen & Goiser 2007; Holman et al. 2008). Data linkage provides 
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researchers the opportunity of the cost-effective alternative to the individual 
prospective studies (Sibthorpe et al. 1995; Brook et al. 2008). It also allows the 
monitoring and evaluation of the community health over time and the outcomes 
of the projects could be used to inform the existing or new health policies 
(Kelman et al. 2002; Bass & Carfield 2002).  
There are some limitations/disadvantages of linking data, including the need of 
good working relationship between the technical and management staff of 
different institutions (Taylor & Lynch 2010). It is argued that the data linkage 
may be vulnerable for breaching the privacy and confidentiality of the 
participants (Flowers & Ferguson 2010). In contrary, research has shown that it 
actually enhances the privacy of the participants by not relying on the name, sex 
or date of birth but a unique identifying number, compared to the primary 
research (Holman et al. 2008). Initially the data linkage project demands high 
technical expertise, cost and time but once it is established then little of these 
are required for the subsequent research (Gissler & Haukka 2004). Sometimes 
the linked dataset is of good quality but the required individual variables may 
not be of good quality or not available (Taylor & Lynch 2010).  
The linkage of three large representative SHeS (1995, 1998 & 2003) with follow-
up of cancer registry, death record, CHD events and psychiatric admission has 
produced a large cohort study that allowed me to explore the association 
between the measure of subjective well-being and adverse outcomes. The 
participants’ information has been linked from 1981 to the data of interview 
which provides the opportunity to know and exclude the existing health 
conditions (Gray et al. 2010). However, this information may be incomplete for 
those who immigrated to Scotland after 1981. The SHeS only interviewed those 
individuals who were living in private households and exclude others which may 
have introduced bias to the original survey and subsequently to the linked data. 
In case of no trace of the mortality record, the linked data assumed the 
individuals to be alive, but in actual may have moved from Scotland and died 
there or had an event.  
One of the limitations of using the linked data is that the outcome variables are 
those which are recorded routinely with complete information and coded in 
correct way. There were age limitations in the SHeS 1995 and 1998 and at the 
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moment the follow-up is relatively short, due to which the number of outcome is 
currently not very high. Therefore, I have to limit my outcome to the CHD 
events, cancer incidence, psychiatric admissions and overall death. 
Furthermore, I could not explore which particular cancer, CHD event, psychiatric 
disease or disease specific mortality is associated with poor subjective well-
being. I have used only the hospitalization records which underestimate the 
actual number of outcome, particularly in case of mental health. The possible 
means of collecting data on the other health outcomes could be the General 
Practitioner (GP) consultations. I used the population based cancer registry 
which records the incidence of all cancer in the Scottish population. I did not 
have the periodic information about the status of subjective well-being over 
time. This may have introduced a potential bias as I had no information whether 
the baseline exposure was valid over the time period of follow-up.  
In Chapter 9, I used the “unhappiness” as the outcome variable but there was no 
standardized questionnaire for it. This may affect its comparability with the 
other relevant studies. Ideally, the exposure information should be recorded 
before the occurrence of the outcome but in Chapters 4 to 9, the exposure 
(adiposity) and the outcome (subjective well-being) was recorded at the same 
time. However, these descriptive epidemiological studies are useful by 
generating hypotheses rather than testing it and further analytical studies may 
confirm their findings. 
10.4 Recommendations 
10.4.1 Future Directions 
Research on adiposity and subjective well-being is still developing. It is 
anticipated that the studies included in this thesis will provide a foundation for 
future research, both in terms of corroborating the findings and investigating 
new questions which have now emerged from these studies. 
Further research is required into whether the associations between adiposity and 
subjective well-being, particularly with the psychosocial aspect are causal, the 
direction of causality, and whether obesity interventions can reduce the risk of 
poor subjective well-being. This requires that the associations are corroborated 
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with cohort studies, to establish temporality, and that intervention studies are 
then used to demonstrate reversibility. Being overweight is linked with poor 
physical well-being but not with mental health or unhappiness in men. The 
apparently protective role of overweight among men for the association with 
poor mental health and unhappiness, and the findings that psychosocial sequelae 
of increased BMI are greater in children than in adults warrant further 
investigation using qualitative as well as quantitative research.  
The findings of the research included in this thesis strongly recommend the use 
of the full-spectrum of BMI (from underweight to class III obese), as merging or 
excluding the underweight or overweight category might not only increase the 
risk of weakening the association between measures of adiposity and subjective 
well-being, but also the risk of missing valuable information associated with 
being in these adiposity groups.  
BMI is a proxy measure of adiposity and is reported to have some important 
limitations (Mei Z et al. 2002). The research included in this thesis used three 
other measures of adiposity (WC, WHR and BF%) along with BMI. Overall, the 
association of BMI with subjective well-being was corroborated by these other 
measure of adiposity. It shows that BMI is a valid measure of adiposity in studies 
of the association with subjective well-being. 
Adiposity increased the odds of poor SRH in men more than in women. In 
contrast, adiposity increased the odds of unhappiness and poor mental health in 
women more than men. This thesis did not explore the underlying mechanism 
but supports the need to consider sex variations in future studies of adiposity 
and subjective well-being and to ensure that interactions are always tested 
before analyses are undertaken as overall results may mask important 
differences and provide misleading results. 
Subjective well-being was a strong independent predictor of adverse outcomes, 
including a range of adverse clinical outcomes and all-cause death. But the 
underlying mechanism is not fully understood, and further studies in different 
population are required to fully elucidate the mechanism. 
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The recent published studies in different countries on the topic of “healthy 
obesity” suggest that weight loss will not be beneficial in this particular group or 
may even increase their risk of cardio-metabolic outcomes. This thesis revealed 
that even if there are obese individuals who do not develop metabolic 
comorbidity, they still have the higher risk of poor subjective well-being, which 
is a strong independent predictor of future adverse health outcomes. This needs 
to be replicated, ideally in a different population. There may be merit in 
designing a cohort study of obese individual with and without comorbidity and 
following them up to understand the risk of developing poor subjective well-
being.  
I linked base-line subjective well-being with few of the adverse outcomes and 
found that it was a strong independent predictor of CHD events, cancer 
incidence, psychiatric admission and overall morality in general population. It 
should be further studied to know what type of particular cancers, CHD, and 
disease-specific death is linked with poor subjective well-being. I only included 
the psychiatric hospitalization which underestimates the mental health cases 
and exploration of GP consultation data or similar might give more information. 
Poor subjective well-being should also be studied with other health outcomes 
such as diabetes, arthritis, pulmonary diseases, stroke and functional ability in 
general population. 
Subjective well-being was a strong independent predictor of adverse outcomes, 
including a range of adverse clinical outcomes and all-cause death. But the 
underlying mechanism is not fully understood, and further studies in different 
population are required to fully elucidate the mechanism. There may be merit in 
conducting a longitudinal study of both quantitative and qualitative data with 
frequent measurements of subjective well-being. Integrating the findings of the 
qualitative and quantitative analysis could be very helpful in explaining the 
underlying mechanism. 
This thesis includes one of the very initial analyses of the UK Biobank. The 
dataset is now linked with the hospital records and the findings from this thesis 
may be useful for the upcoming studies as a baseline. For example I have used 
for the first time the diagnosis of probable major depression and prescription 
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information with the help of UK Biobank mental health group. The baseline 
information should be corroborated with the longitudinal studies. 
10.4.2 Public health and clinical implications 
Worldwide, the prevalence of adiposity has reached an epidemic level, and is 
expected to further rise (World Health Organization 2013). About 62% of Scottish 
adults are either overweight or obese and 27% are obese (NHS Scotland 2013). 
The Foresight report predicted that in the UK alone, 60% of men and 40% of 
women could be clinically obese (BMI > 30kg/m2) by 2050 (Foresight 2007). As 
such, it is critical to understand the experiences and quality of life of the 
individuals and community who have abnormally low or high body fat. Similarly, 
life expectancy at birth has significantly increased, particularly in developed 
countries. Therefore, in the recent past a paradigm shift in the measurement of 
health outcomes has been observed, as subjective well-being has become an 
important part of it (Bowling 2014).The interest in measuring subjective well-
being has also substantially increased in the UK in the last few years (Waldron 
2010). Measures of subjective well-being are now included in major health, 
social and economic surveys. It is anticipated that the findings of several studies 
included in this thesis will inform new or existing policy, clinicians, public health 
physicians and others who are dealing with the subjective well-being of 
individuals or the community in general and in particular those who are 
overweight and obese. 
Overweight children are more likely to develop into overweight adults (Whitaker 
et al.1997), and are at increased risk of many physical conditions (Ebbeling et al. 
2002). Similarly, adiposity is related to many physical conditions in adults (Calle 
et al. 1999). This thesis suggests that they also suffer from impaired subjective 
well-being. Therefore, adiposity is an important public health problem and 
effective interventions are needed urgently to stem the higher prevalence. 
These findings will facilitate clinicians, public health physicians and others to 
educate individuals and the community about the potential adverse effects of 
obesity on their quality of life.  
The sex specific findings could help in targeting or focusing on particular 
subgroups, for example, BMI well above or below normal values is associated 
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with significantly poorer mental health in women only, the psychosocial 
sequelae of increased BMI is greater in children than in adults, and the 
association between being overweight and having poor mental health was 
confined to women. These findings suggest that health care providers should be 
aware that underweight and obese women and children are predisposed to 
poorer mental health and may be in particular need of intervention. The risk 
increases with increasing level of adiposity even after adjusting for a range of 
potential confounders. 
Overall, this thesis provides further evidences to support the injurious effects of 
adiposity on all aspects of health, and supports the need to take action to 
reverse the higher prevalence of obesity. Commonly, population health is 
measured in terms of disease and mortality. This thesis may strengthen the 
growing evidence that subjective well-being provides additional information and 
is predictive of future morbidity and mortality. Individuals with poor subjective 
well-being are a higher risk group who may merit closer surveillance and earlier 
intervention. Subjective well-being is as important as objective measures of 
both health and health risk, and should be considered in identifying how best to 
target public health and health care interventions.  
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22 Present results of any assessment of risk of bias across studies (see Item 15).  100, Figure 
4.2 
119, Figure 
5.2 
Additional 
analysis  
23 Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item 
16]).  
None None 
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Summary of 
evidence  
24 Summarize the main findings including the strength of evidence for each main outcome; consider their 
relevance to key groups (e.g., healthcare providers, users, and policy makers).  
109 128 
Limitations  25 Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval 
of identified research, reporting bias).  
110-11 129-131 
Conclusions  26 Provide a general interpretation of the results in the context of other evidence, and implications for future 
research.  
111 131 
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